C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the localization of NFE2L2 protein" | 21443188 |
C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]" | 21443188 |
C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]" | 21443188 |
C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]" | 21443188 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]" | 24512358 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of and affects the localization of NFE2L2 protein" | 27178040 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased activity of NFE2L2 protein" | 20605904|2467509 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "[1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Cisplatin" | 20605904 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NFE2L2 protein" | 19371629 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 protein affects the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCLC mRNA]" | 19371629 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 protein affects the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of HMOX1 mRNA]" | 19371629 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 protein affects the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NQO1 mRNA]" | 19371629 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 protein affects the reaction [[Acetaminophen co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased expression of GCLC mRNA]" | 19371629 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 protein affects the reaction [[Acetaminophen co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased expression of NQO1 mRNA]" | 19371629 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 protein affects the susceptibility to 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole" | 18417483 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ABCC3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ABCC4 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of AKAP5 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of AKR1B8 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ALDH1A7 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of AMPD3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of BACH1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of BCAT2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of BEX1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CAR2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CCDC158 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CD3EAP mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CDK6 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CLCF1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CORO6 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CREG1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CRYL1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of CSMD1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of DISP1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of DUS4L mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of EGLN3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of EID3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ENTPD5 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of EPB41 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of EPHA3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of G6PDX mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCH1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCLC mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCLM mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GJB2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GNAT1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GPATCH4 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GPX2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GRHL1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GSTA3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GTF2H1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of HMGCR mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of HMOX1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of HPDL mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of HTATIP2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of IER3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of IL17RB mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of LEXM mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of MAFF mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of MAFG mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of MYC mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NCF2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NLE1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NOL8 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NOP56 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NOP58 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NQO1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NRG1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NTRK1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NUDT10 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NUDT11 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PIP4P2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PIR mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PLA2G12A mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PLA2G7 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PLK3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of POLR1E mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of POLR3G mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PPAN mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PPM1J mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PPRC1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PRSS22 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of PTGR1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of RASSF6 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ROPN1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of RPP38 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of RRS1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SAMD4 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC15A1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC1A4 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC25A37 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC35E3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC7A11 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SLC7A1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SNX10 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SPSB1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SRXN1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of SSMEM1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TEX21 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TEX36 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TFAP4 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TMEM86A mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TMPRSS2 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TNRC6A mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TRIB3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TRIM16 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TRMT61A mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TUBB3 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of TXNRD1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of UCHL1 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of UGDH mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of WDR43 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of YDJC mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ZDHHC7 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ZFAND2A mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ZFP418 mRNA]" | 27071940 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of ZFP593 mRNA]" | 27071940 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt affects the localization of NFE2L2 protein" | 22564156 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA]" | 22488045 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 protein]" | 22488045 |
C050642 | 1,2-dihydroxynaphthalene | "1,2-dihydroxynaphthalene analog results in increased activity of NFE2L2 protein" | 25807370 |
C050642 | 1,2-dihydroxynaphthalene | "Buthionine Sulfoximine promotes the reaction [1,2-dihydroxynaphthalene analog results in increased activity of NFE2L2 protein]" | 25807370 |
C050642 | 1,2-dihydroxynaphthalene | "CAT protein inhibits the reaction [1,2-dihydroxynaphthalene analog results in increased activity of NFE2L2 protein]" | 25807370 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to Acrolein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to Cadmium Chloride]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to Hydrogen Peroxide]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to linsidomine]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in increased activity of NFE2L2 protein" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] inhibits the reaction [Hydrogen Peroxide results in increased oxidation of TXN1 protein]" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] inhibits the reaction [Hydrogen Peroxide results in increased oxidation of TXN2 protein]" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Hydrogen Peroxide" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of GSTM2 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of PRDX1 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of PRDX3 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of TXN1 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of TXN2 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of TXNRD1 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of TXNRD2 mRNA" | 22495766 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased activity of CAT protein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased activity of NQO1 protein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of CAT mRNA]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of CAT protein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GCLC mRNA]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GCLC protein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GSR mRNA]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GSR protein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GSTA1 mRNA]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GSTM1 mRNA]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of NQO1 mRNA]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of NQO1 protein]" | 18367636 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in decreased expression of NFE2L2 mRNA" | 19162173 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione affects the localization of and affects the activity of NFE2L2 protein" | 15302862 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]" | 15302862 |
C040756 | 1,2-naphthoquinone | "1,2-naphthoquinone results in increased activity of NFE2L2 protein" | 21384861|2165192 |
C040756 | 1,2-naphthoquinone | "[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to 1,2-naphthoquinone" | 19303893 |
C040756 | 1,2-naphthoquinone | "NFE2L2 protein affects the susceptibility to 1,2-naphthoquinone" | 21384861 |
C040756 | 1,2-naphthoquinone | "NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to 1,2-naphthoquinone]" | 20932822 |
C576882 | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone affects the activity of NFE2L2 protein | 25596134 |
C576882 | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone results in decreased expression of NFE2L2 mRNA | 25596134 |
C033489 | 1,3-dichloro-2-propanol | "1,3-dichloro-2-propanol results in increased expression of NFE2L2 protein" | 26143167 |
C532657 | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one affects the reaction [Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein]]" | 28245986 |
C532657 | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein]" | 24015256 |
C532657 | 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one affects the reaction [[Rotenone co-treated with Bibenzyls] affects the localization of NFE2L2 protein]" | 28245986 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA]" | 23384965 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 affects the localization of and results in increased activity of NFE2L2 protein" | 21728338 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 promotes the reaction [NFE2L2 protein results in increased expression of GCLC protein]" | 21728338 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "ABCC1 protein affects the reaction [15-deoxy-delta(12,14)-prostaglandin J2 promotes the reaction [NFE2L2 protein results in increased expression of GCLC protein]]" | 21728338 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of NFE2L2 protein]" | 21728338 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "NFE2L2 protein affects the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein]" | 21728338 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "NFE2L2 protein promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HMOX1 mRNA]" | 19136476 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "NFE2L2 protein promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of MMP1 mRNA]" | 19136476 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of and affects the localization of NFE2L2 protein" | 22245093 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "manganese chloride inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of NFE2L2 protein]" | 22245093 |
C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 affects the localization of and results in increased activity of NFE2L2 protein | 18785192 |
C119129 | 18alpha-glycyrrhetinic acid | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] | 28414158 |
C119129 | 18alpha-glycyrrhetinic acid | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | 28414158 |
C011688 | 1-bromo-2,4-dinitrobenzene | "1-bromo-2,4-dinitrobenzene results in increased expression of NFE2L2 protein" | 26022718 |
C118559 | 1-bromopropane | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLC mRNA] | 20211940 |
C118559 | 1-bromopropane | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLM mRNA] | 20211940 |
C118559 | 1-bromopropane | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GSR mRNA] | 20211940 |
C118559 | 1-bromopropane | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of HMOX1 mRNA] | 20211940 |
C118559 | 1-bromopropane | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of NQO1 mRNA] | 20211940 |
C118559 | 1-bromopropane | NFE2L2 results in decreased susceptibility to 1-bromopropane | 20211940 |
C118559 | 1-bromopropane | 1-bromopropane results in decreased expression of NFE2L2 mRNA | 27452781 |
C023350 | 1-iodo-2,4-dinitrobenzene | "1-iodo-2,4-dinitrobenzene results in increased expression of NFE2L2 protein" | 19427879 |
C051246 | 1-methylanthracene | [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFE2L2 mRNA | 28329830 |
C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | 28633978 |
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NFE2L2 mRNA | 19933214 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [eupatilin affects the localization of NFE2L2 protein] | 18440740 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] | 23535287 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 23535287 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] | 24211276 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 24211276 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein] | 21971136 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] | 29136249 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 21840424 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [puag-haad results in increased phosphorylation of NFE2L2 protein] | 26102008 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] | 17433488 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 25148906 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein] | 25148906 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form] | 25148906 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 25201354 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [SB 203580 inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] | 17433488 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein | 12446695|2370760 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] | 17433488 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein] | 25773745 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] | 22056766|2433169 |
C046728 | 2,2'-azobis(2-amidinopropane) | "2,2'-azobis(2-amidinopropane) results in increased expression of NFE2L2 protein" | 23712098 |
C046728 | 2,2'-azobis(2-amidinopropane) | "[lucidone co-treated with 2,2'-azobis(2-amidinopropane)] affects the localization of and results in increased activity of NFE2L2 protein" | 23712098 |
C046728 | 2,2'-azobis(2-amidinopropane) | "lucidone promotes the reaction [2,2'-azobis(2-amidinopropane) results in increased expression of NFE2L2 protein]" | 23712098 |
C046728 | 2,2'-azobis(2-amidinopropane) | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] which results in increased expression of and results in increased activity of NFE2L2 protein" | 21130106 |
C060080 | 2,2-bis(bromomethyl)-1,3-propanediol | "2,2-bis(bromomethyl)-1,3-propanediol results in increased expression of NFE2L2 protein" | 22019925 |
C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Plant Extracts results in increased activity of NFE2L2 protein]" | 24646717 |
C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [[Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA]" | 24646717 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NFE2L2 mRNA" | 19114083 |
C014211 | 2,3,7,8-tetrachlorodibenzofuran | "2,3,7,8-tetrachlorodibenzofuran results in increased expression of NFE2L2 mRNA" | 20951181 |
C063002 | 2,3-dimethoxy-1,4-naphthoquinone | "NFE2L2 protein results in decreased susceptibility to 2,3-dimethoxy-1,4-naphthoquinone" | 20932822 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of NFE2L2 mRNA" | 21346803 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butin results in increased activity of NFE2L2 protein] | 22253095 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butin results in increased activity of NFE2L2 protein]] which results in decreased activity of SOD2 protein | 22253095 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butin results in increased activity of NFE2L2 protein]] which results in decreased expression of SOD2 | 22253095 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with tyrphostin AG 1478] inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein] | 28213291 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] | 23535287 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 23535287 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Docosahexaenoic Acids affects the localization of NFE2L2 protein] | 28807874 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | 19781563 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 21840424 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased activity of NFE2L2 protein] | 26577515|2668657 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 25148906 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein] | 25148906 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form] | 25148906 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] | 24355171 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased localization of NFE2L2 protein] | 19073151 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein | 23994249 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [caffeoylquinic acid analog results in increased localization of NFE2L2 protein] | 19647727 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Drugs, Chinese Herbal results in increased localization of NFE2L2 protein]" | 19647727 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [farrerol affects the localization of NFE2L2 protein] | 26111761 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]] | 25895139 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triterpenes analog affects the localization of NFE2L2 protein] | 25239868 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one analog inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] | 24726523 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] | 17640564 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]] | 26048653 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein] | 25773745 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of NFE2L2 protein] | 21397656 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased localization of NFE2L2 protein] | 21397656 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] | 24726523 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 20399244 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol affects the localization of NFE2L2 protein] | 20486211 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of NFE2L2 protein | 18815141 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of NFE2L2 protein | 22406437 |
C019359 | 2,5-di-tert-butylhydroquinone | "NFE2L2 gene mutant form results in increased susceptibility to 2,5-di-tert-butylhydroquinone" | 12842875 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of NFE2L2 mRNA" | 20406850 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of NFE2L2 mRNA" | 21346803 |
C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of NFE2L2 mRNA" | 20307560 |
C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in increased expression of NFE2L2 mRNA" | 20307560 |
C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in increased expression of NFE2L2 mRNA" | 20307560 |
C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of NFE2L2 mRNA" | 20307560 |
C012796 | 2-butenal | 2-butenal affects the localization of NFE2L2 protein | 21238556 |
C012796 | 2-butenal | NFE2L2 protein promotes the reaction [2-butenal results in increased expression of HMOX1 protein] | 21238556 |
C012796 | 2-butenal | NFE2L2 protein results in decreased susceptibility to 2-butenal | 21238556 |
C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] | 21333731 |
C457499 | 2-chloro-5-nitrobenzanilide | NFE2L2 protein affects the susceptibility to 2-chloro-5-nitrobenzanilide | 22851183 |
C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA] | 23954466 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide affects the localization of and results in increased activity of NFE2L2 protein" | 22746536 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide co-treated with Carbon Tetrachloride] results in increased expression of NFE2L2 protein" | 26443840 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of NFE2L2 protein" | 22746536 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "NFE2L2 gene mutant form inhibits the reaction [2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLC mRNA]" | 22746536 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "NFE2L2 gene mutant form inhibits the reaction [2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GCLM mRNA]" | 22746536 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "NFE2L2 gene mutant form inhibits the reaction [2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of GSR mRNA]" | 22746536 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "NFE2L2 gene mutant form inhibits the reaction [2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of HMOX1 mRNA]" | 22746536 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide results in increased expression of NFE2L2 protein" | 22746536 |
C530803 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl amide results in increased activity of NFE2L2 protein" | 22746536 |
C530803 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl amide results in increased expression of NFE2L2 protein" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide affects the localization of and results in increased activity of NFE2L2 protein" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of NFE2L2 protein" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "NFE2L2 gene mutant form inhibits the reaction [(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GCLC mRNA]" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "NFE2L2 gene mutant form inhibits the reaction [(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GCLM mRNA]" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "NFE2L2 gene mutant form inhibits the reaction [(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of GSR mRNA]" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "NFE2L2 gene mutant form inhibits the reaction [(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of HMOX1 mRNA]" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide results in increased expression of NFE2L2 protein" | 22746536 |
C578079 | 2-cyclohexylselenazolidine-4-carboxylic acid | 2-cyclohexylselenazolidine-4-carboxylic acid affects the localization of NFE2L2 protein | 22807314 |
C578079 | 2-cyclohexylselenazolidine-4-carboxylic acid | NFE2L2 mutant form inhibits the reaction [2-cyclohexylselenazolidine-4-carboxylic acid results in increased expression of GCLC mRNA] | 22807314 |
C578079 | 2-cyclohexylselenazolidine-4-carboxylic acid | NFE2L2 mutant form inhibits the reaction [2-cyclohexylselenazolidine-4-carboxylic acid results in increased expression of NQO1 mRNA] | 22807314 |
C578079 | 2-cyclohexylselenazolidine-4-carboxylic acid | NFE2L2 mutant form inhibits the reaction [2-cyclohexylselenazolidine-4-carboxylic acid results in increased expression of TXNRD1 mRNA] | 22807314 |
C087939 | 2''-galloylhyperin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein] | 28213291 |
C087939 | 2''-galloylhyperin | 2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein | 28213291 |
C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Smoke results in increased expression of NFE2L2 mRNA] | 23069111 |
C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Smoke results in increased expression of NFE2L2 protein] | 23069111 |
C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] | 23196670 |
C098340 | 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose | "NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]" | 22917016 |
C022960 | 2-oxindole | 2-oxindole results in decreased ubiquitination of and results in decreased degradation of NFE2L2 protein | 22245129 |
C022960 | 2-oxindole | 2-oxindole results in increased activity of and results in increased expression of and results in increased stability of NFE2L2 protein | 22245129 |
C022960 | 2-oxindole | [2-oxindole results in decreased activity of KEAP1 protein] which results in decreased ubiquitination of NFE2L2 protein | 22245129 |
C552929 | 2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene | "2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene affects the localization of NFE2L2 protein" | 20800667 |
C552929 | 2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene | "2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased expression of NFE2L2 protein" | 20800667 |
C552929 | 2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene | "Glutathione inhibits the reaction [2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased expression of NFE2L2 protein]" | 20800667 |
C051290 | 2-tert-butyl-4-quinone | 2-tert-butyl-4-quinone affects the localization of NFE2L2 protein | 28645578 |
C051290 | 2-tert-butyl-4-quinone | 2-tert-butyl-4-quinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C018855 | 2-tert-butylhydroquinone | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]]" | 21443188 |
C018855 | 2-tert-butylhydroquinone | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]]" | 21443188 |
C018855 | 2-tert-butylhydroquinone | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein]" | 21443188 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone affects the localization of and results in increased activity of NFE2L2 protein | 21443188|2394549 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone affects the localization of NFE2L2 protein | 25003661|2864557 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein] | 21443188 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 21443188 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 22275372 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein | 19715681|2274653 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased susceptibility to arsenite | 22476201 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of and affects the localization of NFE2L2 protein | 21464371 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein | 23589329|2568028 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein | 12446695|1609293 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine | 16092930 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein | 23707609 |
C018855 | 2-tert-butylhydroquinone | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] | 21443188 |
C018855 | 2-tert-butylhydroquinone | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21443188 |
C018855 | 2-tert-butylhydroquinone | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] | 21443188 |
C018855 | 2-tert-butylhydroquinone | ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] | 28645578 |
C018855 | 2-tert-butylhydroquinone | KEAP1 protein mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
C018855 | 2-tert-butylhydroquinone | KEAP1 protein promotes the reaction [2-tert-butylhydroquinone results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
C018855 | 2-tert-butylhydroquinone | Metformin inhibits the reaction [2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein] | 23707609 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | 21464371 |
C018855 | 2-tert-butylhydroquinone | "NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]" | 25680285 |
C018855 | 2-tert-butylhydroquinone | "NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]" | 25680285 |
C018855 | 2-tert-butylhydroquinone | "NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]]" | 25680285 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of EPHX1 exon] | 24704207 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA] | 10874044 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | 24704207 |
C018855 | 2-tert-butylhydroquinone | "NFE2L2 mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 mRNA]" | 25680285 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of CES1 mRNA alternative form] | 19715681 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein mutant form results in increased susceptibility to 2-tert-butylhydroquinone | 23589329 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone binds to NFE2L2 protein | 19786557 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein] | 22983789 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to BCL2 promoter] | 22275372 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 18512965 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 18512965 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein | 22250088|2394549 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased activity of TBX21 protein | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased expression of and results in decreased secretion of IFNG protein | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased expression of IFNG mRNA | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased activity of GATA3 protein | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL13 protein | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL4 protein | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of and results in increased secretion of IL5 protein | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of IL13 mRNA | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of IL4 mRNA | 22250088 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 22250088 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of and affects the localization of NFE2L2 protein | 18512965 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of NFE2L2 mRNA | 19183254|2225008 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein | 23906629 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased stability of NFE2L2 protein | 22275372 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in decreased expression of BAX protein | 22275372 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in increased expression of BCL2 protein | 22275372 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein | 18512965 |
C018855 | 2-tert-butylhydroquinone | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 2-tert-butylhydroquinone] results in increased expression of NFE2L2 protein | 14510636 |
C018855 | 2-tert-butylhydroquinone | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein] | 18512965 |
C018855 | 2-tert-butylhydroquinone | Cadmium Chloride inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]] | 18512965 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of BCL2 mRNA] | 22275372 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | 22275372 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLC mRNA] | 19328227 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of GCLM mRNA] | 19328227 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA] | 10473555 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] | 14998373|1927607 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein affects the susceptibility to 2-tert-butylhydroquinone | 22250088 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] | 23942037 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
C018855 | 2-tert-butylhydroquinone | NFE2L2 protein results in decreased susceptibility to 2-tert-butylhydroquinone | 20932822 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone affects the localization of and results in increased activity of NFE2L2 protein | 15870285 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone affects the localization of NFE2L2 protein | 17676812|2055401 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 mRNA] | 28583816 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 protein] | 28583816 |
C018855 | 2-tert-butylhydroquinone | "2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in decreased expression of NFE2L2 protein]" | 28844481 |
C018855 | 2-tert-butylhydroquinone | [2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA]] which results in decreased susceptibility to Magnesium Chloride | 21107535 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein | 18852027 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein | 17676812|2274653 |
C018855 | 2-tert-butylhydroquinone | decamethrin inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] | 17676812 |
C018855 | 2-tert-butylhydroquinone | N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased localization of NFE2L2 protein] | 15319326 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 21107535 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [[[NFE2L2 protein binds to MAF protein] which binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 15832810 |
C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein | 22476201 |
C561055 | 2-trifluoromethyl-2'-methoxychalone | 2-trifluoromethyl-2'-methoxychalone results in increased expression of NFE2L2 mRNA | 21539383 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene results in increased expression of and results in increased activity of NFE2L2 protein" | 25815690 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "NFE2L2 protein affects the reaction [3,3',4,5'-tetrahydroxystilbene results in increased expression of and results in increased activity of HMOX1 protein]" | 25815690 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene results in increased activity of NFE2L2 protein" | 23712764 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "[3,3',4,5'-tetrahydroxystilbene results in increased activity of NFE2L2 protein] which results in increased activity of HMOX1 protein" | 23712764 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "[3,3',4,5'-tetrahydroxystilbene results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein" | 23712764 |
C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA" | 23583297 |
C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of NFE2L2 protein" | 23583297 |
C016392 | 3,3'-diindolylmethane | "sulforafan promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA]" | 23583297 |
C016392 | 3,3'-diindolylmethane | "sulforafan promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 protein]" | 23583297 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[resveratrol co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased expression of NFE2L2 mRNA" | 24231106 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NFE2L2 mRNA" | 24378064|2677088 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NFE2L2 mRNA" | 23196670 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 22521609 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA]" | 22521609 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]" | 22521609 |
C014464 | 3,4-dichloroaniline | "3,4-dichloroaniline results in increased expression of NFE2L2 mRNA" | 17292976 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | "[3-(4-methylphenylsulfonyl)-2-propenenitrile co-treated with lipopolysaccharide, E. coli O26-B6] results in increased expression of NFE2L2 mRNA" | 22942241 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [NFE2L2 protein results in increased expression of AKR1B1 mRNA] | 18588981 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [NFE2L2 protein results in increased expression of AKR1B1 protein] | 18588981 |
C050224 | 3,5,5-trimethylhexanoylferrocene | "3,5,5-trimethylhexanoylferrocene results in increased expression of and affects the localization of NFE2L2 protein" | 22649188 |
C511179 | 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine | "3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]" | 24512358 |
C093027 | 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone | "3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone affects the localization of NFE2L2 protein" | 19961840 |
C093027 | 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone | "KEAP1 protein inhibits the reaction [3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone affects the localization of NFE2L2 protein]" | 19961840 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid affects the localization of and results in increased activity of NFE2L2 protein | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM protein | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 protein | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | pyrazolanthrone inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] | 23535287 |
C549543 | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | pyrazolanthrone inhibits the reaction [[3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 23535287 |
C047368 | 3-methylquercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] | 24211276 |
C047368 | 3-methylquercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased abundance of Glutathione | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of SESN2 mRNA | 24211276 |
C047368 | 3-methylquercetin | 3-methylquercetin affects the localization of and results in increased phosphorylation of and results in increased activity of NFE2L2 protein | 24211276 |
C047368 | 3-methylquercetin | 3-methylquercetin affects the localization of NFE2L2 protein | 27151496 |
C047368 | 3-methylquercetin | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein]" | 24211276 |
C047368 | 3-methylquercetin | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein]" | 24211276 |
C047368 | 3-methylquercetin | NFE2L2 protein affects the reaction [3-methylquercetin inhibits the reaction [TGFB1 protein results in increased expression of SERPINE1 mRNA]] | 27151496 |
C047368 | 3-methylquercetin | NFE2L2 protein affects the reaction [3-methylquercetin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]] | 27151496 |
C047368 | 3-methylquercetin | NFE2L2 protein affects the susceptibility to 3-methylquercetin | 24211276 |
C047368 | 3-methylquercetin | rottlerin inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] | 24211276 |
C047368 | 3-methylquercetin | rottlerin inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 24211276 |
C047368 | 3-methylquercetin | 3-methylquercetin results in increased activity of NFE2L2 protein | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 24211276 |
C047368 | 3-methylquercetin | [3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein | 24211276 |
C047368 | 3-methylquercetin | NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide] | 24211276 |
C047368 | 3-methylquercetin | NFE2L2 protein affects the susceptibility to 3-methylquercetin | 24211276 |
C527796 | 3-morpholinopropyl isothiocyanate | 3-morpholinopropyl isothiocyanate results in increased expression of NFE2L2 protein | 20498004 |
C033643 | 3-nitrofluoranthene | 3-nitrofluoranthene results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | 28633978 |
C015392 | 3-nitropropionic acid | [naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein | 22871521 |
C490257 | 3-O-caffeoyl-1-methylquinic acid | 3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein | 16631525 |
C490257 | 3-O-caffeoyl-1-methylquinic acid | Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] | 16631525 |
C490257 | 3-O-caffeoyl-1-methylquinic acid | Glutathione inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] | 16631525 |
C490257 | 3-O-caffeoyl-1-methylquinic acid | pyrazolanthrone inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] | 16631525 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one affects the localization of NFE2L2 protein | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of NFE2L2 mRNA | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased activity of NQO1 protein] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of FTH1 mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of G6PD mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of GCLC mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of GCLM mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of GSR mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of HMOX1 mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of HMOX1 protein] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of NQO1 mRNA] | 28790194 |
C000623021 | 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one | NFE2L2 protein affects the reaction [3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of PGD mRNA] | 28790194 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of NFE2L2 mRNA" | 18648102 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 25148906 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein] | 25148906 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form] | 25148906 |
C580935 | 4-((4-hydroxyphenylimino)methyl)benzene-1,2-diol | "4-((4-hydroxyphenylimino)methyl)benzene-1,2-diol results in increased expression of NFE2L2 mRNA" | 28960787 |
C580935 | 4-((4-hydroxyphenylimino)methyl)benzene-1,2-diol | "4-((4-hydroxyphenylimino)methyl)benzene-1,2-diol results in increased expression of NFE2L2 protein" | 28960787 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of NFE2L2 mRNA" | 27188386 |
C113276 | 4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein | "4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein binds to and results in increased activity of NFE2L2 protein" | 19786557 |
C006757 | 4-biphenylamine | 4-biphenylamine results in increased expression of and affects the localization of NFE2L2 protein | 25601990 |
C117304 | 4'-bromoflavone | 4'-bromoflavone affects the localization of NFE2L2 protein | 23035985 |
C000619336 | 4-(E)-((p-tolylimino)-methylbenzene-1,2-diol) | "4-(E)-((p-tolylimino)-methylbenzene-1,2-diol) results in increased expression of NFE2L2 mRNA" | 28960787 |
C000619336 | 4-(E)-((p-tolylimino)-methylbenzene-1,2-diol) | "4-(E)-((p-tolylimino)-methylbenzene-1,2-diol) results in increased expression of NFE2L2 protein" | 28960787 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal affects the localization of NFE2L2 protein | 29108775 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal affects the localization of and results in increased activity of NFE2L2 protein | 24423726 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein | 16322078 |
C027576 | 4-hydroxy-2-nonenal | [GSTA4 protein mutant form results in decreased glutathionylation of 4-hydroxy-2-nonenal] which results in increased activity of NFE2L2 protein | 19880816 |
C027576 | 4-hydroxy-2-nonenal | NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA] | 24423726 |
C027576 | 4-hydroxy-2-nonenal | NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein] | 24423726 |
C027576 | 4-hydroxy-2-nonenal | NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal | 24423726 |
C027576 | 4-hydroxy-2-nonenal | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal] | 24633890 |
C027576 | 4-hydroxy-2-nonenal | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein] | 16322078 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of NFE2L2 protein | 24291486 |
C027576 | 4-hydroxy-2-nonenal | NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA] | 24291486 |
C027576 | 4-hydroxy-2-nonenal | NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA] | 24291486 |
C031364 | 4-hydroxybenzyl isothiocyanate | 4-hydroxybenzyl isothiocyanate results in increased expression of NFE2L2 protein | 22664424 |
C026418 | 4-hydroxyestrone | 4-hydroxyestrone results in decreased expression of NFE2L2 mRNA | 25231996 |
C026418 | 4-hydroxyestrone | NFE2L2 protein results in decreased susceptibility to 4-hydroxyestrone | 25231996 |
C447639 | 4-(methylthio)-3-butenyl isothiocyanate | 4-(methylthio)-3-butenyl isothiocyanate results in increased expression of NFE2L2 protein | 29155359 |
C447639 | 4-(methylthio)-3-butenyl isothiocyanate | Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of NFE2L2 protein] | 29155359 |
C447639 | 4-(methylthio)-3-butenyl isothiocyanate | 4-(methylthio)-3-butenyl isothiocyanate results in increased expression of NFE2L2 protein | 22664424 |
C029915 | 4-nitrobenzaldehyde | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to 4-nitrobenzaldehyde] | 20932822 |
C114459 | 4-phenyl-2-propionamidotetraline | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] | 25550330 |
C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] | 20399799 |
C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 protein] | 20399799 |
C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased expression of NFE2L2 protein | 19033392 |
C029728 | 4-phenylenediamine | NFE2L2 mRNA promotes the reaction [4-phenylenediamine results in increased expression of HMOX1 mRNA] | 26244607 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione affects the localization of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione promotes the reaction [NFE2L2 protein binds to KEAP1 protein]" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in decreased phosphorylation of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of and results in decreased degradation of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of NFE2L2 protein" | 19121294 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione affects the localization of and results in increased activity of NFE2L2 protein" | 19121294 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione affects the localization of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione promotes the reaction [NFE2L2 protein binds to KEAP1 protein]" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in decreased phosphorylation of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of and results in decreased degradation of NFE2L2 protein" | 22558124 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of NFE2L2 protein" | 19121294 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "NFE2L2 protein affects the susceptibility to 5,6-dihydrocyclopenta-1,2-dithiole-3-thione" | 19121294 |
C522589 | 5,6-dihydrocyclopenta-1,2-dithiole-3-thione | "5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased activity of and results in decreased ubiquitination of NFE2L2 protein" | 22558124 |
C521815 | 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone | "5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone affects the localization of and results in increased activity of NFE2L2 protein" | 23542513 |
C521815 | 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone | "NFE2L2 protein promotes the reaction [5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone results in increased expression of HMOX1 mRNA]" | 23542513 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein]" | 24211276 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein]" | 24211276 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein]" | 26634892 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]" | 24355171 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of NFE2L2 mRNA" | 27188386 |
C560597 | 6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein]" | 21573189 |
C560597 | 6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide inhibits the reaction [methoxyacetic acid results in decreased expression of NFE2L2 protein]" | 21573189 |
C560597 | 6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide results in increased expression of NFE2L2 protein" | 21573189 |
C111855 | 6-formylindolo(3,2-b)carbazole | "NFE2L2 promotes the reaction [sodium arsenite promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]]" | 26535918 |
C111855 | 6-formylindolo(3,2-b)carbazole | "6-formylindolo(3,2-b)carbazole results in increased expression of NFE2L2 mRNA" | 27709270 |
C111984 | 6-methylsulfinylhexyl isothiocyanate | 6-methylsulfinylhexyl isothiocyanate results in increased expression of NFE2L2 protein | 21382770 |
C111984 | 6-methylsulfinylhexyl isothiocyanate | NFE2L2 results in increased susceptibility to 6-methylsulfinylhexyl isothiocyanate | 21382770 |
C111984 | 6-methylsulfinylhexyl isothiocyanate | 6-methylsulfinylhexyl isothiocyanate results in increased localization of and results in increased activity of NFE2L2 protein | 11706044 |
C031477 | 7-hydroxycoumarin | 7-hydroxycoumarin results in increased expression of and affects the localization of NFE2L2 protein | 28263721 |
C031477 | 7-hydroxycoumarin | 7-hydroxycoumarin results in increased expression of NFE2L2 mRNA | 28263721 |
C579811 | 7-O-galloyltaxifolin | 7-O-galloyltaxifolin affects the localization of NFE2L2 protein | 23294286 |
C015929 | 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP | "8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased expression of NFE2L2 mRNA" | 27160211 |
C005399 | 9,10-phenanthrenequinone | "9,10-phenanthrenequinone affects the localization of NFE2L2 protein" | 29108775 |
C040810 | 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 | "NFE2L2 protein affects the reaction [9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 analog results in increased expression of GDNF mRNA]" | 22982731 |
C037112 | 9-deoxy-delta-9-prostaglandin D2 | [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] results in increased activity of NFE2L2 protein | 15150131 |
C496492 | abrine | abrine results in increased expression of NFE2L2 mRNA | 22595364 |
D000082 | Acetaminophen | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] | 29136249 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of NFE2L2 | 24631341 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of NFE2L2 mRNA | 26739624 |
D000082 | Acetaminophen | [Chlorogenic Acid co-treated with Acetaminophen] results in increased activity of and affects the localization of NFE2L2 protein | 29136249 |
D000082 | Acetaminophen | [Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein | 29136249 |
D000082 | Acetaminophen | NFE2L2 protein affects the susceptibility to Acetaminophen | 21540358 |
D000082 | Acetaminophen | U 0126 inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] | 29136249 |
D000082 | Acetaminophen | ABCC3 protein affects the reaction [NFE2L2 protein affects the glucuronidation of Acetaminophen] | 19246624 |
D000082 | Acetaminophen | Acetaminophen affects the expression of NFE2L2 mRNA | 17562736 |
D000082 | Acetaminophen | Acetaminophen affects the localization of NFE2L2 protein | 17935745 |
D000082 | Acetaminophen | Acetaminophen results in increased activity of and results in increased localization of NFE2L2 protein | 15122755 |
D000082 | Acetaminophen | [Acetaminophen results in increased activity of and results in increased localization of NFE2L2 protein] which results in increased expression of EPHX1 mRNA | 15122755 |
D000082 | Acetaminophen | [Acetaminophen results in increased activity of and results in increased localization of NFE2L2 protein] which results in increased expression of GCLC mRNA | 15122755 |
D000082 | Acetaminophen | [Acetaminophen results in increased activity of and results in increased localization of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 15122755 |
D000082 | Acetaminophen | Acetaminophen results in increased activity of NFE2L2 protein | 17002867 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of NFE2L2 mRNA | 11287661 |
D000082 | Acetaminophen | Acetaminophen results in increased localization of NFE2L2 protein | 18078705 |
D000082 | Acetaminophen | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] | 22491424 |
D000082 | Acetaminophen | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] which affects the susceptibility to Acetaminophen | 22491424 |
D000082 | Acetaminophen | [Chlorogenic Acid co-treated with Acetaminophen] affects the localization of and results in increased activity of NFE2L2 protein | 29136249 |
D000082 | Acetaminophen | [IL4 gene mutant form results in increased susceptibility to Acetaminophen] which affects the activity of NFE2L2 protein | 22107450 |
D000082 | Acetaminophen | NFE2L2 gene mutant form results in increased susceptibility to Acetaminophen | 17935745|2549971 |
D000082 | Acetaminophen | NFE2L2 mutant form promotes the reaction [Acetaminophen results in increased expression of FMO3 mRNA] | 25193093 |
D000082 | Acetaminophen | NFE2L2 mutant form promotes the reaction [Acetaminophen results in increased expression of FMO3 protein] | 25193093 |
D000082 | Acetaminophen | [NFE2L2 protein affects the expression of UGT1A6 mRNA] which affects the susceptibility to Acetaminophen | 11134556 |
D000082 | Acetaminophen | NFE2L2 protein affects the glucuronidation of Acetaminophen | 19246624 |
D000082 | Acetaminophen | NFE2L2 protein affects the glutathionylation of Acetaminophen | 19246624 |
D000082 | Acetaminophen | "NFE2L2 protein affects the reaction [[Acetaminophen co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased expression of GCLC mRNA]" | 19371629 |
D000082 | Acetaminophen | "NFE2L2 protein affects the reaction [[Acetaminophen co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased expression of NQO1 mRNA]" | 19371629 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of ABCC3 mRNA] | 17935745 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of ABCC3 protein] | 17935745 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of ABCC4 mRNA] | 17935745 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of ABCC4 protein] | 17935745 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of GCLC mRNA] | 17935745|1937162 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of GCLC protein] | 17935745 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of HMOX1 mRNA] | 19371629 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of NQO1 mRNA] | 17935745|1937162 |
D000082 | Acetaminophen | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of NQO1 protein] | 17935745 |
D000082 | Acetaminophen | NFE2L2 protein affects the sulfation of Acetaminophen | 19246624 |
D000082 | Acetaminophen | NFE2L2 protein affects the susceptibility to Acetaminophen | 19371629 |
D000082 | Acetaminophen | NFE2L2 protein results in decreased susceptibility to Acetaminophen | 11134556|1128766 |
D000082 | Acetaminophen | NFE2L2 results in decreased susceptibility to Acetaminophen | 20404090|2305618 |
D000082 | Acetaminophen | Acetaminophen affects the expression of NFE2L2 mRNA | 16701773 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of and affects the localization of NFE2L2 protein | 26767949 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of NFE2L2 mRNA | 17202758 |
D000082 | Acetaminophen | Acetaminophen results in increased ubiquitination of and results in decreased expression of NFE2L2 protein | 26767949 |
D000082 | Acetaminophen | morin inhibits the reaction [Acetaminophen results in decreased expression of and affects the localization of NFE2L2 protein] | 26767949 |
D000082 | Acetaminophen | morin inhibits the reaction [Acetaminophen results in increased ubiquitination of and results in decreased expression of NFE2L2 protein] | 26767949 |
C056165 | acetovanillone | [acetovanillone co-treated with AGT protein] results in increased expression of and affects the localization of NFE2L2 protein | 27983965 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] | 24291008 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
C099158 | acetyl-aspartyl-glutamyl-valyl-aspartal | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein] | 22964297 |
D000111 | Acetylcysteine | Acetylcysteine affects the localization of NFE2L2 protein | 22564156 |
D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of NFE2L2 protein]" | 21728338 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] | 16631525 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [4-(methylthio)-3-butenyl isothiocyanate results in increased expression of NFE2L2 protein] | 29155359 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of NFE2L2 protein] | 19350554|2500366 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NFE2L2 protein] | 21787718 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein] | 17979524 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] | 24489685 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA] | 25263748 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein] | 25263748 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFE2L2 protein] | 19033392 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Docosahexaenoic Acids affects the localization of NFE2L2 protein] | 28807874 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]] | 26163453 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of and affects the localization of NFE2L2 protein] | 26163453 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of NFE2L2 promoter] | 21643505 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 18156441 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] | 11909699 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Indomethacin results in increased localization of NFE2L2 protein] | 11909699 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 17959236 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein] | 17959236 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein] | 27917510 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]] | 22546375 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the susceptibility to Silver] | 22546375 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of NFE2L2 protein] | 16806455 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] | 20851755 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein] | 24361488 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Silver analog results in increased expression of NFE2L2 mRNA] | 24126012 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 16959797|2629127 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]] | 26291278 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein] | 19234301 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [sulforafan affects the localization of NFE2L2 protein] | 22019695 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] | 24355171 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NFE2L2 protein] | 25568320 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein] | 24157283 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Particulate Matter analog affects the localization of NFE2L2 protein] | 15322212 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Vehicle Emissions analog affects the localization of NFE2L2 protein] | 15322212 |
D000111 | Acetylcysteine | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21384399 |
D000111 | Acetylcysteine | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein] | 21384399 |
D000111 | Acetylcysteine | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein] | 21384399 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of and affects the localization of NFE2L2 protein] | 24634002 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [decamethrin affects the localization of NFE2L2 protein] | 17540521 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [decamethrin results in increased activity of NFE2L2 protein] | 17540521 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [decamethrin results in increased expression of NFE2L2 protein] | 17540521 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [ferrous sulfate affects the localization of NFE2L2 protein] | 28583816 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA] | 22129741 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein] | 26079211 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [triptolide affects the expression of NFE2L2 protein] | 25169008 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [zinc protoporphyrin results in increased expression of NFE2L2 protein] | 19735445 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000171 | Acrolein | Acrolein affects the localization of NFE2L2 protein | 16480751 |
D000171 | Acrolein | Acrolein affects the localization of NFE2L2 protein | 12084617|1804880 |
D000171 | Acrolein | Acrolein results in decreased expression of NFE2L2 protein | 17197552|1825820 |
D000171 | Acrolein | Acrolein results in increased activity of NFE2L2 protein | 12084617 |
D000171 | Acrolein | Acrolein results in increased expression of NFE2L2 protein | 28109747 |
D000171 | Acrolein | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein] | 19608619 |
D000171 | Acrolein | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein | 19608619 |
D000171 | Acrolein | lipoamide inhibits the reaction [Acrolein results in decreased expression of NFE2L2 protein] | 18258206 |
D000171 | Acrolein | NFE2L2 gene mutant form results in increased susceptibility to Acrolein | 19608619 |
D000171 | Acrolein | NFE2L2 protein affects the reaction [Curcumin analog results in decreased susceptibility to Acrolein] | 23954767 |
D000171 | Acrolein | NFE2L2 protein affects the reaction [Curcumin results in decreased susceptibility to Acrolein] | 23954767 |
D000171 | Acrolein | NFE2L2 protein promotes the reaction [Acrolein results in increased expression of HMOX1 mRNA] | 18048804 |
D000171 | Acrolein | PRKCD protein promotes the reaction [Acrolein affects the localization of NFE2L2 protein] | 18048804 |
D000171 | Acrolein | rottlerin inhibits the reaction [Acrolein affects the localization of NFE2L2 protein] | 18048804 |
D000171 | Acrolein | Thioctic Acid inhibits the reaction [Acrolein results in decreased expression of NFE2L2 protein] | 17197552|1825820 |
D000171 | Acrolein | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to Acrolein]" | 18367636 |
D000171 | Acrolein | Acrolein affects the localization of NFE2L2 protein | 12763045 |
D000171 | Acrolein | Acrolein results in increased expression of NFE2L2 protein | 28482051 |
D000171 | Acrolein | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Acrolein] | 19303893 |
D000171 | Acrolein | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Acrolein]] | 20932822 |
D000171 | Acrolein | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Acrolein | 19303893 |
D000171 | Acrolein | NFE2L2 gene mutant form results in increased susceptibility to Acrolein | 27633142 |
D000171 | Acrolein | NFE2L2 protein affects the reaction [[cafestol co-treated with kahweol] results in decreased susceptibility to Acrolein] | 18028974 |
D000171 | Acrolein | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Acrolein] | 20932822 |
D000171 | Acrolein | NFE2L2 results in decreased susceptibility to Acrolein | 18367636 |
D000171 | Acrolein | Acrolein affects the localization of NFE2L2 protein | 25145656 |
D020106 | Acrylamide | Acrylamide results in decreased expression of NFE2L2 mRNA | 28159594 |
D020106 | Acrylamide | Acrylamide results in decreased expression of NFE2L2 protein | 28159594 |
D020106 | Acrylamide | salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 mRNA] | 28159594 |
D020106 | Acrylamide | salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein] | 28159594 |
D020106 | Acrylamide | Acrylamide affects the localization of NFE2L2 protein | 28526328 |
D020106 | Acrylamide | Acrylamide results in increased expression of NFE2L2 protein | 27836571 |
D020106 | Acrylamide | Acrylamide results in decreased expression of NFE2L2 mRNA | 28959563 |
D012436 | S-Adenosylmethionine | S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein] | 20146260 |
D012436 | S-Adenosylmethionine | S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]] | 20146260 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of NFE2L2 gene | 27153756 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of NFE2L2 protein | 25154877 |
D016604 | Aflatoxin B1 | Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] | 25154877 |
D016604 | Aflatoxin B1 | NFE2L2 gene mutant form results in increased susceptibility to Aflatoxin B1 | 27071940 |
D000393 | Air Pollutants | Air Pollutants results in increased expression of NFE2L2 protein | 23649983 |
D000393 | Air Pollutants | Glutathione inhibits the reaction [Air Pollutants results in increased expression of NFE2L2 protein] | 23649983 |
D000393 | Air Pollutants | Air Pollutants results in increased expression of NFE2L2 mRNA | 18367723 |
D000393 | Air Pollutants | Air Pollutants results in increased expression of and affects the localization of NFE2L2 protein | 28389379 |
D000393 | Air Pollutants | Air Pollutants results in increased expression of NFE2L2 mRNA | 28389379 |
C000188 | alachlor | alachlor results in increased activity of NFE2L2 protein | 20143881 |
D000450 | Aldosterone | Aldosterone results in increased activity of NFE2L2 protein | 25204689 |
D000450 | Aldosterone | Spironolactone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 25204689 |
D000450 | Aldosterone | tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 25204689 |
D000450 | Aldosterone | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]" | 24512358 |
D000450 | Aldosterone | "3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]" | 24512358 |
D000450 | Aldosterone | acetovanillone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | Acetylcysteine inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | Aldosterone results in increased expression of and results in increased activity of NFE2L2 protein | 24512358 |
D000450 | Aldosterone | diphenyleneiodonium inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | eplerenone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | Ro 32-0432 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | Thioctic Acid inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D000450 | Aldosterone | W 7 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
C526957 | alisol B 23-acetate | alisol B 23-acetate inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | 28578904 |
C103303 | alitretinoin | [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] results in increased activity of NFE2L2 protein | 15150131 |
C006452 | allicin | allicin inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein] | 27561292 |
C004471 | allyl isothiocyanate | allyl isothiocyanate results in increased activity of NFE2L2 protein | 24036144 |
C004471 | allyl isothiocyanate | NFE2L2 protein affects the reaction [allyl isothiocyanate results in increased expression of GCLC mRNA] | 24036144 |
C004471 | allyl isothiocyanate | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to allyl isothiocyanate] | 20932822 |
C004471 | allyl isothiocyanate | allyl isothiocyanate results in increased expression of NFE2L2 protein | 22664424 |
C038491 | allyl sulfide | NFE2L2 protein promotes the reaction [allyl sulfide results in increased expression of NQO1 mRNA] | 17353348 |
C571662 | alpha-iso-cubebenol | alpha-iso-cubebenol affects the localization of NFE2L2 protein | 24997245 |
C571662 | alpha-iso-cubebenol | alpha-iso-cubebenol results in increased expression of NFE2L2 mRNA | 24997245 |
D017962 | alpha-Linolenic Acid | NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of CYP2A6 mRNA] | 28555106 |
D017962 | alpha-Linolenic Acid | NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of CYP2A6 protein] | 28555106 |
D017962 | alpha-Linolenic Acid | NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of GSTA1 mRNA] | 28555106 |
C011512 | alpha-naphthoflavone | NFE2L2 protein affects the susceptibility to [beta-Naphthoflavone co-treated with alpha-naphthoflavone] | 19233942 |
D024502 | alpha-Tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | 22389237 |
C064176 | alpha-viniferin | alpha-viniferin results in increased expression of and results in increased activity of NFE2L2 protein | 24859013 |
C064176 | alpha-viniferin | NFE2L2 protein affects the reaction [alpha-viniferin results in increased expression of HMOX1 mRNA] | 24859013 |
C064176 | alpha-viniferin | NFE2L2 protein affects the susceptibility to alpha-viniferin | 24859013 |
C064176 | alpha-viniferin | [NFE2L2 protein results in increased expression of HMOX1] affects the reaction [alpha-viniferin results in decreased susceptibility to Lipopolysaccharides] | 24859013 |
C005197 | alternariol | alternariol affects the localization of NFE2L2 protein | 23154127 |
C018206 | alternariol monomethyl ether | alternariol monomethyl ether affects the localization of NFE2L2 protein | 23154127 |
C050234 | altertoxin II | altertoxin II results in decreased expression of NFE2L2 mRNA | 27178040 |
C050234 | altertoxin II | altertoxin II results in increased expression of and affects the localization of NFE2L2 protein | 27178040 |
C067527 | aluminum maltolate | aluminum maltolate results in decreased expression of NFE2L2 protein | 24878590 |
D000577 | Amides | Amides affects the localization of NFE2L2 protein | 23063670 |
D000577 | Amides | Amides results in increased activity of NFE2L2 protein | 23063670 |
D000577 | Amides | Amides results in increased expression of NFE2L2 mRNA | 23063670 |
D000577 | Amides | Amides results in increased expression of NFE2L2 protein | 23063670 |
D000622 | Aminolevulinic Acid | NFE2L2 gene mutant form inhibits the reaction [Aminolevulinic Acid results in increased expression of CYP2A5 mRNA] | 22859313 |
D000622 | Aminolevulinic Acid | NFE2L2 gene mutant form promotes the reaction [Aminolevulinic Acid results in increased expression of HMOX1 mRNA] | 22859313 |
D006710 | Homocysteine | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] | 22964297 |
D006710 | Homocysteine | Homocysteine affects the localization of NFE2L2 protein modified form | 22964297 |
D006710 | Homocysteine | Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein | 22964297 |
D006710 | Homocysteine | Homocysteine results in increased expression of NFE2L2 mRNA | 22964297 |
D006710 | Homocysteine | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein] | 22964297 |
D006710 | Homocysteine | Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein | 22964297 |
D006710 | Homocysteine | L 709049 inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein] | 22964297 |
D006710 | Homocysteine | N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] | 22964297 |
D019804 | Mesalamine | [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased activity of NFE2L2 protein | 27818126 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NFE2L2 mRNA | 16483693 |
C101036 | ammonium metavanadate | ammonium metavanadate affects the reaction [sulforafan affects the localization of NFE2L2 mRNA] | 20599494 |
C101036 | ammonium metavanadate | ammonium metavanadate affects the reaction [Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA] | 20599494 |
C088115 | anacardic acid | anacardic acid inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein] | 29054681 |
C088115 | anacardic acid | anacardic acid results in increased expression of NFE2L2 mRNA | 29054681 |
C088115 | anacardic acid | [anacardic acid results in increased susceptibility to manganese chloride] which results in increased expression of NFE2L2 mRNA | 29054681 |
C088115 | anacardic acid | manganese chloride promotes the reaction [anacardic acid results in increased expression of NFE2L2 mRNA] | 29054681 |
C030419 | andrographolide | NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]] | 27297870 |
C030419 | andrographolide | andrographolide results in increased activity of NFE2L2 protein | 25110055 |
C044613 | angelicae sinensis extract | angelicae sinensis extract results in decreased methylation of NFE2L2 promoter | 23441843 |
C019257 | angelica lactone | angelica lactone affects the activity of NFE2L2 protein | 11309284 |
D000970 | Antineoplastic Agents | NFE2L2 protein affects the susceptibility to Antineoplastic Agents | 20124447 |
D000975 | Antioxidants | NFE2L2 gene mutant form results in decreased abundance of Antioxidants | 27633142 |
D047310 | Apigenin | Apigenin affects the localization of and results in increased activity of NFE2L2 protein | 22864849 |
C015000 | arecaidine esters | NFE2L2 protein affects the susceptibility to arecaidine esters | 22851183 |
C000228 | aristolochic acid I | aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein | 24530882 |
C000228 | aristolochic acid I | aristolochic acid I results in decreased expression of NFE2L2 mRNA | 24530882 |
C000228 | aristolochic acid I | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein]" | 24530882 |
C000228 | aristolochic acid I | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [aristolochic acid I results in decreased expression of NFE2L2 mRNA]" | 24530882 |
D001151 | Arsenic | [Arsenic results in increased abundance of Hydrogen Peroxide] which results in increased expression of and results in increased localization of NFE2L2 protein | 14567983 |
D001151 | Arsenic | [Arsenic results in increased abundance of Hydrogen Peroxide] which results in increased expression of NFE2L2 mRNA | 14567983 |
D001151 | Arsenic | Arsenic results in increased expression of NFE2L2 protein | 26385919 |
D001151 | Arsenic | CAT protein inhibits the reaction [Arsenic results in increased expression of NFE2L2 protein] | 26385919 |
D001151 | Arsenic | NFE2L2 mutant form inhibits the reaction [Arsenic results in increased expression of SQSTM1 protein] | 26385919 |
D001151 | Arsenic | NFE2L2 mutant form promotes the reaction [Arsenic results in decreased expression of BCL2L1 protein] | 26385919 |
D001151 | Arsenic | NFE2L2 mutant form promotes the reaction [Arsenic results in decreased expression of BCL2 protein] | 26385919 |
D001151 | Arsenic | NFE2L2 mutant form promotes the reaction [Arsenic results in decreased expression of CAT protein] | 26385919 |
D001151 | Arsenic | NFE2L2 mutant form promotes the reaction [Arsenic results in decreased expression of SOD2 protein] | 26385919 |
D001151 | Arsenic | SOD1 protein inhibits the reaction [Arsenic results in increased expression of NFE2L2 protein] | 26385919 |
D001151 | Arsenic | SOD2 protein inhibits the reaction [Arsenic results in increased expression of NFE2L2 protein] | 26385919 |
D001151 | Arsenic | SQSTM1 mutant form inhibits the reaction [Arsenic results in increased expression of NFE2L2 protein] | 26385919 |
D001151 | Arsenic | Arsenic binds to NFE2L2 protein | 19786557 |
D001151 | Arsenic | Arsenic results in increased activity of NFE2L2 protein | 19808700 |
D001151 | Arsenic | Arsenic results in increased expression of NFE2L2 mRNA | 23000044 |
D001151 | Arsenic | Arsenic results in increased expression of NFE2L2 protein | 19786557|1980870 |
D001151 | Arsenic | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of GCLC mRNA] | 23000044 |
D001151 | Arsenic | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of HMOX1 mRNA] | 23000044 |
D001151 | Arsenic | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of NQO1 mRNA] | 23000044 |
D001151 | Arsenic | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of SRXN1 mRNA] | 23000044 |
D001151 | Arsenic | NFE2L2 mRNA affects the susceptibility to Arsenic | 23000044 |
D001151 | Arsenic | NFE2L2 protein affects the susceptibility to Arsenic | 19786557 |
D001151 | Arsenic | NFE2L2 results in decreased susceptibility to Arsenic | 19538980 |
C025657 | arsenic acid | arsenic acid affects the localization of NFE2L2 protein | 19429247 |
C025657 | arsenic acid | Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein] | 19429247 |
D001152 | Arsenicals | Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [NFE2L2 protein binds to EP300 protein]] | 24632381 |
D001152 | Arsenicals | Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of and affects the localization of NFE2L2 protein] | 24632381 |
D001152 | Arsenicals | Arsenicals results in increased expression of NFE2L2 mRNA | 24632381 |
C050510 | arsenic trichloride | NFE2L2 protein affects the reaction [arsenic trichloride results in increased expression of NQO1 mRNA] | 19276070 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide affects the localization of NFE2L2 protein] | 19350554|2500366 |
C006632 | arsenic trioxide | allicin inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein] | 27561292 |
C006632 | arsenic trioxide | arsenic trioxide affects the localization of NFE2L2 protein | 19350554|2500366 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [resveratrol results in increased expression of NFE2L2 protein] | 26772155 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of NFE2L2 protein | 22155346|2756129 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NFE2L2 protein | 22155346|2268402 |
C006632 | arsenic trioxide | NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to arsenic trioxide] | 26708503 |
C006632 | arsenic trioxide | NFE2L2 mRNA results in decreased susceptibility to arsenic trioxide | 26708503 |
C006632 | arsenic trioxide | NFE2L2 protein affects the susceptibility to arsenic trioxide | 20707922 |
C006632 | arsenic trioxide | NFE2L2 protein inhibits the reaction [arsenic trioxide results in increased abundance of Reactive Oxygen Species] | 21327864 |
C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein] | 21327864|2500366 |
C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [arsenic trioxide results in increased expression of KEAP1 protein] | 22684020 |
C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [arsenic trioxide results in increased expression of NQO1 protein] | 25003661 |
C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [arsenic trioxide results in increased expression of PPARG mRNA] | 22684020 |
C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [rosiglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
C006632 | arsenic trioxide | NFE2L2 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
C006632 | arsenic trioxide | NFE2L2 protein results in decreased susceptibility to arsenic trioxide | 22684020 |
C006632 | arsenic trioxide | resveratrol promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 26772155 |
C006632 | arsenic trioxide | Tretinoin inhibits the reaction [arsenic trioxide affects the localization of NFE2L2 protein] | 25003661 |
C006632 | arsenic trioxide | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA]" | 22488045 |
C006632 | arsenic trioxide | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 protein]" | 22488045 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein] | 24157283 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of NFE2L2 mRNA | 25966753 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 mRNA] | 25815309 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 protein] | 25815309 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of NFE2L2 protein | 24157283 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NFE2L2 mRNA | 22488045|2618789 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NFE2L2 protein | 22488045|2618789 |
C006632 | arsenic trioxide | Lutein promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA] | 26187899 |
C006632 | arsenic trioxide | Lutein promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 26187899 |
C006632 | arsenic trioxide | NFE2L2 protein affects the reaction [arsenic trioxide results in decreased expression of TNF protein] | 29049341 |
C006632 | arsenic trioxide | NFE2L2 protein affects the reaction [arsenic trioxide results in increased expression of GCLC mRNA] | 29049341 |
C006632 | arsenic trioxide | NFE2L2 protein affects the reaction [arsenic trioxide results in increased expression of HMOX1 mRNA] | 29049341 |
C006632 | arsenic trioxide | NFE2L2 protein affects the reaction [arsenic trioxide results in increased expression of NQO1 mRNA] | 29049341 |
C006632 | arsenic trioxide | SB 203580 inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA] | 22488045 |
C006632 | arsenic trioxide | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA] | 22488045 |
C006632 | arsenic trioxide | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 22488045 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of and affects the localization of NFE2L2 protein] | 24634002 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of NFE2L2 mRNA | 24327821 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of and affects the localization of NFE2L2 protein | 24634002 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NFE2L2 protein | 27592447|2771317 |
C006632 | arsenic trioxide | Buthionine Sulfoximine promotes the reaction [arsenic trioxide results in increased expression of and affects the localization of NFE2L2 protein] | 24634002 |
C006632 | arsenic trioxide | oxymatrine promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 27713174 |
C006632 | arsenic trioxide | resveratrol inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 mRNA] | 24327821 |
C015001 | arsenite | [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in decreased susceptibility to arsenite | 22476201 |
C015001 | arsenite | arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 18550526 |
C015001 | arsenite | arsenite results in decreased expression of NFE2L2 mRNA | 28688901 |
C015001 | arsenite | arsenite results in decreased expression of NFE2L2 protein | 28688901 |
C015001 | arsenite | arsenite results in increased expression of and results in increased activity of NFE2L2 protein | 25680285 |
C015001 | arsenite | arsenite results in increased expression of NFE2L2 mRNA | 22476201 |
C015001 | arsenite | arsenite results in increased expression of NFE2L2 protein | 22476201 |
C015001 | arsenite | arsenite results in increased localization of and results in increased activity of NFE2L2 protein | 18550526 |
C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of NFE2L2 mRNA] | 22476201 |
C015001 | arsenite | KEAP1 protein affects the reaction [arsenite results in increased expression of NFE2L2 protein] | 22476201 |
C015001 | arsenite | "[lipopolysaccharide, E coli O55-B5 co-treated with arsenite] results in increased expression of NFE2L2 protein" | 25680285 |
C015001 | arsenite | MIR155 promotes the reaction [arsenite results in decreased expression of NFE2L2 mRNA] | 28688901 |
C015001 | arsenite | MIR155 promotes the reaction [arsenite results in decreased expression of NFE2L2 protein] | 28688901 |
C015001 | arsenite | "NFE2L2 mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]" | 25680285 |
C015001 | arsenite | "NFE2L2 mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]" | 25680285 |
C015001 | arsenite | "NFE2L2 mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]]" | 25680285 |
C015001 | arsenite | "NFE2L2 mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with arsenite] results in increased expression of NQO1 mRNA]" | 25680285 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite affects the expression of NFE2L1 mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite affects the expression of NFE2L1 protein] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite affects the expression of NQO1 protein] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of GCLC mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of GCLC protein] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of GCLM mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of HMOX1 mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of HMOX1 protein] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of NQO1 mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of SRXN1 mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein affects the susceptibility to arsenite | 22476201 |
C015001 | arsenite | NFE2L2 protein inhibits the reaction [arsenite results in increased expression of KEAP1 mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein inhibits the reaction [arsenite results in increased expression of KEAP1 protein] | 22476201 |
C015001 | arsenite | NFE2L2 protein promotes the reaction [arsenite results in decreased expression of KEAP1 mRNA] | 22476201 |
C015001 | arsenite | NFE2L2 protein promotes the reaction [arsenite results in decreased expression of KEAP1 protein] | 22476201 |
C015001 | arsenite | arsenite affects the localization of NFE2L2 protein | 19429247 |
C015001 | arsenite | "NFE2L2 gene mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]" | 25680285 |
C015001 | arsenite | "NFE2L2 gene mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]" | 25680285 |
C015001 | arsenite | NFE2L2 gene mutant form inhibits the reaction [arsenite results in increased expression of NQO1 mRNA] | 25680285 |
C015001 | arsenite | "NFE2L2 gene mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with arsenite] results in increased expression of NQO1 mRNA]" | 25680285 |
C015001 | arsenite | NFE2L2 protein affects the reaction [arsenite results in increased expression of HMOX1 mRNA] | 10473555 |
C015001 | arsenite | Sodium Selenite promotes the reaction [arsenite affects the localization of NFE2L2 protein] | 19429247 |
C039726 | artesunate | artesunate affects the localization of NFE2L2 protein | 26340163 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 23492819|2513042 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 23492819|2513042 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [resveratrol results in increased activity of NFE2L2 promoter] | 21199573 |
D001205 | Ascorbic Acid | Ascorbic Acid affects the localization of NFE2L2 protein | 23027624 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Estradiol affects the localization of NFE2L2 protein] | 23027624 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]] | 23027624 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 23492819 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 23492819 |
D001205 | Ascorbic Acid | Ascorbic Acid promotes the reaction [Cadmium results in increased expression of NFE2L2 protein] | 22008531 |
D001205 | Ascorbic Acid | Ascorbic Acid results in increased expression of NFE2L2 protein | 22008531|2302762 |
C030693 | Ashwagandha | Ashwagandha results in increased expression of and results in increased activity of NFE2L2 protein | 27166148 |
C005948 | astaxanthine | [astaxanthine co-treated with Docosahexaenoic Acids] results in increased expression of NFE2L2 mRNA | 24157545 |
C005948 | astaxanthine | [astaxanthine co-treated with Eicosapentaenoic Acid] results in increased expression of NFE2L2 mRNA | 24157545 |
C005948 | astaxanthine | astaxanthine results in increased expression of NFE2L2 mRNA | 24157545 |
C005948 | astaxanthine | [astaxanthine co-treated with Cyclophosphamide] results in increased expression of NFE2L2 protein | 20038455 |
C005948 | astaxanthine | astaxanthine promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein] | 23272707 |
C005948 | astaxanthine | astaxanthine results in increased expression of NFE2L2 protein | 20038455 |
C005948 | astaxanthine | tin protoporphyrin IX inhibits the reaction [astaxanthine promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein]] | 23272707 |
C052064 | astragaloside A | astragaloside A affects the localization of NFE2L2 protein | 25422538 |
C052064 | astragaloside A | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein | 25422538 |
D001280 | Atrazine | Atrazine results in increased expression of NFE2L2 mRNA | 27102619 |
D001280 | Atrazine | lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] | 27102619 |
C105832 | aurapten | NFE2L2 protein affects the susceptibility to aurapten | 19150646 |
D001379 | Azathioprine | NFE2L2 protein affects the reaction [Azathioprine results in increased activity of NQO1 protein] | 21803983 |
D001397 | Azoxymethane | NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]] | 21355597 |
D001397 | Azoxymethane | NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]] | 21355597 |
D001397 | Azoxymethane | NFE2L2 protein promotes the reaction [resveratrol promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]] | 21355597 |
D001397 | Azoxymethane | NFE2L2 protein promotes the reaction [resveratrol promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]] | 21355597 |
D001397 | Azoxymethane | NFE2L2 results in decreased susceptibility to [Dextran Sulfate co-treated with Azoxymethane] | 23056183 |
C028559 | bathocuproine sulfonate | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of NFE2L2 mRNA | 15477007 |
C007725 | bendiocarb | bendiocarb results in increased activity of NFE2L2 protein | 20143881 |
D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of NFE2L2 mRNA | 17292976 |
D019324 | beta-Naphthoflavone | NFE2L2 protein affects the susceptibility to [beta-Naphthoflavone co-treated with alpha-naphthoflavone] | 19233942 |
D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of NFE2L2 protein | 12446695 |
C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased expression of NFE2L2 mRNA | 26377693 |
C009999 | benzonidazole | benzonidazole affects the localization of NFE2L2 protein | 27180241 |
C009999 | benzonidazole | NFE2L2 protein affects the reaction [benzonidazole results in increased expression of ABCC2 protein] | 27180241 |
C009999 | benzonidazole | NFE2L2 protein affects the reaction [benzonidazole results in increased expression of ABCC2 mRNA] | 27180241 |
D001578 | Benzopyrans | Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] | 25154877 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the activity of NFE2L2 protein | 20624995 |
D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NFE2L2 mRNA | 25946486 |
D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NFE2L2 protein | 25946486 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [ARNT protein binds to NFE2L2 promoter] | 21507987 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [BRCA1 protein binds to NFE2L2 promoter] | 21507987 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [[BRCA1 protein binds to NFE2L2 promoter] which results in increased expression of NFE2L2 mRNA] | 21507987|2150798 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NFE2L2 mRNA | 20106945|2125695 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NFE2L2 protein | 20498004|2150798 |
D001564 | Benzo(a)pyrene | BRCA1 protein affects the reaction [Benzo(a)pyrene promotes the reaction [ARNT protein binds to NFE2L2 promoter]] | 21507987 |
D001564 | Benzo(a)pyrene | BRCA1 protein affects the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 protein] | 21507987 |
D001564 | Benzo(a)pyrene | kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21256954 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of HMOX1 mRNA] | 25946486 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of HMOX1 protein] | 25946486 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NQO1 mRNA] | 25946486 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NQO1 protein] | 25946486 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of SOD1 mRNA] | 25946486 |
D001564 | Benzo(a)pyrene | NFE2L2 protein affects the reaction [BRCA1 protein affects the susceptibility to Benzo(a)pyrene] | 21507987 |
D001564 | Benzo(a)pyrene | NFE2L2 protein inhibits the reaction [BRCA1 inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]] | 22192953 |
D001564 | Benzo(a)pyrene | NFE2L2 protein promotes the reaction [Ketoconazole inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]] | 21753779 |
D001564 | Benzo(a)pyrene | Quercetin inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21256954 |
D001564 | Benzo(a)pyrene | [resveratrol results in increased expression of and results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Benzo(a)pyrene | 22192953 |
D001564 | Benzo(a)pyrene | [sulforafan results in increased expression of and results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Benzo(a)pyrene | 22192953 |
D001564 | Benzo(a)pyrene | AHR affects the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21995607 |
D001564 | Benzo(a)pyrene | AHR mutant form inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21569840 |
D001564 | Benzo(a)pyrene | AHR mutant form inhibits the reaction [CAT protein promotes the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA]] | 21569840 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to NFE2L2 promoter] | 21995607 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [NFE2L2 protein binds to GSTA1 gene] | 11961136 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 21569840 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of NFE2L2 protein | 26546711 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of and affects the localization of NFE2L2 protein | 21569840 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NFE2L2 mRNA | 15034205|2156981 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NFE2L2 protein | 18321868|2156984 |
D001564 | Benzo(a)pyrene | CAT protein promotes the reaction [Benzo(a)pyrene promotes the reaction [NFE2L2 protein binds to NQO1 promoter]] | 21569840 |
D001564 | Benzo(a)pyrene | CAT protein promotes the reaction [Benzo(a)pyrene results in increased expression of and affects the localization of NFE2L2 protein] | 21569840 |
D001564 | Benzo(a)pyrene | CAT protein promotes the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21569840 |
D001564 | Benzo(a)pyrene | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 mRNA | 25820237 |
D001564 | Benzo(a)pyrene | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 protein | 25820237 |
D001564 | Benzo(a)pyrene | [Curcumin co-treated with Benzo(a)pyrene] affects the localization of NFE2L2 protein | 18321868 |
D001564 | Benzo(a)pyrene | hesperetin inhibits the reaction [Benzo(a)pyrene results in decreased expression of NFE2L2 protein] | 26546711 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA] | 21569840 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [Benzo(a)pyrene results in increased expression of NQO1 protein] | 21569840 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [CAT protein promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 mRNA]] | 21569840 |
D001564 | Benzo(a)pyrene | NFE2L2 mutant form inhibits the reaction [CAT protein promotes the reaction [Benzo(a)pyrene results in increased expression of NQO1 protein]] | 21569840 |
D001564 | Benzo(a)pyrene | NFE2L2 results in decreased susceptibility to Benzo(a)pyrene | 23056183 |
D001564 | Benzo(a)pyrene | AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 19497421 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NFE2L2 mRNA | 19497421 |
D016227 | Benzoquinones | Benzoquinones analog results in increased activity of and affects the localization of NFE2L2 protein | 21651925 |
D016227 | Benzoquinones | NFE2L2 protein results in decreased susceptibility to Benzoquinones analog | 21651925 |
C031403 | benzyl isothiocyanate | benzyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein | 28821405 |
C031403 | benzyl isothiocyanate | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to benzyl isothiocyanate | 19303893 |
C031403 | benzyl isothiocyanate | NFE2L2 protein promotes the reaction [benzyl isothiocyanate results in increased expression of ALDH1A1 mRNA] | 28821405 |
C031403 | benzyl isothiocyanate | NFE2L2 protein promotes the reaction [benzyl isothiocyanate results in increased expression of ALDH2 mRNA] | 28821405 |
C031403 | benzyl isothiocyanate | NFE2L2 protein promotes the reaction [benzyl isothiocyanate results in increased expression of ALDH3A1 mRNA] | 28821405 |
C031403 | benzyl isothiocyanate | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to benzyl isothiocyanate] | 20932822 |
C031403 | benzyl isothiocyanate | NFE2L2 protein results in increased susceptibility to benzyl isothiocyanate | 28821405 |
C031403 | benzyl isothiocyanate | benzyl isothiocyanate results in increased expression of NFE2L2 protein | 22664424 |
C090535 | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | 12441344 |
C090535 | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal results in increased expression of NFE2L2 protein | 12441344 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | 2-tert-butyl-4-quinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | 2-tert-butylhydroquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA] | 25263748 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein] | 25263748 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] | 22964297 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased stability of and results in increased ubiquitination of NFE2L2 protein | 20722399 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein | 12446695|2080693 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein] which results in increased expression of CBR3 mRNA | 20806931 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased localization of and results in increased activity of NFE2L2 protein | 18550526 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein | 28645578 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | cyanoginosin LR inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 20722399 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | hydroquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | quinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 2-tert-butylhydroquinone] results in increased expression of NFE2L2 protein | 14510636 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Cycloheximide] results in increased expression of NFE2L2 protein | 14510636 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Particulate Matter analog results in increased expression of NFE2L2 protein]] | 15322212 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Vehicle Emissions analog results in increased expression of NFE2L2 protein]] | 15322212 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein] | 18512965 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride affects the ubiquitination of NFE2L2 protein] | 18512965 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of NFE2L2 protein | 14510636 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of NFE2L2 protein | 12441344 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and affects the localization of NFE2L2 protein | 18512965 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein | 12441344|1451063 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein | 27939242 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | exenatide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 27939242 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of NFE2L2 protein] | 15319326 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of NFE2L2 protein | 26598004 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein | 22606287 |
C048081 | beraprost | "beraprost inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA]" | 28887131 |
D001599 | Berberine | Berberine results in increased expression of NFE2L2 protein | 23954465 |
D001599 | Berberine | NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]] | 23954465 |
D001599 | Berberine | NFE2L2 mutant form inhibits the reaction [Berberine results in increased expression of HMOX1 protein] | 23954465 |
D001599 | Berberine | NFE2L2 mutant form inhibits the reaction [Berberine results in increased expression of NGF protein] | 23954465 |
D001599 | Berberine | Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] | 23523906 |
D001599 | Berberine | Berberine results in increased expression of NFE2L2 protein | 23523906 |
D004958 | Estradiol | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 23492819|2513042 |
D004958 | Estradiol | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 23492819|2513042 |
D004958 | Estradiol | Estradiol results in decreased expression of NFE2L2 mRNA | 23492819|2358329 |
D004958 | Estradiol | Estradiol results in decreased expression of NFE2L2 protein | 23492819|2513042 |
D004958 | Estradiol | Estradiol results in increased methylation of NFE2L2 promoter | 24894866 |
D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 25130429 |
D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 25130429 |
D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in increased methylation of NFE2L2 promoter] | 24894866 |
D004958 | Estradiol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | 22389237 |
D004958 | Estradiol | Ascorbic Acid inhibits the reaction [Estradiol affects the localization of NFE2L2 protein] | 23027624 |
D004958 | Estradiol | Ascorbic Acid inhibits the reaction [Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]] | 23027624 |
D004958 | Estradiol | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 23492819 |
D004958 | Estradiol | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 23492819 |
D004958 | Estradiol | Butylated Hydroxyanisole inhibits the reaction [Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]] | 23027624 |
D004958 | Estradiol | Estradiol affects the expression of NFE2L2 mRNA | 24777823 |
D004958 | Estradiol | Estradiol affects the expression of NFE2L2 protein | 22389237 |
D004958 | Estradiol | Estradiol affects the localization of NFE2L2 protein | 23027624 |
D004958 | Estradiol | Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter] | 23027624 |
D004958 | Estradiol | Estradiol results in decreased expression of NFE2L2 mRNA | 23492819|2489486 |
D004958 | Estradiol | Estradiol results in decreased expression of NFE2L2 protein | 23027624|2349281 |
D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 24894866 |
D004958 | Estradiol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 24894866 |
C118460 | beta-hydroxyisovalerylshikonin | beta-hydroxyisovalerylshikonin affects the localization of and results in increased activity of NFE2L2 protein | 24365262 |
C118460 | beta-hydroxyisovalerylshikonin | [beta-hydroxyisovalerylshikonin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 24365262 |
C044887 | beta-methylcholine | beta-methylcholine affects the expression of NFE2L2 mRNA | 21179406 |
D024503 | beta-Tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | 22389237 |
D001632 | Bibenzyls | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one affects the reaction [Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein]]" | 28245986 |
D001632 | Bibenzyls | Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein] | 28245986 |
D001632 | Bibenzyls | PARK7 protein affects the reaction [Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein]] | 28245986 |
D001632 | Bibenzyls | [Rotenone co-treated with Bibenzyls] results in increased expression of NFE2L2 protein | 28245986 |
D001632 | Bibenzyls | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one affects the reaction [[Rotenone co-treated with Bibenzyls] affects the localization of NFE2L2 protein]" | 28245986 |
D001632 | Bibenzyls | [Bibenzyls co-treated with Rotenone] affects the localization of NFE2L2 protein | 27180985 |
D001632 | Bibenzyls | PARK7 protein affects the reaction [[Rotenone co-treated with Bibenzyls] affects the localization of NFE2L2 protein] | 28245986 |
D001632 | Bibenzyls | [Rotenone co-treated with Bibenzyls] affects the localization of and results in increased expression of NFE2L2 protein | 28245986 |
D001647 | Bile Acids and Salts | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased abundance of Bile Acids and Salts] | 19181614 |
D001663 | Bilirubin | Bilirubin affects the localization of NFE2L2 protein | 23628428 |
D001663 | Bilirubin | Bilirubin promotes the reaction [NFE2L2 protein results in increased expression of CYP2A5 mRNA] | 23628428 |
D001688 | Biological Products | Biological Products affects the localization of NFE2L2 protein | 23266269 |
C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane affects the localization of NFE2L2 protein | 17535857 |
C034786 | bis(4-hydroxycinnamoyl)methane | [demethoxycurcumin co-treated with bis(4-hydroxycinnamoyl)methane] affects the localization of NFE2L2 protein | 17535857 |
C034786 | bis(4-hydroxycinnamoyl)methane | NFE2L2 protein affects the reaction [bis(4-hydroxycinnamoyl)methane results in increased expression of HMOX1 mRNA] | 17535857 |
C067982 | bis(N,N-diethyldithiocarbamate)Cu (II) complex | "NFE2L2 protein affects the reaction [bis(N,N-diethyldithiocarbamate)Cu (II) complex results in increased expression of MT1A mRNA]" | 26961606 |
C067982 | bis(N,N-diethyldithiocarbamate)Cu (II) complex | "NFE2L2 protein affects the reaction [bis(N,N-diethyldithiocarbamate)Cu (II) complex results in increased expression of MT1E mRNA]" | 26961606 |
C006780 | bisphenol A | bisphenol A affects the expression of NFE2L2 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in increased expression of NFE2L2 mRNA | 23606268 |
C006780 | bisphenol A | [nonylphenol co-treated with bisphenol A] results in increased expression of NFE2L2 mRNA | 23606268 |
C006780 | bisphenol A | bisphenol A results in decreased phosphorylation of NFE2L2 protein | 29275510 |
C006780 | bisphenol A | bisphenol A results in increased expression of NFE2L2 mRNA | 23360430|2927551 |
C006780 | bisphenol A | bisphenol A results in increased stability of NFE2L2 protein modified form | 23360430 |
C006780 | bisphenol A | bisphenol A affects the methylation of NFE2L2 promoter | 27334623 |
C006780 | bisphenol A | bisphenol A promotes the reaction [NFE2L2 protein binds to SREBF1 promoter] | 28796629 |
C006780 | bisphenol A | bisphenol A results in decreased methylation of NFE2L2 promoter | 28796629 |
C006780 | bisphenol A | bisphenol A results in increased expression of NFE2L2 mRNA | 28796629 |
C006780 | bisphenol A | bisphenol A results in increased expression of NFE2L2 protein | 28796629 |
C006780 | bisphenol A | bisphenol A results in decreased expression of NFE2L2 protein | 27208089 |
C006780 | bisphenol A | bisphenol A results in increased expression of NFE2L2 mRNA | 25181051 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of NFE2L2 mRNA | 17553608 |
D001761 | Bleomycin | Bleomycin affects the localization of NFE2L2 protein | 23570914 |
D001761 | Bleomycin | Bleomycin results in decreased expression of NFE2L2 protein | 23570914 |
D001761 | Bleomycin | Bleomycin results in increased phosphorylation of NFE2L2 protein | 23570914 |
D001761 | Bleomycin | caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | 23570914 |
D001761 | Bleomycin | U 0126 inhibits the reaction [Bleomycin affects the localization of NFE2L2 protein] | 23570914 |
D001761 | Bleomycin | U 0126 inhibits the reaction [Bleomycin results in increased phosphorylation of NFE2L2 protein] | 23570914 |
D001761 | Bleomycin | Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] | 23523906 |
D001761 | Bleomycin | Bleomycin results in decreased expression of NFE2L2 mRNA | 26093215 |
D001761 | Bleomycin | Bleomycin results in decreased expression of NFE2L2 protein | 26768587 |
D001761 | Bleomycin | Bleomycin results in increased expression of NFE2L2 protein | 23523906 |
D001761 | Bleomycin | Methylprednisolone inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] | 26093215 |
D001761 | Bleomycin | Phytochemicals inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] | 26093215 |
D001761 | Bleomycin | tripterine inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | 26768587 |
D001786 | Blood Glucose | NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MYH7 mRNA] | 28373008 |
D001786 | Blood Glucose | NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPA mRNA] | 28373008 |
D001786 | Blood Glucose | NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPB mRNA] | 28373008 |
D001786 | Blood Glucose | NFE2L2 gene mutant form results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency] | 28373008 |
D001786 | Blood Glucose | Ethanol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein] | 26747958 |
D001786 | Blood Glucose | [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein | 26747958 |
D001786 | Blood Glucose | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein | 26747958 |
D000069286 | Bortezomib | Bortezomib results in increased expression of NFE2L2 protein | 20806931 |
D000069286 | Bortezomib | [Bortezomib results in increased expression of NFE2L2 protein] which results in increased expression of CBR3 mRNA | 20806931 |
D020126 | Brefeldin A | Brefeldin A inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | 20805060 |
C032036 | bromobenzene | bromobenzene analog results in increased expression of NFE2L2 protein | 19427879 |
C032036 | bromobenzene | bromobenzene results in increased localization of NFE2L2 protein | 18078705 |
D001971 | Bromocriptine | Bromocriptine results in increased localization of NFE2L2 protein | 21867702 |
C020237 | brusatol | brusatol inhibits the reaction [Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein]] | 29274434 |
C020237 | brusatol | brusatol results in decreased expression of NFE2L2 protein | 27639429|2927443 |
C020237 | brusatol | brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein | 21205897 |
C020237 | brusatol | [brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein] which results in increased susceptibility to Cisplatin | 21205897 |
C020237 | brusatol | [KEAP1 protein results in decreased expression of NFE2L2 protein] which results in decreased susceptibility to brusatol | 21205897 |
D002065 | Buspirone | Buspirone results in decreased expression of NFE2L2 mRNA | 24136188 |
D003931 | Diacetyl | Diacetyl affects the localization of NFE2L2 protein | 25145656 |
C040918 | butein | butein affects the localization of NFE2L2 protein | 23318726 |
D019328 | Buthionine Sulfoximine | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein] | 21971136 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine affects the expression of NFE2L2 protein | 20934533 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein] | 19608619 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] | 19608619 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide] | 19608619 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione] | 19608619 |
D019328 | Buthionine Sulfoximine | "Buthionine Sulfoximine promotes the reaction [1,2-dihydroxynaphthalene analog results in increased activity of NFE2L2 protein]" | 25807370 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
D019328 | Buthionine Sulfoximine | [Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein | 21971136 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine affects the localization of and results in increased activity of NFE2L2 protein | 18785192 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Acrolein] | 19303893 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Chlorambucil] | 19303893 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Acrolein]] | 20932822 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Chlorambucil]] | 20932822 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to cumene hydroperoxide]] | 20932822 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in increased expression of NFE2L2 mRNA | 17980396 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [decamethrin results in increased expression of and affects the localization of NFE2L2 protein] | 23585199 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [decamethrin results in increased expression of NFE2L2 mRNA] | 23585199 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine promotes the reaction [arsenic trioxide results in increased expression of and affects the localization of NFE2L2 protein] | 24634002 |
C051437 | butin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butin results in increased activity of NFE2L2 protein] | 22253095 |
C051437 | butin | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butin results in increased activity of NFE2L2 protein]] which results in decreased activity of SOD2 protein | 22253095 |
C051437 | butin | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [butin results in increased activity of NFE2L2 protein]] which results in decreased expression of SOD2 | 22253095 |
C051437 | butin | butin affects the localization of and results in increased activity of NFE2L2 protein | 22253095 |
C051437 | butin | butin inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein] | 22253095 |
C051437 | butin | butin promotes the reaction [NFE2L2 protein results in increased expression of SOD2] | 22253095 |
C051437 | butin | Hydrogen Peroxide inhibits the reaction [butin affects the localization of and results in increased activity of NFE2L2 protein] | 22253095 |
C051437 | butin | NFE2L2 protein affects the reaction [butin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SOD2 protein]] | 22253095 |
C051437 | butin | NFE2L2 protein affects the reaction [butin results in increased activity of SOD2 protein] | 22253095 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased stability of and results in increased expression of NFE2L2 protein | 22530035 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole affects the activity of NFE2L2 protein | 11309284 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole binds to and results in increased activity of NFE2L2 protein | 15919853 |
D002083 | Butylated Hydroxyanisole | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA | 15833929 |
D002083 | Butylated Hydroxyanisole | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC3 mRNA | 15833929 |
D002083 | Butylated Hydroxyanisole | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC4 mRNA | 15833929 |
D002083 | Butylated Hydroxyanisole | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC5 mRNA | 15833929 |
D002083 | Butylated Hydroxyanisole | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC6 mRNA | 15833929 |
D002083 | Butylated Hydroxyanisole | NFE2L2 protein affects the reaction [Butylated Hydroxyanisole results in increased activity of GSTM1 protein] | 11895860 |
D002083 | Butylated Hydroxyanisole | NFE2L2 protein affects the reaction [Butylated Hydroxyanisole results in increased activity of GSTP1 protein] | 11895860 |
D002083 | Butylated Hydroxyanisole | NFE2L2 protein affects the reaction [Butylated Hydroxyanisole results in increased expression of GSTP1 protein] | 11895860 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole inhibits the reaction [Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]] | 23027624 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased expression of NFE2L2 protein | 23027624 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole binds to and results in increased activity of NFE2L2 protein | 15833929 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole promotes the reaction [[[NFE2L2 protein binds to MAF protein] which binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 15832810 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole results in increased activity of NFE2L2 protein | 22429928|2324701 |
D002083 | Butylated Hydroxyanisole | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] promotes the reaction [[NFE2L2 protein binds to CBR1 promoter] which results in increased expression of CBR1 mRNA] | 23247010 |
D002084 | Butylated Hydroxytoluene | NFE2L2 protein results in decreased susceptibility to Butylated Hydroxytoluene | 10535991 |
C027561 | butylbenzyl phthalate | butylbenzyl phthalate results in decreased expression of NFE2L2 mRNA | 27923775 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of GCLC mRNA] | 19233942 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of GPX1 mRNA] | 19233942 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA] | 19233942 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the susceptibility to tert-Butylhydroperoxide | 19233942 |
D020122 | tert-Butylhydroperoxide | nectandrin-B inhibits the reaction [tert-Butylhydroperoxide affects the localization of NFE2L2 protein] | 27511913 |
D020122 | tert-Butylhydroperoxide | NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide] | 20028456 |
D020122 | tert-Butylhydroperoxide | Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | 20100471 |
D020122 | tert-Butylhydroperoxide | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | 27050144 |
D020122 | tert-Butylhydroperoxide | Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | 27050144 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide affects the localization of NFE2L2 protein | 27511913|2802512 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein | 20100471|2705014 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of NFE2L2 mRNA | 27509014 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide] | 24211276 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] | 19647727 |
D020122 | tert-Butylhydroperoxide | NFE2L2 protein results in decreased susceptibility to tert-Butylhydroperoxide | 20932822 |
D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of and affects the localization of NFE2L2 protein | 24161444 |
D002101 | Cacodylic Acid | NFE2L2 mutant form inhibits the reaction [Cacodylic Acid results in increased expression of NQO1 protein] | 24161444 |
D002104 | Cadmium | Cadmium affects the localization of NFE2L2 protein | 16959797 |
D002104 | Cadmium | Cadmium results in increased activity of NFE2L2 promoter | 21643505 |
D002104 | Cadmium | Cadmium results in increased activity of NFE2L2 protein | 21172416 |
D002104 | Cadmium | diacetyldichlorofluorescein inhibits the reaction [Cadmium affects the localization of NFE2L2 protein] | 16959797 |
D002104 | Cadmium | NFE2L2 gene mutant form inhibits the reaction [Cadmium results in increased expression of HMOX1 protein] | 18512965 |
D002104 | Cadmium | NFE2L2 protein affects the reaction [Cadmium results in increased expression of HMOX1 mRNA] | 10473555 |
D002104 | Cadmium | NFE2L2 protein promotes the reaction [Cadmium results in increased expression of CYP2A5 mRNA] | 15041070 |
D002104 | Cadmium | NFE2L2 results in decreased susceptibility to Cadmium | 23056183 |
D002104 | Cadmium | Ascorbic Acid promotes the reaction [Cadmium results in increased expression of NFE2L2 protein] | 22008531 |
D002104 | Cadmium | [Cadmium co-treated with Plant Preparations] results in increased expression of NFE2L2 mRNA | 22995158 |
D002104 | Cadmium | Cadmium results in increased expression of and results in increased localization of NFE2L2 protein | 17573173 |
D002104 | Cadmium | Cadmium results in increased expression of NFE2L2 mRNA | 21787725|2299515 |
D002104 | Cadmium | Cadmium results in increased expression of NFE2L2 protein | 22008531|2765854 |
C028031 | cadmium acetate | Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NFE2L2 protein] | 21787718 |
C028031 | cadmium acetate | cadmium acetate results in increased expression of and affects the localization of NFE2L2 protein | 21787718 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to GCLM promoter] | 26827822 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to MT2A promoter] | 26827822 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of GCLM protein] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of HMOX1 protein] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of MT2A mRNA] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of NQO1 protein] | 26827822 |
D019256 | Cadmium Chloride | Cadmium Chloride affects the activity of NFE2L2 protein | 25596134 |
D019256 | Cadmium Chloride | Cadmium Chloride affects the localization of NFE2L2 protein | 16959797|2093453 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [NFE2L2 protein binds to BCL2L1 promoter] | 25157103 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [NFE2L2 protein binds to BCL2 promoter] | 25157103 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [NFE2L2 protein binds to SQSTM1 promoter] | 25157103 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to TXNRD1 promoter] | 15521073 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of NFE2L2 mRNA | 25596134 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of and affects the localization of NFE2L2 protein | 28229933 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of NFE2L2 protein | 15878868|2093453 |
D019256 | Cadmium Chloride | diacetyldichlorofluorescein inhibits the reaction [Cadmium Chloride affects the localization of NFE2L2 protein] | 16959797 |
D019256 | Cadmium Chloride | NFE2L2 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA] | 10874044 |
D019256 | Cadmium Chloride | NFE2L2 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of SQSTM1 protein] | 25157103 |
D019256 | Cadmium Chloride | NFE2L2 mutant form promotes the reaction [Cadmium Chloride results in decreased expression of BCL2L1 protein] | 25157103 |
D019256 | Cadmium Chloride | NFE2L2 mutant form promotes the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] | 25157103 |
D019256 | Cadmium Chloride | Ro 31-7549 inhibits the reaction [Cadmium Chloride affects the localization of NFE2L2 protein] | 21787730 |
D019256 | Cadmium Chloride | rottlerin inhibits the reaction [Cadmium Chloride affects the localization of NFE2L2 protein] | 21787730 |
D019256 | Cadmium Chloride | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to Cadmium Chloride]" | 18367636 |
D019256 | Cadmium Chloride | benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | 12441344 |
D019256 | Cadmium Chloride | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride affects the ubiquitination of NFE2L2 protein] | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride affects the reaction [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
D019256 | Cadmium Chloride | [Cadmium Chloride affects the reaction [NFE2L2 protein binds to KEAP1 protein]] affects the localization of [NFE2L2 protein binds to KEAP1 protein] | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride affects the ubiquitination of NFE2L2 protein | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to KEAP1 protein]] | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 protein] | 26827822 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to CYP2A5 promoter] | 17303623 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of and results in increased stability of NFE2L2 protein | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of and affects the localization of NFE2L2 protein | 18512965 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of and results in increased activity of NFE2L2 protein | 12441344 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased localization of NFE2L2 protein | 17303623 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased stability of NFE2L2 protein | 12441344 |
D019256 | Cadmium Chloride | Cycloheximide inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased activity of NFE2L2 protein] | 12441344 |
D019256 | Cadmium Chloride | KEAP1 gene mutant form promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | 26827822 |
D019256 | Cadmium Chloride | lactacystin promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | 12441344 |
D019256 | Cadmium Chloride | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Cadmium Chloride | 19303893 |
D019256 | Cadmium Chloride | NFE2L2 gene mutant form inhibits the reaction [Cadmium Chloride results in increased activity of NQO1 protein] | 18512965 |
D019256 | Cadmium Chloride | NFE2L2 gene mutant form inhibits the reaction [Cadmium Chloride results in increased expression of GCLM protein] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 gene mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 gene mutant form inhibits the reaction [Cadmium Chloride results in increased expression of MT1 mRNA] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 gene mutant form inhibits the reaction [Cadmium Chloride results in increased expression of MT2 mRNA] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA] | 10874044 |
D019256 | Cadmium Chloride | NFE2L2 protein affects the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA] | 22003191 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of CYP2A5 mRNA] | 15041070 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [Cadmium Chloride results in increased expression of MT1 mRNA] | 26827822 |
D019256 | Cadmium Chloride | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Cadmium Chloride] | 20932822 |
D019256 | Cadmium Chloride | NFE2L2 protein results in decreased susceptibility to Cadmium Chloride | 22677785 |
D019256 | Cadmium Chloride | NFE2L2 results in decreased susceptibility to Cadmium Chloride | 18367636|1851296 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of NFE2L2 protein | 26462792 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of NFE2L2 protein | 19682480 |
D019256 | Cadmium Chloride | GCLC affects the reaction [NFE2L2 protein results in decreased susceptibility to Cadmium Chloride] | 19682480 |
D019256 | Cadmium Chloride | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of NFE2L2 mRNA | 25719599 |
D019256 | Cadmium Chloride | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of NFE2L2 protein | 25719599 |
D019256 | Cadmium Chloride | Grape Seed Proanthocyanidins inhibits the reaction [Cadmium Chloride results in decreased expression of NFE2L2 protein] | 26462792 |
D019256 | Cadmium Chloride | HMOX1 affects the reaction [NFE2L2 protein results in decreased susceptibility to Cadmium Chloride] | 19682480 |
D019256 | Cadmium Chloride | NFE2L2 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 protein] | 19682480 |
D019256 | Cadmium Chloride | NFE2L2 protein results in decreased susceptibility to Cadmium Chloride | 19682480 |
C028337 | cadmium telluride | cadmium telluride analog results in increased activity of NFE2L2 protein | 23485651 |
C053400 | cafestol | [cafestol co-treated with kahweol palmitate] affects the activity of NFE2L2 protein | 11309284 |
C053400 | cafestol | NFE2L2 protein affects the reaction [[cafestol co-treated with kahweol] results in decreased susceptibility to Acrolein] | 18028974 |
C053400 | cafestol | NFE2L2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA] | 18028974 |
C053400 | cafestol | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] | 17110534 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester promotes the reaction [Nitrogen Mustard Compounds results in increased expression of NFE2L2 protein] | 17204746 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | 23570914 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased activity of NFE2L2 protein | 23570914 |
C472707 | caffeoylquinic acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [caffeoylquinic acid analog results in increased localization of NFE2L2 protein] | 19647727 |
C472707 | caffeoylquinic acid | caffeoylquinic acid analog results in increased localization of and results in increased activity of NFE2L2 protein | 19647727 |
C472707 | caffeoylquinic acid | NFE2L2 protein affects the reaction [caffeoylquinic acid analog results in increased expression of HMOX1 protein] | 19647727 |
D002211 | Capsaicin | Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein] | 17979524 |
D002211 | Capsaicin | Capsaicin results in increased localization of NFE2L2 protein | 17979524 |
D002219 | Carbamates | Carbamates results in increased activity of NFE2L2 protein | 18482591 |
D002220 | Carbamazepine | Carbamazepine affects the expression of NFE2L2 mRNA | 25979313 |
D002220 | Carbamazepine | Carbamazepine results in increased activity of NFE2L2 protein | 24752500 |
D002246 | Carbon Disulfide | Carbon Disulfide affects the localization of NFE2L2 protein | 27530093 |
D002248 | Carbon Monoxide | Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 18845810 |
D002248 | Carbon Monoxide | Carbon Monoxide promotes the reaction [NFE2L2 protein binds to NRF1 promoter] | 18845810 |
D002248 | Carbon Monoxide | Carbon Monoxide results in decreased phosphorylation of NFE2L2 protein | 18845810 |
D002248 | Carbon Monoxide | Carbon Monoxide results in increased expression of NFE2L2 mRNA | 18845810 |
D002248 | Carbon Monoxide | Carbon Monoxide results in increased localization of NFE2L2 protein | 18845810 |
D002248 | Carbon Monoxide | CAT protein inhibits the reaction [Carbon Monoxide results in increased localization of NFE2L2 protein] | 18845810 |
D002248 | Carbon Monoxide | NFE2L2 protein affects the reaction [Carbon Monoxide results in increased activity of HMOX1 protein] | 18845810 |
D002248 | Carbon Monoxide | NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of HMOX1 mRNA] | 18845810 |
D002248 | Carbon Monoxide | NFE2L2 protein affects the reaction [Carbon Monoxide results in increased expression of SOD2 mRNA] | 18845810 |
D002248 | Carbon Monoxide | Carbon Monoxide results in increased expression of NFE2L2 protein | 25348283 |
D002248 | Carbon Monoxide | Carbon Monoxide results in increased localization of NFE2L2 protein | 18845810 |
D002248 | Carbon Monoxide | phenylmethylpyrazolone promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 protein] | 25348283 |
D002251 | Carbon Tetrachloride | "[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide co-treated with Carbon Tetrachloride] results in increased expression of NFE2L2 protein" | 26443840 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the localization of NFE2L2 protein | 23341968 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA | 25471833 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NFE2L2 protein | 22902988 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased localization of NFE2L2 protein | 18078705 |
D002251 | Carbon Tetrachloride | Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] | 23341968 |
D002251 | Carbon Tetrachloride | [Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride | 23341968 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFKBIA protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL3A1 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of EGFR mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of EGFR protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of FN1 mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of FN1 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of IFNG protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of NLRP3 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFBR1 mRNA]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFBR1 protein]] | 27477297 |
D002251 | Carbon Tetrachloride | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]] | 27477297 |
D002251 | Carbon Tetrachloride | Quercetin inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA] | 25471833 |
D002251 | Carbon Tetrachloride | Quercetin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] | 22902988 |
D002251 | Carbon Tetrachloride | Rutin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] | 22902988 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the localization of NFE2L2 protein | 24975872 |
D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA | 28935427 |
D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 protein | 28935427 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of and affects the localization of NFE2L2 protein | 24293383 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA | 17202758 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NFE2L2 protein | 18081878 |
D002251 | Carbon Tetrachloride | diallyl disulfide inhibits the reaction [Carbon Tetrachloride results in decreased expression of and affects the localization of NFE2L2 protein] | 24293383 |
D002251 | Carbon Tetrachloride | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA] | 28935427 |
D002251 | Carbon Tetrachloride | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 protein] | 28935427 |
D002251 | Carbon Tetrachloride | puerarin inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] | 24975872 |
D002330 | Carmustine | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Carmustine | 19303893 |
C068623 | carnosol | carnosol results in increased localization of NFE2L2 protein | 20116392 |
C068623 | carnosol | NFE2L2 mutant form inhibits the reaction [carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] | 20116392 |
C068623 | carnosol | NFE2L2 mutant form inhibits the reaction [carnosol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]] | 20116392 |
C068623 | carnosol | NFE2L2 mutant form inhibits the reaction [carnosol results in increased expression of HMOX1 protein] | 20116392 |
C068623 | carnosol | [NFE2L2 mutant form inhibits the reaction [carnosol results in increased expression of HMOX1 protein]] which results in increased expression of ICAM1 protein | 20116392 |
C068623 | carnosol | NFE2L2 mutant form inhibits the reaction [carnosol results in increased glutathionylation of RELA protein] | 20116392 |
C068623 | carnosol | NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] | 23942037 |
C068623 | carnosol | NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D002351 | Carrageenan | Carrageenan affects the localization of NFE2L2 protein | 28844677 |
D002351 | Carrageenan | procyanidin B2 inhibits the reaction [Carrageenan affects the localization of NFE2L2 protein] | 28844677 |
D002392 | Catechin | Catechin results in increased expression of NFE2L2 protein | 16799064 |
C030583 | ceric oxide | ceric oxide affects the localization of NFE2L2 protein | 19429248 |
D002599 | Chalcone | Chalcone affects the localization of NFE2L2 protein | 17320913 |
D047188 | Chalcones | Chalcones analog results in increased expression of NFE2L2 protein | 23963778 |
D002635 | Chenodeoxycholic Acid | [Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA | 17724089 |
D002635 | Chenodeoxycholic Acid | [Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 17724089 |
D002635 | Chenodeoxycholic Acid | [Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 17724089 |
D002635 | Chenodeoxycholic Acid | [Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXN mRNA | 17724089 |
D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased expression of and results in increased localization of and results in increased activity of NFE2L2 protein | 17724089 |
D002635 | Chenodeoxycholic Acid | NFE2L2 protein results in decreased susceptibility to Chenodeoxycholic Acid | 17724089 |
D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased expression of NFE2L2 mRNA | 25582706 |
D048271 | Chitosan | [Chitosan metabolite results in decreased susceptibility to Copper] which results in increased phosphorylation of NFE2L2 protein | 25542178 |
D002699 | Chlorambucil | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] | 19608619 |
D002699 | Chlorambucil | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil | 19608619 |
D002699 | Chlorambucil | NFE2L2 gene mutant form results in increased susceptibility to Chlorambucil | 19608619 |
D002699 | Chlorambucil | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Chlorambucil] | 19303893 |
D002699 | Chlorambucil | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Chlorambucil]] | 20932822 |
D002699 | Chlorambucil | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Chlorambucil | 19303893 |
D002699 | Chlorambucil | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Chlorambucil] | 20932822 |
C004656 | chloroacetaldehyde | chloroacetaldehyde affects the activity of NFE2L2 protein | 25596134 |
C004656 | chloroacetaldehyde | chloroacetaldehyde results in decreased expression of NFE2L2 mRNA | 25596134 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of NFE2L2 mRNA | 17851650 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of NFE2L2 mRNA | 23650126 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of NFE2L2 mRNA | 25270620 |
D002726 | Chlorogenic Acid | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] | 29136249 |
D002726 | Chlorogenic Acid | Chlorogenic Acid affects the localization of NFE2L2 protein | 29136249 |
D002726 | Chlorogenic Acid | [Chlorogenic Acid co-treated with Acetaminophen] results in increased activity of and affects the localization of NFE2L2 protein | 29136249 |
D002726 | Chlorogenic Acid | [Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein | 29136249 |
D002726 | Chlorogenic Acid | NFE2L2 results in increased susceptibility to Chlorogenic Acid | 29136249 |
D002726 | Chlorogenic Acid | U 0126 inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] | 29136249 |
D002726 | Chlorogenic Acid | [Chlorogenic Acid co-treated with Acetaminophen] affects the localization of and results in increased activity of NFE2L2 protein | 29136249 |
D002726 | Chlorogenic Acid | Chlorogenic Acid results in increased localization of NFE2L2 protein | 15944151 |
D002726 | Chlorogenic Acid | NFE2L2 gene mutant form results in decreased susceptibility to Chlorogenic Acid | 29136249 |
D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of NFE2L2 mRNA | 26272509 |
C100187 | chloropicrin | chloropicrin results in decreased expression of NFE2L2 mRNA | 26352163 |
D002746 | Chlorpromazine | Chlorpromazine affects the activity of NFE2L2 protein | 25596134 |
D002746 | Chlorpromazine | Chlorpromazine results in decreased expression of NFE2L2 mRNA | 25596134 |
D004390 | Chlorpyrifos | [Copper co-treated with Chlorpyrifos] results in decreased expression of NFE2L2 mRNA | 21356183 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of and affects the localization of NFE2L2 protein | 23850137 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of NFE2L2 mRNA | 23850137 |
D002791 | Cholesterol, Dietary | "[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein" | 27394961 |
D002791 | Cholesterol, Dietary | "MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein]" | 27394961 |
D019826 | Cholic Acid | Cholic Acid results in increased expression of NFE2L2 mRNA | 25582706 |
D002793 | Cholic Acids | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NFE2L2 mRNA | 27344345 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency] affects the localization of NFE2L2 protein | 20350562 |
D002794 | Choline | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CD36 mRNA] | 20350562 |
D002794 | Choline | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of FGF21 mRNA] | 20350562 |
D002794 | Choline | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA] | 20350562 |
D002794 | Choline | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of KEAP1 mRNA] | 20350562 |
D002794 | Choline | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of NQO1 mRNA] | 20350562 |
D002794 | Choline | NFE2L2 affects the susceptibility to [Choline deficiency co-treated with Methionine deficiency] | 20350562 |
C074702 | chromium hexavalent ion | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 mRNA | 25820237 |
C074702 | chromium hexavalent ion | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 protein | 25820237 |
C499843 | chromium histidinate | chromium histidinate inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 21539728 |
C499843 | chromium histidinate | chromium histidinate inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 22790776 |
C017133 | chromous chloride | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to chromous chloride] | 20932822 |
C043561 | chrysin | chrysin inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Doxorubicin] | 23994249 |
C043561 | chrysin | chrysin results in decreased expression of NFE2L2 mRNA | 23994249 |
C043561 | chrysin | chrysin results in decreased expression of NFE2L2 protein | 23994249 |
C043561 | chrysin | chrysin affects the localization of and results in increased activity of NFE2L2 protein | 22864849 |
C043561 | chrysin | NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLC protein] | 22864849 |
C043561 | chrysin | NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLM protein] | 22864849 |
C043561 | chrysin | NFE2L2 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] | 22864849 |
C043561 | chrysin | chrysin inhibits the reaction [[NFE2L2 protein results in increased expression of [HMOX1 protein co-treated with AKR1B10 protein co-treated with ABCC5 protein]] which results in decreased susceptibility to Doxorubicin] | 23994249 |
C059262 | cidofovir | cidofovir affects the activity of NFE2L2 protein | 25596134 |
C059262 | cidofovir | cidofovir affects the expression of NFE2L2 mRNA | 25596134 |
C045645 | cilostazol | cilostazol results in increased expression of NFE2L2 protein | 20131233 |
C045645 | cilostazol | NFE2L2 mutant form inhibits the reaction [cilostazol results in increased expression of HMOX1 protein] | 20131233 |
C045645 | cilostazol | NFE2L2 results in increased susceptibility to cilostazol | 20131233 |
C012843 | cinnamic aldehyde | cinnamic aldehyde affects the localization of NFE2L2 protein | 18304597|2146973 |
C012843 | cinnamic aldehyde | cinnamic aldehyde analog results in increased expression of NFE2L2 protein | 18482591 |
C012843 | cinnamic aldehyde | [cinnamic aldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein affects the localization of RELA protein] | 20351055 |
C012843 | cinnamic aldehyde | [cinnamic aldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] | 20351055 |
C012843 | cinnamic aldehyde | [cinnamic aldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | 20351055 |
C012843 | cinnamic aldehyde | [cinnamic aldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 20351055 |
C012843 | cinnamic aldehyde | [cinnamic aldehyde results in increased activity of NFE2L2 protein] which results in increased glutathionylation of RELA protein | 20351055 |
C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of NFE2L2 protein | 18482591|1903339 |
C012843 | cinnamic aldehyde | NFE2L2 mRNA affects the reaction [cinnamic aldehyde results in increased expression of GCLC protein] | 21469739 |
C012843 | cinnamic aldehyde | NFE2L2 mRNA promotes the reaction [cinnamic aldehyde results in increased expression of AKR1C2 mRNA] | 26244607 |
C012843 | cinnamic aldehyde | NFE2L2 mRNA promotes the reaction [cinnamic aldehyde results in increased expression of HMOX1 mRNA] | 26244607 |
C012843 | cinnamic aldehyde | cinnamic aldehyde affects the expression of NFE2L2 protein | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 affects the susceptibility to cinnamic aldehyde | 23564646 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in decreased abundance of Glutathione] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased abundance of Reactive Oxygen Species] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased expression of CCL3 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased expression of CXCL10 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased expression of CXCL1 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased expression of IL12A mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased expression of IL1B mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of CAT mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of GPX1 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of GPX2 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of GPX5 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of GPX6 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of GSR mRNA] | 28219650 |
C012843 | cinnamic aldehyde | NFE2L2 protein promotes the reaction [cinnamic aldehyde results in increased expression of NOS2 mRNA] | 28219650 |
C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased activity of NFE2L2 protein | 18482591 |
C020722 | cinnamyl alcohol | NFE2L2 mRNA promotes the reaction [cinnamyl alcohol results in increased expression of HMOX1 mRNA] | 26244607 |
C073341 | citraconic acid | citraconic acid affects the localization of NFE2L2 protein | 27277809 |
C073341 | citraconic acid | citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein] | 28289076 |
C073341 | citraconic acid | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] | 28289076 |
C073341 | citraconic acid | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA] | 27277809 |
C073341 | citraconic acid | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA] | 27277809 |
C073341 | citraconic acid | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA] | 27277809 |
C073341 | citraconic acid | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA] | 27277809 |
C073341 | citraconic acid | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] | 27277809 |
D004002 | Clodronic Acid | Clodronic Acid affects the activity of NFE2L2 protein | 25596134 |
D002994 | Clofibrate | Clofibrate results in increased expression of NFE2L2 mRNA | 25270620 |
D002994 | Clofibrate | Clofibrate results in increased expression of NFE2L2 protein | 20180811 |
D003010 | Clorgyline | Clorgyline results in increased expression of NFE2L2 mRNA | 19691856 |
D003024 | Clozapine | NFE2L2 protein affects the susceptibility to Clozapine | 21540358 |
D003033 | Coal Tar | Coal Tar results in increased localization of NFE2L2 protein | 23348739 |
D003035 | Cobalt | Cobalt results in increased activity of NFE2L2 promoter | 21643505 |
D003035 | Cobalt | CAT protein inhibits the reaction [[[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA] | 20528745 |
D003035 | Cobalt | [tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein | 20528745 |
D003035 | Cobalt | [[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 20528745 |
C007095 | cobaltiprotoporphyrin | BRD4 mutant form promotes the reaction [cobaltiprotoporphyrin promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]] | 24763052 |
C007095 | cobaltiprotoporphyrin | BRD4 mutant form promotes the reaction [cobaltiprotoporphyrin results in increased expression of and affects the localization of NFE2L2 protein] | 24763052 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the localization of NFE2L2 protein | 24041027 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 24763052 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in decreased degradation of NFE2L2 protein | 17065227 |
C007095 | cobaltiprotoporphyrin | [[cobaltiprotoporphyrin results in decreased expression of BACH1 protein] co-treated with [cobaltiprotoporphyrin results in increased expression of NFE2L2 protein]] results in increased expression of HMOX1 mRNA | 17065227 |
C007095 | cobaltiprotoporphyrin | [[cobaltiprotoporphyrin results in decreased expression of BACH1 protein] co-treated with [cobaltiprotoporphyrin results in increased expression of NFE2L2 protein]] results in increased expression of HMOX1 protein | 17065227 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in increased expression of and affects the localization of NFE2L2 protein | 24763052 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in increased expression of and results in increased localization of NFE2L2 protein | 19608869 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in increased expression of NFE2L2 protein | 17065227|2013123 |
C007095 | cobaltiprotoporphyrin | NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of COX4I1 protein] | 24041027 |
C007095 | cobaltiprotoporphyrin | NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 protein] | 20131233 |
C007095 | cobaltiprotoporphyrin | NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of NDUFB8 protein] | 24041027 |
C007095 | cobaltiprotoporphyrin | NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of NRF1 mRNA] | 24041027 |
C007095 | cobaltiprotoporphyrin | NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of PPARGC1A mRNA] | 24041027 |
C007095 | cobaltiprotoporphyrin | NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of UQCRC1 protein] | 24041027 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 mRNA] | 17065227 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]] | 19608869 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of IL6 protein]] | 19608869 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] | 19608869 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein promotes the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 protein] | 19608869 |
C007095 | cobaltiprotoporphyrin | NFE2L2 results in increased susceptibility to cobaltiprotoporphyrin | 20131233 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the expression of NFE2L2 protein | 25171655 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the localization of NFE2L2 protein | 22859313 |
C007095 | cobaltiprotoporphyrin | [Lipopolysaccharides co-treated with cobaltiprotoporphyrin] results in increased expression of NFE2L2 protein | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 gene mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of CYP2A5 mRNA] | 22859313 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the cleavage of CASP3 protein] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of BCL2L1 protein] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of BCL2 protein] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of CXCL10 mRNA] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of HMOX1 protein] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of IL1B mRNA] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of TNF mRNA] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the phosphorylation of AKT1 protein] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the phosphorylation of STAT3 protein] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of FOXO1 protein]] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] | 25171655 |
C007095 | cobaltiprotoporphyrin | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]] | 25171655 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the expression of NFE2L2 mRNA | 23704825 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the expression of NFE2L2 protein | 23704825 |
C018021 | cobaltous chloride | NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]] | 27297870 |
D009249 | NADP | NFE2L2 protein affects the abundance of NADP | 21775727 |
C024989 | coenzyme Q10 | coenzyme Q10 inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 27174133 |
D003069 | Coffee | Coffee affects the expression of NFE2L2 mRNA | 21448860|2294651 |
D003069 | Coffee | Coffee affects the localization of NFE2L2 protein | 21448860|2294651 |
D003069 | Coffee | Coffee results in increased expression of NFE2L2 mRNA | 22314914|2294651 |
D003069 | Coffee | NFE2L2 promoter polymorphism affects the reaction [UGT1A1 promoter polymorphism affects the susceptibility to Coffee] | 25606436 |
D003069 | Coffee | NFE2L2 promoter SNP affects the reaction [Coffee results in increased expression of GSTA1 mRNA] | 25606436 |
D003069 | Coffee | NFE2L2 promoter SNP affects the reaction [Coffee results in increased expression of NFE2L2 mRNA] | 25606436|2560643 |
D003069 | Coffee | NFE2L2 promoter SNP affects the susceptibility to Coffee | 25606436 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of CYP1A2 mRNA] | 18028974 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of GCLC mRNA] | 18028974 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of GSTA1 mRNA] | 18028974 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of GSTA3 mRNA] | 18028974 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of GSTA4 mRNA] | 18028974 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of NQO1 mRNA] | 18028974 |
D003069 | Coffee | NFE2L2 protein promotes the reaction [Coffee results in increased expression of UGT1A6 mRNA] | 18028974 |
C075384 | coniferaldehyde | coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein | 26275128 |
C075384 | coniferaldehyde | MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 26275128 |
C075384 | coniferaldehyde | MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 26275128 |
C075384 | coniferaldehyde | NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein] | 26275128 |
C075384 | coniferaldehyde | NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] | 26275128 |
C075384 | coniferaldehyde | PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 26275128 |
C075384 | coniferaldehyde | coniferaldehyde results in increased expression of NFE2L2 protein | 26275128 |
D003300 | Copper | Copper results in increased expression of NFE2L2 mRNA | 24403277 |
D003300 | Copper | Copper results in increased expression of NFE2L2 mRNA | 25461751 |
D003300 | Copper | Copper affects the localization of and results in decreased activity of NFE2L2 protein | 25562835 |
D003300 | Copper | Copper affects the localization of and results in increased activity of NFE2L2 protein | 25087001 |
D003300 | Copper | Copper promotes the reaction [NFE2L2 protein binds to SOD1 promoter] | 25087001 |
D003300 | Copper | Copper results in increased expression of NFE2L2 mRNA | 25087001 |
D003300 | Copper | Inositol inhibits the reaction [Copper affects the localization of and results in decreased activity of NFE2L2 protein] | 25562835 |
D003300 | Copper | [Copper co-treated with Chlorpyrifos] results in decreased expression of NFE2L2 mRNA | 21356183 |
D003300 | Copper | Copper results in decreased expression of NFE2L2 mRNA | 21356183 |
D003300 | Copper | [Chitosan metabolite results in decreased susceptibility to Copper] which results in increased phosphorylation of NFE2L2 protein | 25542178 |
D003300 | Copper | Copper results in increased activity of NFE2L2 promoter | 21643505 |
D003300 | Copper | NFE2L2 gene promotes the reaction [Copper results in increased expression of MT1 mRNA] | 24462598 |
D003300 | Copper | NFE2L2 gene results in decreased susceptibility to Copper | 24462598 |
D003300 | Copper | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA | 20302851 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of NFE2L2 mRNA | 19549813 |
D019327 | Copper Sulfate | NFE2L2 protein affects the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA] | 22003191 |
D003348 | Cortisone | [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
D003348 | Cortisone | [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein]] | 22606287 |
D003348 | Cortisone | [HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein | 22606287 |
C030123 | coumarin | coumarin affects the activity of NFE2L2 protein | 11309284 |
D003404 | Creatinine | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine | 28710020 |
D003436 | Croton Oil | NFE2L2 affects the susceptibility to Croton Oil | 23564646 |
C007164 | cumene hydroperoxide | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide] | 19608619 |
C007164 | cumene hydroperoxide | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide | 19608619 |
C007164 | cumene hydroperoxide | NFE2L2 gene mutant form results in increased susceptibility to cumene hydroperoxide | 19608619 |
C007164 | cumene hydroperoxide | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to cumene hydroperoxide]] | 20932822 |
C007164 | cumene hydroperoxide | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to cumene hydroperoxide | 19303893 |
C007164 | cumene hydroperoxide | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to cumene hydroperoxide] | 20932822 |
D003471 | Cuprizone | Cuprizone results in increased expression of NFE2L2 mRNA | 26577399 |
D003474 | Curcumin | Curcumin affects the localization of NFE2L2 protein | 23954767 |
D003474 | Curcumin | Curcumin analog affects the localization of NFE2L2 protein | 23954767 |
D003474 | Curcumin | Curcumin promotes the reaction [NFE2L2 protein binds to GSTP1 promoter] | 17449203 |
D003474 | Curcumin | Curcumin promotes the reaction [NFE2L2 protein results in increased expression of GSTP1 mRNA] | 17449203 |
D003474 | Curcumin | Curcumin promotes the reaction [quinocetone results in increased expression of NFE2L2 mRNA] | 27375190 |
D003474 | Curcumin | Curcumin results in increased expression of and affects the localization of NFE2L2 protein | 23710286 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of GCLC mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of GCLM mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of HMOX1 mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of HMOX1 protein] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of NQO1 mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin analog results in increased expression of NQO1 protein] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of GCLC mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of GCLM mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of HMOX1 mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of HMOX1 protein] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of NQO1 mRNA] | 23954767 |
D003474 | Curcumin | NFE2L2 mutant form inhibits the reaction [Curcumin results in increased expression of NQO1 protein] | 23954767 |
D003474 | Curcumin | NFE2L2 protein affects the reaction [Curcumin analog results in decreased susceptibility to Acrolein] | 23954767 |
D003474 | Curcumin | NFE2L2 protein affects the reaction [Curcumin results in decreased susceptibility to Acrolein] | 23954767 |
D003474 | Curcumin | Curcumin results in increased expression of NFE2L2 mRNA | 21256849 |
D003474 | Curcumin | Curcumin results in increased expression of NFE2L2 protein | 21256849 |
D003474 | Curcumin | Curcumin affects the localization of NFE2L2 protein | 17535857|1832186 |
D003474 | Curcumin | Curcumin analog results in decreased methylation of NFE2L2 promoter | 26991801 |
D003474 | Curcumin | Curcumin analog results in increased expression of NFE2L2 mRNA | 26991801 |
D003474 | Curcumin | Curcumin analog results in increased expression of NFE2L2 protein | 26991801 |
D003474 | Curcumin | [Curcumin co-treated with Benzo(a)pyrene] affects the localization of NFE2L2 protein | 18321868 |
D003474 | Curcumin | Curcumin results in increased expression of NFE2L2 mRNA | 19183254 |
D003474 | Curcumin | Curcumin results in increased expression of NFE2L2 protein | 18321868|2387178 |
D003474 | Curcumin | "NFE2L2 gene mutant form affects the reaction [Curcumin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 protein]]" | 25387343 |
D003474 | Curcumin | "NFE2L2 gene mutant form inhibits the reaction [Curcumin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]]" | 25387343 |
D003474 | Curcumin | "NFE2L2 gene mutant form inhibits the reaction [Curcumin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]]" | 25387343 |
D003474 | Curcumin | "NFE2L2 gene mutant form inhibits the reaction [Curcumin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 mRNA]]" | 25387343 |
D003474 | Curcumin | NFE2L2 protein affects the reaction [Curcumin results in increased expression of HMOX1 mRNA] | 17535857 |
D003474 | Curcumin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] | 17640564 |
D003474 | Curcumin | Curcumin affects the localization of NFE2L2 protein | 17640564 |
D003474 | Curcumin | Curcumin inhibits the reaction [maleic acid affects the expression of NFE2L2 protein] | 25119790 |
D003474 | Curcumin | Curcumin inhibits the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 25169090 |
D003474 | Curcumin | Curcumin inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein] | 25169090 |
D003474 | Curcumin | Curcumin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 protein] | 24952339 |
D003474 | Curcumin | Curcumin inhibits the reaction [Streptozocin affects the localization of NFE2L2 protein] | 25541178 |
D003474 | Curcumin | Curcumin promotes the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA] | 26361869 |
D003474 | Curcumin | Curcumin promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 18006204 |
D003474 | Curcumin | Curcumin results in increased localization of NFE2L2 protein | 18006204 |
D003474 | Curcumin | NFE2L2 protein promotes the reaction [Curcumin results in increased activity of RELA protein] | 18588981 |
D003474 | Curcumin | NFE2L2 protein promotes the reaction [Curcumin results in increased expression of AKR1B1 mRNA] | 17640564|1858898 |
D003474 | Curcumin | NFE2L2 protein promotes the reaction [Curcumin results in increased expression of AKR1B1 protein] | 18588981 |
D003474 | Curcumin | pyrazolanthrone inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] | 17640564 |
D003474 | Curcumin | SB 203580 inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] | 17640564 |
D003474 | Curcumin | Curcumin results in increased expression of NFE2L2 | 18462866 |
C017154 | cyanidin | cyanidin affects the expression of NFE2L2 protein | 26505893 |
C017154 | cyanidin | cyanidin results in increased activity of NFE2L2 protein | 27166148 |
C114438 | cyanidin 3-O-glucoside | [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin 3-O-glucoside] results in increased activity of NFE2L2 protein | 27818126 |
C114438 | cyanidin 3-O-glucoside | cyanidin 3-O-glucoside results in increased activity of NFE2L2 protein | 27166148 |
C057862 | cyanoginosin LR | cyanoginosin LR affects the expression of NFE2L2 protein | 20600217 |
C057862 | cyanoginosin LR | [cyanoginosin LR affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 20722399 |
C057862 | cyanoginosin LR | [cyanoginosin LR affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 20722399 |
C057862 | cyanoginosin LR | cyanoginosin LR inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 20722399 |
C057862 | cyanoginosin LR | cyanoginosin LR promotes the reaction [sulforafan affects the localization of NFE2L2 protein] | 20600217 |
C057862 | cyanoginosin LR | cyanoginosin LR results in decreased degradation of NFE2L2 protein | 20722399 |
C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of and results in increased activity of and affects the localization of NFE2L2 protein | 20722399 |
C057862 | cyanoginosin LR | NFE2L2 protein affects the susceptibility to cyanoginosin LR | 20722399 |
C057862 | cyanoginosin LR | NFE2L2 protein affects the susceptibility to [cyanoginosin LR results in increased expression of HMOX1 protein] | 20722399 |
C057862 | cyanoginosin LR | NFE2L2 protein affects the susceptibility to [cyanoginosin LR results in increased expression of NQO1 protein] | 20722399 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Quercetin results in increased expression of NFE2L2 protein] | 25896339 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [SB 203580 affects the reaction [Quercetin affects the localization of NFE2L2 protein]] | 22197970 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [[SB 203580 co-treated with Quercetin] results in increased expression of NFE2L2 protein] | 22197970 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
D003513 | Cycloheximide | Cycloheximide results in decreased expression of NFE2L2 protein | 25896339 |
D003513 | Cycloheximide | [SB 203580 co-treated with Cycloheximide] inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] | 22197970 |
D003513 | Cycloheximide | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Cycloheximide] results in increased expression of NFE2L2 protein | 14510636 |
D003513 | Cycloheximide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Particulate Matter analog results in increased expression of NFE2L2 protein]] | 15322212 |
D003513 | Cycloheximide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Vehicle Emissions analog results in increased expression of NFE2L2 protein]] | 15322212 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased activity of NFE2L2 protein] | 12441344 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Particulate Matter analog results in increased expression of NFE2L2 protein] | 15322212 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Vehicle Emissions analog results in increased expression of NFE2L2 protein] | 15322212 |
D003513 | Cycloheximide | Cycloheximide results in decreased expression of NFE2L2 protein | 12441344|1451063 |
D003513 | Cycloheximide | exenatide inhibits the reaction [Cycloheximide results in decreased expression of NFE2L2 protein] | 27939242 |
D003520 | Cyclophosphamide | Cyclophosphamide promotes the reaction [NFE2L2 gene mutant form results in decreased expression of CAT protein] | 27633142 |
D003520 | Cyclophosphamide | Cyclophosphamide promotes the reaction [NFE2L2 gene mutant form results in decreased expression of GCLC protein] | 27633142 |
D003520 | Cyclophosphamide | Cyclophosphamide promotes the reaction [NFE2L2 gene mutant form results in decreased expression of NQO1 protein] | 27633142 |
D003520 | Cyclophosphamide | NFE2L2 gene mutant form inhibits the reaction [Cyclophosphamide results in increased expression of NQO1 mRNA] | 27633142 |
D003520 | Cyclophosphamide | NFE2L2 gene mutant form promotes the reaction [Cyclophosphamide results in decreased expression of CAT protein] | 27633142 |
D003520 | Cyclophosphamide | NFE2L2 gene mutant form promotes the reaction [Cyclophosphamide results in decreased expression of NQO1 protein] | 27633142 |
D003520 | Cyclophosphamide | NFE2L2 gene mutant form results in increased susceptibility to Cyclophosphamide | 27633142 |
D003520 | Cyclophosphamide | [astaxanthine co-treated with Cyclophosphamide] results in increased expression of NFE2L2 protein | 20038455 |
D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of NFE2L2 protein | 20038455|2043364 |
D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of NFE2L2 protein | 20038455 |
D003520 | Cyclophosphamide | Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 protein] | 20433640 |
D016572 | Cyclosporine | Cyclosporine affects the activity of NFE2L2 protein | 25596134 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of NFE2L2 mRNA | 20106945|2497309 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of NFE2L2 protein | 23958496 |
D016572 | Cyclosporine | Cyclosporine affects the activity of NFE2L2 protein | 25596134 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of NFE2L2 mRNA | 25596134 |
C075687 | cynaropicrin | AHR mutant form inhibits the reaction [cynaropicrin affects the localization of NFE2L2 protein] | 25680693 |
C075687 | cynaropicrin | AHR mutant form inhibits the reaction [cynaropicrin results in increased expression of NFE2L2 mRNA] | 25680693 |
C075687 | cynaropicrin | cynaropicrin affects the localization of NFE2L2 protein | 25680693 |
C075687 | cynaropicrin | cynaropicrin results in increased expression of NFE2L2 mRNA | 25680693 |
C075687 | cynaropicrin | NFE2L2 mutant form inhibits the reaction [cynaropicrin results in increased expression of NQO1 mRNA] | 25680693 |
D003609 | Dactinomycin | Dactinomycin inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA] | 24632381 |
C012864 | dazomet | dazomet results in increased activity of NFE2L2 protein | 20143881 |
C017180 | decamethrin | Acetylcysteine inhibits the reaction [decamethrin affects the localization of NFE2L2 protein] | 17540521 |
C017180 | decamethrin | Acetylcysteine inhibits the reaction [decamethrin results in increased activity of NFE2L2 protein] | 17540521 |
C017180 | decamethrin | Acetylcysteine inhibits the reaction [decamethrin results in increased expression of NFE2L2 protein] | 17540521 |
C017180 | decamethrin | Buthionine Sulfoximine inhibits the reaction [decamethrin results in increased expression of and affects the localization of NFE2L2 protein] | 23585199 |
C017180 | decamethrin | Buthionine Sulfoximine inhibits the reaction [decamethrin results in increased expression of NFE2L2 mRNA] | 23585199 |
C017180 | decamethrin | decamethrin affects the localization of NFE2L2 protein | 17540521|1767681 |
C017180 | decamethrin | decamethrin inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] | 17676812 |
C017180 | decamethrin | decamethrin results in increased activity of NFE2L2 protein | 17540521|1767681 |
C017180 | decamethrin | decamethrin results in increased expression of and affects the localization of NFE2L2 protein | 23585199 |
C017180 | decamethrin | decamethrin results in increased expression of NFE2L2 | 21398409 |
C017180 | decamethrin | decamethrin results in increased expression of NFE2L2 mRNA | 16758951|1754052 |
C017180 | decamethrin | decamethrin results in increased expression of NFE2L2 protein | 17540521|1767681 |
C014347 | decitabine | [decitabine co-treated with trichostatin A] results in decreased methylation of NFE2L2 promoter | 26991801 |
D003671 | DEET | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein | 28659758 |
D003676 | Deferoxamine | Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein] | 26945724 |
D003676 | Deferoxamine | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] | 26945724 |
D003676 | Deferoxamine | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein]] | 26945724 |
C548688 | dehydroglyasperin C | dehydroglyasperin C affects the localization of NFE2L2 protein | 20088509 |
C479072 | delta-tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | 22389237 |
C050229 | demethoxycurcumin | demethoxycurcumin affects the localization of NFE2L2 protein | 17535857 |
C050229 | demethoxycurcumin | [demethoxycurcumin co-treated with bis(4-hydroxycinnamoyl)methane] affects the localization of NFE2L2 protein | 17535857 |
C050229 | demethoxycurcumin | NFE2L2 protein affects the reaction [demethoxycurcumin results in increased expression of HMOX1 mRNA] | 17535857 |
D003840 | Deoxycholic Acid | [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | 17724089 |
D003840 | Deoxycholic Acid | [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 17724089 |
D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased expression of NFE2L2 mRNA | 25582706 |
D003891 | Desipramine | NFE2L2 protein affects the susceptibility to Desipramine | 21540358 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26363199 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of NFE2L2 mRNA | 17627975 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [NFE2L2 protein results in increased expression of GSTA2 mRNA] | 15870285 |
C031710 | dexamethasone 21-methanesulfonate | dexamethasone 21-methanesulfonate affects the localization of and results in increased activity of NFE2L2 protein | 18785192 |
D016264 | Dextran Sulfate | Dextran Sulfate results in decreased expression of NFE2L2 protein | 23261717 |
D016264 | Dextran Sulfate | NFE2L2 affects the susceptibility to Dextran Sulfate | 20404090 |
D016264 | Dextran Sulfate | NFE2L2 results in decreased susceptibility to [Dextran Sulfate co-treated with Azoxymethane] | 23056183 |
C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [Cadmium affects the localization of NFE2L2 protein] | 16959797 |
C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [Cadmium Chloride affects the localization of NFE2L2 protein] | 16959797 |
C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [Hemin affects the localization of NFE2L2 protein] | 16959797 |
C029569 | diacetyldichlorofluorescein | diacetyldichlorofluorescein inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 16959797 |
C028009 | diallyl disulfide | diallyl disulfide inhibits the reaction [Carbon Tetrachloride results in decreased expression of and affects the localization of NFE2L2 protein] | 24293383 |
C042577 | diallyl trisulfide | Acetylcysteine inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] | 24489685 |
C042577 | diallyl trisulfide | diallyl trisulfide promotes the reaction [KEAP1 mutant form affects the localization of NFE2L2 protein] | 24489685 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of and affects the localization of NFE2L2 protein | 24489685 |
C042577 | diallyl trisulfide | Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] | 24489685 |
C042577 | diallyl trisulfide | NFE2L2 mutant form inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein] | 24489685 |
C042577 | diallyl trisulfide | NFE2L2 mutant form inhibits the reaction [diallyl trisulfide results in increased expression of NQO1 protein] | 24489685 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of and affects the localization of NFE2L2 protein | 24489685 |
C042577 | diallyl trisulfide | NFE2L2 gene mutant form inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein] | 24489685 |
C042577 | diallyl trisulfide | diallyl trisulfide inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 23453443 |
C042577 | diallyl trisulfide | diallyl trisulfide promotes the reaction [Glucose results in increased expression of and affects the localization of NFE2L2 protein] | 23453443 |
C042577 | diallyl trisulfide | diallyl trisulfide promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer] | 20237067 |
C042577 | diallyl trisulfide | [diallyl trisulfide promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA | 20237067 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased activity of NFE2L2 protein | 20237067 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of and affects the localization of NFE2L2 protein | 25896937 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of NFE2L2 mRNA | 18768114 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of NFE2L2 protein | 20237067|2345344 |
C042577 | diallyl trisulfide | NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]] | 23453443 |
C042577 | diallyl trisulfide | NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]] | 25896937 |
C042577 | diallyl trisulfide | NFE2L2 protein promotes the reaction [diallyl trisulfide results in increased expression of HMOX1 protein] | 25896937 |
C042577 | diallyl trisulfide | PIK3R1 protein promotes the reaction [diallyl trisulfide results in increased expression of NFE2L2 protein] | 25896937 |
D003958 | Diamide | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Diamide | 19303893 |
D003974 | Diatrizoate Meglumine | Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA | 28412091 |
D003974 | Diatrizoate Meglumine | Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA] | 28412091 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of NFE2L2 mRNA | 21266533 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of NFE2L2 protein | 28295950 |
D003993 | Dibutyl Phthalate | [sulforafan co-treated with Dibutyl Phthalate] results in increased expression of NFE2L2 protein | 28295950 |
D003994 | Bucladesine | NFE2L2 gene mutant form promotes the reaction [Bucladesine results in increased expression of CYP2A5 mRNA] | 22859313 |
D003994 | Bucladesine | NFE2L2 gene mutant form promotes the reaction [Bucladesine results in increased expression of G6PC mRNA] | 22859313 |
D003994 | Bucladesine | NFE2L2 gene mutant form results in increased susceptibility to Bucladesine | 22859313 |
D003994 | Bucladesine | [NFE2L2 gene mutant form results in increased susceptibility to Bucladesine] which results in increased expression of ALAS1 mRNA | 22859313 |
D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of NFE2L2 mRNA | 28962523 |
D002945 | Cisplatin | [brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein] which results in increased susceptibility to Cisplatin | 21205897 |
D002945 | Cisplatin | Cisplatin affects the activity of NFE2L2 protein | 25596134 |
D002945 | Cisplatin | Cisplatin results in increased expression of NFE2L2 mRNA | 27594783|2895953 |
D002945 | Cisplatin | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Cisplatin | 20530669 |
D002945 | Cisplatin | NFE2L2 mutant form results in increased susceptibility to Cisplatin | 24817946 |
D002945 | Cisplatin | NFE2L2 protein affects the susceptibility to Cisplatin | 23933386 |
D002945 | Cisplatin | NFE2L2 protein results in decreased susceptibility to Cisplatin | 21489257|2589633 |
D002945 | Cisplatin | NFE2L2 results in decreased susceptibility to Cisplatin | 20530669|2184220 |
D002945 | Cisplatin | [sulforafan results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Cisplatin | 25159039 |
D002945 | Cisplatin | "[1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Cisplatin" | 20605904 |
D002945 | Cisplatin | "1,3-dimethylthiourea promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA]" | 23384965 |
D002945 | Cisplatin | Cisplatin results in increased expression of NFE2L2 mRNA | 23384965 |
D002945 | Cisplatin | Cisplatin results in increased expression of NFE2L2 protein | 26193055 |
D002945 | Cisplatin | erdosteine promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] | 26193055 |
D002945 | Cisplatin | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Cisplatin | 19303893 |
D002945 | Cisplatin | NFE2L2 protein inhibits the reaction [Cisplatin results in increased activity of RELA protein] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of ABCC2 mRNA] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of ABCC2 protein] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of ABCC4 mRNA] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of ABCC4 protein] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of GCLC mRNA] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of GCLC protein] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of HMOX1 mRNA] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of HMOX1 protein] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of NQO1 mRNA] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of NQO1 protein] | 20605904 |
D002945 | Cisplatin | NFE2L2 protein results in decreased susceptibility to Cisplatin | 20605904|2093282 |
D002945 | Cisplatin | acetovanillone inhibits the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] | 24291008 |
D002945 | Cisplatin | Cisplatin results in increased expression of NFE2L2 mRNA | 24291008 |
D002945 | Cisplatin | Cisplatin results in increased expression of NFE2L2 protein | 27616468 |
D002945 | Cisplatin | Silymarin inhibits the reaction [Cisplatin results in increased expression of NFE2L2 protein] | 27616468 |
D002945 | Cisplatin | tangeretin inhibits the reaction [Cisplatin results in increased expression of NFE2L2 protein] | 27616468 |
D003633 | Dichlorodiphenyl Dichloroethylene | Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA] | 25263748 |
D003633 | Dichlorodiphenyl Dichloroethylene | Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein] | 25263748 |
D003633 | Dichlorodiphenyl Dichloroethylene | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA] | 25263748 |
D003633 | Dichlorodiphenyl Dichloroethylene | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein] | 25263748 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA | 25263748 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein | 25263748 |
D004006 | Dichlorvos | Dichlorvos results in increased activity of NFE2L2 protein | 20143881 |
D004006 | Dichlorvos | Dichlorvos results in decreased expression of NFE2L2 mRNA | 25891459 |
D004006 | Dichlorvos | Dichlorvos results in decreased expression of NFE2L2 protein | 26814074 |
D004006 | Dichlorvos | PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA] | 25891459 |
D004006 | Dichlorvos | PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein] | 26814074 |
D004008 | Diclofenac | Diclofenac results in increased stability of NFE2L2 protein | 24752500 |
D004008 | Diclofenac | NFE2L2 protein affects the reaction [Diclofenac results in increased expression of SRXN1 mRNA] | 24752500 |
C121718 | dicyclanil | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | 19182440 |
C121718 | dicyclanil | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of NFE2L2 mRNA] | 19182440 |
D004040 | Dietary Carbohydrates | [Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein | 21289251 |
D004040 | Dietary Carbohydrates | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
D004040 | Dietary Carbohydrates | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
D004040 | Dietary Carbohydrates | [Dietary Carbohydrates co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein | 22535755 |
D004040 | Dietary Carbohydrates | Quercetin inhibits the reaction [[Dietary Carbohydrates co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | 22535755 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein | 21289251 |
D004041 | Dietary Fats | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
D004041 | Dietary Fats | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NFE2L2 mRNA | 27070252 |
D004041 | Dietary Fats | resveratrol inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NFE2L2 mRNA] | 27070252 |
D004041 | Dietary Fats | [APOE protein affects the susceptibility to Dietary Fats] promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA] | 24330719 |
D004041 | Dietary Fats | [APOE protein affects the susceptibility to Dietary Fats] promotes the reaction [Vehicle Emissions results in increased expression of NFE2L2 mRNA] | 24330719 |
D004041 | Dietary Fats | Dietary Fats affects the localization of NFE2L2 protein | 28555106 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of and affects the localization of NFE2L2 protein | 27370414 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of NFE2L2 | 27311796 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of NFE2L2 mRNA | 24812660 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of NFE2L2 mRNA | 27260466|2855510 |
D004041 | Dietary Fats | [gastrodin co-treated with Dietary Fats] results in increased phosphorylation of NFE2L2 protein | 26634892 |
D004041 | Dietary Fats | NFE2L2 gene mutant form results in increased susceptibility to Dietary Fats | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats affects the activity of GPT protein] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in decreased expression of NR1H3 mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in decreased expression of NR1H4 mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in decreased expression of PPARA mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in increased expression of ACACA mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in increased expression of CYP2A5 protein] | 28555106 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in increased expression of FASN mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in increased expression of PPARGC1A mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [Dietary Fats results in increased expression of SREBF1 mRNA] | 27311796 |
D004041 | Dietary Fats | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Dietary Fats results in increased activity of CASP3 protein]] | 20418481 |
D004041 | Dietary Fats | NFE2L2 protein affects the susceptibility to Dietary Fats | 28555106 |
D004041 | Dietary Fats | Quercetin inhibits the reaction [Dietary Fats results in increased expression of NFE2L2 mRNA] | 27260466 |
D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] | 24812660 |
D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of NFE2L2 mRNA] | 27260466 |
D004041 | Dietary Fats | [Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA | 24707343 |
D004041 | Dietary Fats | [Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein | 24707343 |
D004041 | Dietary Fats | sulforafan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA] | 24707343 |
D004041 | Dietary Fats | sulforafan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | 24707343 |
D004041 | Dietary Fats | Thioctic Acid inhibits the reaction [Dietary Fats results in increased expression of NFE2L2 mRNA] | 27260466 |
D004041 | Dietary Fats | Zinc deficiency promotes the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 27370414 |
D004041 | Dietary Fats | Zinc inhibits the reaction [Dietary Fats results in decreased expression of and affects the localization of NFE2L2 protein] | 27370414 |
D004041 | Dietary Fats | chromium histidinate inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 21539728 |
D004041 | Dietary Fats | [Dietary Carbohydrates co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein | 22535755 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of NFE2L2 protein | 21539728|2355192 |
D004041 | Dietary Fats | Fish Oils inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 23551926 |
D004041 | Dietary Fats | Quercetin inhibits the reaction [[Dietary Carbohydrates co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | 22535755 |
D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 23551926 |
D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NFE2L2 mRNA | 27070252 |
D019422 | Dietary Sucrose | resveratrol inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NFE2L2 mRNA] | 27070252 |
D004051 | Diethylhexyl Phthalate | Curcumin promotes the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA] | 26361869 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA | 22672789|2636186 |
D004051 | Diethylhexyl Phthalate | resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA] | 26361869 |
C014476 | diethyl maleate | diethyl maleate affects the localization of NFE2L2 protein | 27982581 |
C014476 | diethyl maleate | diethyl maleate binds to and results in increased activity of NFE2L2 protein | 20806931 |
C014476 | diethyl maleate | diethyl maleate results in increased expression of NFE2L2 protein | 27358234 |
C014476 | diethyl maleate | NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] | 27982581 |
C014476 | diethyl maleate | diethyl maleate affects the localization of NFE2L2 protein | 12235164 |
C014476 | diethyl maleate | NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA] | 12235164 |
C014476 | diethyl maleate | NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] | 22003191 |
C014476 | diethyl maleate | NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] | 22003191 |
C014476 | diethyl maleate | NFE2L2 results in decreased susceptibility to diethyl maleate | 12235164 |
C014476 | diethyl maleate | diethyl maleate results in increased expression of NFE2L2 protein | 21465251 |
D004052 | Diethylnitrosamine | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | 19182440 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of NFE2L2 mRNA | 21607683 |
D004052 | Diethylnitrosamine | [Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein | 28634113 |
D004052 | Diethylnitrosamine | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | 19690152 |
D004052 | Diethylnitrosamine | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of NFE2L2 mRNA] | 19182440 |
D004052 | Diethylnitrosamine | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA] | 22129741 |
D004052 | Diethylnitrosamine | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA | 28935427 |
D004052 | Diethylnitrosamine | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 protein | 28935427 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA | 28414157 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein | 28414157 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NFE2L2 protein | 20935162 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NFE2L2 mRNA | 23830814 |
D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein | 18775883 |
D004052 | Diethylnitrosamine | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA] | 28935427 |
D004052 | Diethylnitrosamine | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 protein] | 28935427 |
D004052 | Diethylnitrosamine | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | 22129741 |
D004052 | Diethylnitrosamine | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA | 20302851 |
D004052 | Diethylnitrosamine | myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA] | 28414157 |
D004052 | Diethylnitrosamine | myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein] | 28414157 |
D004052 | Diethylnitrosamine | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA] | 28414157 |
D004052 | Diethylnitrosamine | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein] | 28414157 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of NFE2L2 protein | 25242112 |
C039060 | dihydroartemisinin | dihydroartemisinin analog affects the localization of NFE2L2 protein | 26340163 |
C015144 | dihydrolipoic acid | dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer] | 20237067 |
C015144 | dihydrolipoic acid | [dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA | 20237067 |
C015144 | dihydrolipoic acid | dihydrolipoic acid results in increased activity of NFE2L2 protein | 20237067 |
C015144 | dihydrolipoic acid | dihydrolipoic acid results in increased expression of NFE2L2 protein | 20237067 |
D006873 | Hydroquinones | NFE2L2 protein results in decreased susceptibility to Hydroquinones | 20932822 |
D002117 | Calcitriol | Calcitriol results in increased expression of NFE2L2 mRNA | 12040012 |
C042080 | diisodecyl phthalate | [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein | 27871981 |
C552122 | dimerumic acid | dimerumic acid results in increased activity of NFE2L2 protein | 24036144 |
C552122 | dimerumic acid | NFE2L2 protein affects the reaction [dimerumic acid results in decreased expression of ACTA2 mRNA] | 24036144 |
C552122 | dimerumic acid | NFE2L2 protein affects the reaction [dimerumic acid results in decreased expression of AGER mRNA] | 24036144 |
C552122 | dimerumic acid | NFE2L2 protein affects the reaction [dimerumic acid results in decreased expression of COL1A1 mRNA] | 24036144 |
C552122 | dimerumic acid | NFE2L2 protein affects the reaction [dimerumic acid results in decreased expression of PDGFRB mRNA] | 24036144 |
C552122 | dimerumic acid | NFE2L2 protein affects the reaction [dimerumic acid results in increased expression of GCLC mRNA] | 24036144 |
C521105 | dimethoxycurcumin | dimethoxycurcumin affects the localization of NFE2L2 protein | 19177192 |
C521105 | dimethoxycurcumin | NFE2L2 protein affects the reaction [dimethoxycurcumin results in increased expression of HMOX1 protein] | 19177192 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA" | 24995432 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein" | 24995432 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFE2L2 protein" | 22406437 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA]" | 24995432 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]" | 24995432 |
D000069462 | Dimethyl Fumarate | Dimethyl Fumarate affects the localization of NFE2L2 protein | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTH1 mRNA] | 28289076 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTL mRNA] | 28289076 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTL protein] | 28289076 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein] | 28790194 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of COX3 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of CYTB mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLC mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLM mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GSR mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of HMOX1 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of MTERF1A mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of MTERF3 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of ND1 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of ND2 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of ND5 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of NQO1 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of POLG2 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of POLRMT mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of SSBP1 mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of TFAM mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of TFB1M mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of TFB2M mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of TWNK mRNA] | 27277809 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein inhibits the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 23942037 |
D000069462 | Dimethyl Fumarate | NFE2L2 protein promotes the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D019813 | 1,2-Dimethylhydrazine | "NFE2L2 protein affects the reaction [1,2-Dimethylhydrazine affects the expression of HDAC3 protein]" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "NFE2L2 protein affects the reaction [sulforafan affects the reaction [1,2-Dimethylhydrazine affects the expression of HDAC3 protein]]" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which affects the susceptibility to sulforafan" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of CDKN2B mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of MLH1 mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of SERPINB5 mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of CDKN2A mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ETS1 mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of IGF2R mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of TRP53 mRNA" | 26388957 |
D019813 | 1,2-Dimethylhydrazine | "sulforafan inhibits the reaction [[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of CDKN2A mRNA]" | 26388957 |
D004121 | Dimethyl Sulfoxide | [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26497626 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide results in decreased expression of NFE2L2 protein | 26497626 |
C007488 | dinitrobenzenesulfonic acid | dinitrobenzenesulfonic acid results in increased expression of NFE2L2 protein | 19427879 |
D004137 | Dinitrochlorobenzene | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFE2L2 protein] | 19033392 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene affects the localization of and results in increased activity of NFE2L2 protein | 27492222 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of NFE2L2 protein | 19033392|1942787 |
D004137 | Dinitrochlorobenzene | NFE2L2 mRNA promotes the reaction [Dinitrochlorobenzene results in increased expression of HMOX1 mRNA] | 26244607 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein affects the reaction [Dinitrochlorobenzene results in increased expression of DNAJB4 mRNA] | 27965148 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein affects the reaction [Dinitrochlorobenzene results in increased expression of GCLM mRNA] | 27965148 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene affects the expression of NFE2L2 protein | 28219650 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene affects the localization of and results in increased activity of NFE2L2 protein | 18785192 |
D004137 | Dinitrochlorobenzene | NFE2L2 affects the susceptibility to Dinitrochlorobenzene | 23564646 |
D004137 | Dinitrochlorobenzene | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Dinitrochlorobenzene | 19303893 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in decreased abundance of Glutathione] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased abundance of Reactive Oxygen Species] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL3 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased expression of CXCL10 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased expression of CXCL1 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased expression of IL1B mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of BCL2 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of CAT mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GPX1 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GPX2 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GPX5 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GPX6 mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GSR mRNA] | 28219650 |
D004137 | Dinitrochlorobenzene | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of NOS2 mRNA] | 28219650 |
D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of NFE2L2 protein | 19427879|2602271 |
C019357 | dioscin | dioscin inhibits the reaction [Doxorubicin results in decreased expression of and affects the localization of NFE2L2 protein] | 28082111 |
C019357 | dioscin | NR1H4 protein affects the reaction [dioscin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]] | 28082111 |
D004147 | Dioxins | Dioxins affects the expression of NFE2L2 mRNA | 20463971 |
C493087 | diphenylarsinic acid | diphenylarsinic acid affects the localization of NFE2L2 protein | 17628625 |
C493087 | diphenylarsinic acid | diphenylarsinic acid results in increased activity of NFE2L2 protein | 17628625 |
C493087 | diphenylarsinic acid | diphenylarsinic acid results in increased expression of NFE2L2 protein | 26645585|2808783 |
C493087 | diphenylarsinic acid | pyrazolanthrone inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | 28087833 |
C493087 | diphenylarsinic acid | SCH772984 inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | 28087833 |
C493087 | diphenylarsinic acid | U 0126 inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | 28087833 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [phenethyl isothiocyanate affects the localization of NFE2L2 protein] | 26945724 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D004178 | Diquat | Diquat results in increased activity of NFE2L2 protein | 20143881|2117241 |
D004178 | Diquat | Diquat results in increased activity of NFE2L2 protein | 16962985 |
D004178 | Diquat | Diquat results in increased expression of NFE2L2 protein | 20826540 |
D004178 | Diquat | KEAP1 gene mutant form inhibits the reaction [NFE2L2 gene mutant form results in increased susceptibility to Diquat] | 22762311 |
D004178 | Diquat | NFE2L2 gene mutant form promotes the reaction [Diquat results in decreased abundance of Glutathione] | 22762311 |
D004178 | Diquat | NFE2L2 gene mutant form results in increased susceptibility to Diquat | 16962985|2276231 |
D004178 | Diquat | NFE2L2 results in decreased susceptibility to Diquat | 23056183 |
D004178 | Diquat | PROP1 protein affects the reaction [Diquat results in increased expression of NFE2L2 protein] | 20826540 |
D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] | 24489685 |
D004237 | Diuron | Diuron results in increased expression of NFE2L2 mRNA | 21551480 |
D004281 | Docosahexaenoic Acids | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Docosahexaenoic Acids affects the localization of NFE2L2 protein] | 28807874 |
D004281 | Docosahexaenoic Acids | Acetylcysteine inhibits the reaction [Docosahexaenoic Acids affects the localization of NFE2L2 protein] | 28807874 |
D004281 | Docosahexaenoic Acids | Acetylcysteine inhibits the reaction [Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]] | 26163453 |
D004281 | Docosahexaenoic Acids | Acetylcysteine inhibits the reaction [Docosahexaenoic Acids results in increased expression of and affects the localization of NFE2L2 protein] | 26163453 |
D004281 | Docosahexaenoic Acids | [astaxanthine co-treated with Docosahexaenoic Acids] results in increased expression of NFE2L2 mRNA | 24157545 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids affects the localization of NFE2L2 protein | 28807874 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 26163453 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased expression of and affects the localization of NFE2L2 protein | 26163453 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased expression of NFE2L2 mRNA | 24157545 |
D004281 | Docosahexaenoic Acids | NFE2L2 protein promotes the reaction [Docosahexaenoic Acids results in increased expression of OSGIN1 protein] | 28807874 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased expression of NFE2L2 protein | 25545062 |
D004281 | Docosahexaenoic Acids | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] which results in increased expression of and results in increased activity of NFE2L2 protein" | 21130106 |
D004317 | Doxorubicin | chrysin inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Doxorubicin] | 23994249 |
D004317 | Doxorubicin | [Doxorubicin co-treated with resveratrol] results in decreased expression of NFE2L2 protein | 26969377 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of NFE2L2 protein | 26969377 |
D004317 | Doxorubicin | NFE2L2 mRNA results in decreased susceptibility to Doxorubicin | 26708503 |
D004317 | Doxorubicin | NFE2L2 protein affects the reaction [ERBB2 protein results in decreased susceptibility to Doxorubicin] | 25467193 |
D004317 | Doxorubicin | NFE2L2 protein results in decreased susceptibility to Doxorubicin | 23994249 |
D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Lovastatin results in increased expression of NFE2L2 mRNA] | 22712078 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of NFE2L2 mRNA | 21040762|2271207 |
D004317 | Doxorubicin | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] | 28710503 |
D004317 | Doxorubicin | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of NFE2L2 mRNA | 21040762 |
D004317 | Doxorubicin | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Doxorubicin | 19303893 |
D004317 | Doxorubicin | NSC 23766 inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] | 28710503 |
D004317 | Doxorubicin | dioscin inhibits the reaction [Doxorubicin results in decreased expression of and affects the localization of NFE2L2 protein] | 28082111 |
D004317 | Doxorubicin | Doxorubicin results in decreased activity of NFE2L2 protein | 25268985 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of and affects the localization of NFE2L2 protein | 28082111 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of NFE2L2 mRNA | 25268985 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of NFE2L2 protein | 25169008 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of NFE2L2 protein | 24211725 |
D004317 | Doxorubicin | [Doxorubicin results in increased expression of NFE2L2 protein] which results in increased expression of GSTP1 mRNA | 24211725 |
D004317 | Doxorubicin | [Doxorubicin results in increased expression of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 24211725 |
D004317 | Doxorubicin | [Doxorubicin results in increased expression of NFE2L2 protein] which results in increased expression of UGT1A1 mRNA | 24211725 |
D004317 | Doxorubicin | NR1H4 protein affects the reaction [dioscin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]] | 28082111 |
D004317 | Doxorubicin | thymoquinone inhibits the reaction [Doxorubicin results in decreased activity of NFE2L2 protein] | 25268985 |
D004317 | Doxorubicin | thymoquinone inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA] | 25268985 |
D004317 | Doxorubicin | chrysin inhibits the reaction [[NFE2L2 protein results in increased expression of [HMOX1 protein co-treated with AKR1B10 protein co-treated with ABCC5 protein]] which results in decreased susceptibility to Doxorubicin] | 23994249 |
D004317 | Doxorubicin | [NFE2L2 protein results in increased expression of [HMOX1 protein co-treated with AKR1B10 protein co-treated with ABCC5 protein]] which results in decreased susceptibility to Doxorubicin | 23994249 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein" | 28733231 |
D004365 | Drugs, Chinese Herbal | "NFE2L2 protein promotes the reaction [Drugs, Chinese Herbal results in increased expression of HMOX1 protein]" | 28733231 |
D004365 | Drugs, Chinese Herbal | "U 0126 inhibits the reaction [Drugs, Chinese Herbal results in increased expression of and affects the localization of NFE2L2 protein]" | 28733231 |
D004365 | Drugs, Chinese Herbal | "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Drugs, Chinese Herbal results in increased localization of NFE2L2 protein]" | 19647727 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased localization of and results in increased activity of NFE2L2 protein" | 19647727 |
D004365 | Drugs, Chinese Herbal | "NFE2L2 protein affects the reaction [Drugs, Chinese Herbal results in increased expression of HMOX1 protein]" | 19647727 |
C060297 | echinacoside | echinacoside results in increased activity of and affects the localization of NFE2L2 protein | 22735309 |
D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] | 21443188 |
D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21443188 |
D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] | 21443188 |
D015118 | Eicosapentaenoic Acid | [astaxanthine co-treated with Eicosapentaenoic Acid] results in increased expression of NFE2L2 mRNA | 24157545 |
D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in increased expression of NFE2L2 mRNA | 24157545 |
D004610 | Ellagic Acid | Ellagic Acid affects the localization of NFE2L2 protein | 22386815 |
D004610 | Ellagic Acid | Ellagic Acid results in increased expression of and affects the localization of NFE2L2 protein | 23546295 |
D004610 | Ellagic Acid | Ellagic Acid results in increased expression of NFE2L2 mRNA | 22386815|2354629 |
D004610 | Ellagic Acid | Ellagic Acid results in increased expression of NFE2L2 protein | 23546295 |
D004610 | Ellagic Acid | NFE2L2 protein affects the susceptibility to Ellagic Acid | 22386815 |
D004610 | Ellagic Acid | [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein | 23546295 |
D004610 | Ellagic Acid | [Paraquat co-treated with Ellagic Acid] results in increased expression of NFE2L2 mRNA | 23546295 |
C509870 | EM703 | EM703 inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein] | 23291319 |
C509870 | EM703 | EM703 inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein] | 23291319 |
D004642 | Emodin | Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of NFE2L2 protein] | 26139382 |
D004642 | Emodin | Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of NFE2L2 mRNA] | 26139382 |
D004656 | Enalapril | Enalapril results in decreased expression of NFE2L2 mRNA | 18765277 |
D004785 | Environmental Pollutants | Environmental Pollutants results in increased expression of NFE2L2 mRNA | 20064776 |
C062669 | epicatechin gallate | ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] | 29061316 |
C062669 | epicatechin gallate | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein | 29061316 |
C045651 | epigallocatechin gallate | ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] | 29061316 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of NFE2L2 protein | 16799064 |
C045651 | epigallocatechin gallate | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein | 29061316 |
C045651 | epigallocatechin gallate | epigallocatechin gallate affects the localization of NFE2L2 protein | 25585349 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of NFE2L2 mRNA | 25585349 |
C045651 | epigallocatechin gallate | NFE2L2 protein affects the reaction [epigallocatechin gallate results in increased expression of GSTO1 mRNA] | 22521609 |
C045651 | epigallocatechin gallate | NFE2L2 protein affects the reaction [epigallocatechin gallate results in increased expression of NQO1 mRNA] | 22521609 |
C045651 | epigallocatechin gallate | epigallocatechin gallate promotes the reaction [[[NFE2L2 protein binds to MAF protein] which binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 15832810 |
C414690 | eplerenone | eplerenone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
C078846 | epoxomicin | epoxomicin results in increased expression of NFE2L2 protein | 22558124 |
C078846 | epoxomicin | epoxomicin results in increased expression of NFE2L2 protein | 22558124 |
C048498 | erdosteine | erdosteine promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] | 26193055 |
C015860 | ergosta-4,6,8(14),22-tetraen-3-one | "ergosta-4,6,8(14),22-tetraen-3-one inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein]" | 28578904 |
C007619 | eriodictyol | eriodictyol results in increased expression of NFE2L2 protein | 16799064 |
D004917 | Erythromycin | Erythromycin inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein] | 23291319 |
D004917 | Erythromycin | Erythromycin inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein] | 23291319 |
C007628 | esculetin | esculetin results in increased localization of NFE2L2 protein | 20933534 |
D004976 | Ethacrynic Acid | Ethacrynic Acid affects the localization of NFE2L2 protein | 20934533|2581789 |
D004976 | Ethacrynic Acid | Ethacrynic Acid results in increased expression of NFE2L2 protein | 20934533 |
D004976 | Ethacrynic Acid | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] | 26945724 |
D004976 | Ethacrynic Acid | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Ethacrynic Acid | 19303893 |
D004976 | Ethacrynic Acid | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Ethacrynic Acid] | 20932822 |
D000431 | Ethanol | [Ethanol affects the activity of CYP2E1 protein] which affects the localization of NFE2L2 protein | 22530035 |
D000431 | Ethanol | [[Ethanol affects the activity of CYP2E1 protein] which affects the localization of NFE2L2 protein] which results in increased expression of CYP2A6 | 22530035 |
D000431 | Ethanol | Ethanol affects the localization of NFE2L2 protein | 17433488|2253003 |
D000431 | Ethanol | [Ethanol affects the localization of NFE2L2 protein] which results in increased expression of CYP2A6 | 22530035 |
D000431 | Ethanol | Ethanol results in increased expression of NFE2L2 protein | 23994065 |
D000431 | Ethanol | [lucidone co-treated with Ethanol] results in increased expression of NFE2L2 mRNA | 22484158 |
D000431 | Ethanol | NFE2L2 protein inhibits the reaction [Ethanol results in increased abundance of Reactive Oxygen Species] | 23994065 |
D000431 | Ethanol | NFE2L2 protein inhibits the reaction [Ethanol results in increased cleavage of and results in increased activity of CASP3 protein] | 23994065 |
D000431 | Ethanol | NFE2L2 protein inhibits the reaction [Ethanol results in increased expression of CASP3 protein modified form] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of and results in increased activity of CAT protein] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of and results in increased activity of SOD1 protein] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of CAT mRNA] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of GPX3 mRNA] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of GPX3 protein] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of NQO1 mRNA] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of NQO1 protein] | 23994065 |
D000431 | Ethanol | NFE2L2 protein promotes the reaction [Ethanol results in increased expression of SOD1 mRNA] | 23994065 |
D000431 | Ethanol | NFE2L2 protein results in decreased susceptibility to Ethanol | 23994065 |
D000431 | Ethanol | Staurosporine inhibits the reaction [Ethanol affects the localization of NFE2L2 protein] | 22530035 |
D000431 | Ethanol | U 0126 inhibits the reaction [Ethanol affects the localization of NFE2L2 protein] | 22530035 |
D000431 | Ethanol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
D000431 | Ethanol | Ethanol inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of FGF21 protein] | 28131861 |
D000431 | Ethanol | Ethanol inhibits the reaction [NFE2L2 gene mutant form results in increased expression of PPARA protein] | 28131861 |
D000431 | Ethanol | Ethanol results in decreased expression of NFE2L2 mRNA | 15513904 |
D000431 | Ethanol | Ethanol results in increased expression of and affects the localization of NFE2L2 protein | 25449124 |
D000431 | Ethanol | Ethanol results in increased expression of NFE2L2 protein | 22996800|2399406 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in decreased expression of PPARA protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of ACTA2 protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of COL1A1 protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of FN1 protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of HIF1A mRNA]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of HIF1A protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of RELA protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of SREBF1 protein]] | 27837167 |
D000431 | Ethanol | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of TNF protein]] | 27837167 |
D000431 | Ethanol | "NFE2L2 protein affects the reaction [Ethanol results in increased abundance of Fatty Acids, Nonesterified]" | 22627062 |
D000431 | Ethanol | NFE2L2 protein affects the reaction [Ethanol results in increased abundance of Triglycerides] | 22627062 |
D000431 | Ethanol | NFE2L2 protein affects the reaction [Ethanol results in increased expression of and results in increased activity of CYP2A5 protein] | 22552773 |
D000431 | Ethanol | NFE2L2 protein affects the reaction [Ethanol results in increased expression of CYP2A5 protein] | 28131861 |
D000431 | Ethanol | NFE2L2 protein affects the reaction [Ethanol results in increased expression of SREBF1 mRNA] | 22627062 |
D000431 | Ethanol | NFE2L2 protein affects the susceptibility to Ethanol | 22627062 |
D000431 | Ethanol | [Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein | 25449124 |
D000431 | Ethanol | pyrazolanthrone inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
D000431 | Ethanol | SB 203580 promotes the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
D000431 | Ethanol | Ethanol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein] | 26747958 |
D000431 | Ethanol | Ethanol results in decreased expression of and affects the localization of NFE2L2 protein | 25111957 |
D000431 | Ethanol | Ethanol results in decreased expression of NFE2L2 protein | 26460608 |
D000431 | Ethanol | [Fish Oils co-treated with Ethanol] results in increased expression of NFE2L2 mRNA | 17347304 |
D000431 | Ethanol | Oleanolic Acid inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein] | 25111957 |
D000431 | Ethanol | Oleanolic Acid promotes the reaction [Ethanol affects the localization of NFE2L2 protein] | 25111957 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol promotes the reaction [IL1B protein results in increased expression of NFE2L2 mRNA] | 12072388 |
D005000 | Ethionamide | NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to arsenic trioxide] | 26708503 |
D005015 | Ethoxyquin | NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] | 21277289 |
D005015 | Ethoxyquin | Ethoxyquin affects the activity of NFE2L2 protein | 11309284 |
D005015 | Ethoxyquin | Ethoxyquin binds to and results in increased activity of NFE2L2 protein | 15919853 |
D005015 | Ethoxyquin | [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA | 15833929 |
D005015 | Ethoxyquin | [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC3 mRNA | 15833929 |
D005015 | Ethoxyquin | [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC4 mRNA | 15833929 |
D005015 | Ethoxyquin | [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC5 mRNA | 15833929 |
D005015 | Ethoxyquin | [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC6 mRNA | 15833929 |
D005015 | Ethoxyquin | Ethoxyquin binds to and results in increased activity of NFE2L2 protein | 15833929 |
D005015 | Ethoxyquin | Ethoxyquin results in increased activity of NFE2L2 protein | 22429928 |
C043180 | ethyl 3-phenylglycidate | NFE2L2 protein results in decreased susceptibility to ethyl 3-phenylglycidate | 20932822 |
C004919 | ethylene dimethacrylate | NFE2L2 mRNA promotes the reaction [ethylene dimethacrylate results in increased expression of HMOX1 mRNA] | 26244607 |
D005047 | Etoposide | NFE2L2 mRNA results in decreased susceptibility to Etoposide | 26708503 |
D005047 | Etoposide | NFE2L2 protein affects the reaction [Etoposide results in increased expression of SRXN1 protein] | 27982581 |
D005047 | Etoposide | NFE2L2 protein affects the reaction [Etoposide results in increased expression of TP53 protein] | 27982581 |
D005054 | Eugenol | Eugenol affects the expression of NFE2L2 protein | 17275817 |
D005054 | Eugenol | Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] | 17275817 |
C045325 | eupatilin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [eupatilin affects the localization of NFE2L2 protein] | 18440740 |
C045325 | eupatilin | eupatilin affects the localization of NFE2L2 protein | 18440740 |
C074031 | exenatide | exenatide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 27939242 |
C074031 | exenatide | exenatide inhibits the reaction [Cycloheximide results in decreased expression of NFE2L2 protein] | 27939242 |
C074031 | exenatide | exenatide promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 27939242 |
C074031 | exenatide | exenatide results in increased expression of NFE2L2 protein | 27939242 |
C074031 | exenatide | exenatide results in increased phosphorylation of NFE2L2 protein | 27939242 |
C074031 | exenatide | NFE2L2 protein affects the reaction [exenatide results in increased expression of HMOX1 protein] | 27939242 |
C074031 | exenatide | PRKCD protein affects the reaction [exenatide results in increased phosphorylation of NFE2L2 protein] | 27939242 |
C074031 | exenatide | NFE2L2 protein affects the reaction [exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]] | 27939242 |
C034379 | falcarindiol | falcarindiol inhibits the reaction [KEAP1 protein results in decreased activity of NFE2L2 protein] | 20026152 |
C034379 | falcarindiol | falcarindiol affects the localization of NFE2L2 protein | 20026152 |
C015881 | farrerol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [farrerol affects the localization of NFE2L2 protein] | 26111761 |
C015881 | farrerol | farrerol affects the localization of NFE2L2 protein | 26111761 |
C015881 | farrerol | NFE2L2 protein promotes the reaction [farrerol results in increased expression of HMOX1 protein] | 26111761 |
C015881 | farrerol | SB 203580 inhibits the reaction [farrerol affects the localization of NFE2L2 protein] | 26111761 |
C015881 | farrerol | U 0126 inhibits the reaction [farrerol affects the localization of NFE2L2 protein] | 26111761 |
D005230 | Fatty Acids, Nonesterified | "NFE2L2 protein affects the reaction [Ethanol results in increased abundance of Fatty Acids, Nonesterified]" | 22627062 |
D011345 | Fenofibrate | Fenofibrate affects the activity of NFE2L2 protein | 25596134 |
D011345 | Fenofibrate | Fenofibrate affects the activity of NFE2L2 protein | 25596134 |
D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein | 18775883 |
D011345 | Fenofibrate | Fenofibrate results in decreased expression of NFE2L2 mRNA | 25596134 |
C024555 | ferric chloride | ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] | 28645578 |
C024555 | ferric chloride | ferric chloride promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein] | 28645578 |
C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate affects the localization of NFE2L2 protein | 18617210 |
C029451 | ferrous chloride | ferrous chloride results in increased expression of and affects the localization of NFE2L2 protein | 27037625 |
C029451 | ferrous chloride | ferrous chloride results in increased expression of NFE2L2 mRNA | 27037625 |
C020748 | ferrous sulfate | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] | 26945724 |
C020748 | ferrous sulfate | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein]] | 26945724 |
C020748 | ferrous sulfate | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 mRNA] | 28583816 |
C020748 | ferrous sulfate | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 protein] | 28583816 |
C020748 | ferrous sulfate | Acetylcysteine inhibits the reaction [ferrous sulfate affects the localization of NFE2L2 protein] | 28583816 |
C020748 | ferrous sulfate | ferrous sulfate results in increased expression of and affects the localization of NFE2L2 protein | 28583816 |
C020748 | ferrous sulfate | ferrous sulfate results in increased expression of NFE2L2 mRNA | 28583816 |
C017875 | fisetin | fisetin results in increased expression of NFE2L2 protein | 16799064 |
D005395 | Fish Oils | [Fish Oils co-treated with Ethanol] results in increased expression of NFE2L2 mRNA | 17347304 |
D005395 | Fish Oils | Fish Oils inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 23551926 |
C007738 | fluoranthene | [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFE2L2 mRNA | 28329830 |
D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of NFE2L2 mRNA | 21607683 |
D016650 | Fluorescein-5-isothiocyanate | [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein | 27871981 |
D005459 | Fluorides | Fluorides affects the expression of NFE2L2 mRNA | 20709135 |
D005472 | Fluorouracil | NFE2L2 protein affects the susceptibility to Fluorouracil | 18692501 |
D005472 | Fluorouracil | NFE2L2 protein results in decreased susceptibility to Fluorouracil | 21489257 |
D005472 | Fluorouracil | NFE2L2 results in decreased susceptibility to Fluorouracil | 20722640 |
D005485 | Flutamide | NFE2L2 protein affects the susceptibility to Flutamide | 21540358 |
D005485 | Flutamide | Flutamide results in increased expression of NFE2L2 mRNA | 24136188 |
C094127 | FOE 5043 | FOE 5043 results in increased activity of NFE2L2 protein | 20143881 |
C100163 | formetanate | formetanate results in increased activity of NFE2L2 protein | 20143881 |
C552409 | forsythoside B | forsythoside B results in increased activity of and affects the localization of NFE2L2 protein | 22735309 |
D005632 | Fructose | Fructose results in increased expression of NFE2L2 protein | 27531227 |
D005632 | Fructose | Plant Preparations inhibits the reaction [Fructose results in increased expression of NFE2L2 protein] | 27531227 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | 19781563 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] | 24726523 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] | 24726523 |
C056933 | fumonisin B1 | fumonisin B1 results in increased expression of NFE2L2 mRNA | 16221962 |
D005664 | Furazolidone | CDKN1A mutant form inhibits the reaction [Furazolidone results in increased expression of NFE2L2 protein] | 26687534 |
D005664 | Furazolidone | CDKN1A protein promotes the reaction [Furazolidone results in increased expression of NFE2L2 protein] | 26687534 |
D005664 | Furazolidone | Furazolidone results in increased expression of NFE2L2 protein | 26687534 |
D005665 | Furosemide | Furosemide results in increased localization of NFE2L2 protein | 18078705 |
D005665 | Furosemide | NFE2L2 protein results in decreased susceptibility to Furosemide | 24813929 |
D005688 | Galactosamine | "beraprost inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA]" | 28887131 |
D005688 | Galactosamine | "[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA" | 28887131 |
D005688 | Galactosamine | "ONO 1301 inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA]" | 28887131 |
D005688 | Galactosamine | Galactosamine affects the localization of NFE2L2 protein | 22310181 |
D005688 | Galactosamine | Galactosamine results in decreased expression of NFE2L2 protein | 22310181 |
D005688 | Galactosamine | mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein] | 22310181 |
D005688 | Galactosamine | mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein] | 22310181 |
D005690 | Galactose | Galactose affects the localization of NFE2L2 protein | 25892055 |
D005690 | Galactose | Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] | 25892055 |
D005707 | Gallic Acid | ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] | 29061316 |
D005707 | Gallic Acid | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein | 29061316 |
C027235 | gallium nitrate | gallium nitrate results in increased activity of NFE2L2 protein | 18586083 |
C027235 | gallium nitrate | SB 203580 inhibits the reaction [gallium nitrate results in increased activity of NFE2L2 protein] | 18586083 |
C057580 | gallocatechol | ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] | 29061316 |
C057580 | gallocatechol | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein | 29061316 |
D024504 | gamma-Tocopherol | gamma-Tocopherol results in increased expression of NFE2L2 mRNA | 19115203 |
D024504 | gamma-Tocopherol | gamma-Tocopherol results in increased expression of NFE2L2 protein | 19115203 |
D024504 | gamma-Tocopherol | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | 22389237 |
C045345 | gastrodin | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein]" | 26634892 |
C045345 | gastrodin | [gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein | 26634892 |
C045345 | gastrodin | gastrodin results in increased phosphorylation of and affects the localization of NFE2L2 protein | 26634892 |
C045345 | gastrodin | [gastrodin co-treated with Dietary Fats] results in increased phosphorylation of NFE2L2 protein | 26634892 |
C056507 | gemcitabine | NFE2L2 protein results in decreased susceptibility to gemcitabine | 21489257 |
D019833 | Genistein | Genistein results in increased expression of NFE2L2 protein | 21573189 |
D019833 | Genistein | Genistein results in decreased expression of NFE2L2 mRNA | 24967385 |
D019833 | Genistein | Genistein results in increased expression of NFE2L2 mRNA | 23295412 |
D019833 | Genistein | Genistein inhibits the reaction [lead acetate results in decreased expression of NFE2L2 protein] | 26797587 |
C024603 | Geraniin | "Geraniin promotes the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of NFE2L2 protein]" | 27181634 |
C507965 | ginsenoside 20S-protopanaxatriol | ginsenoside 20S-protopanaxatriol results in increased expression of NFE2L2 mRNA | 22780686 |
C507965 | ginsenoside 20S-protopanaxatriol | [ginsenoside Rb1 co-treated with ginsenoside 20S-protopanaxatriol] results in increased expression of NFE2L2 protein | 22780686 |
C507965 | ginsenoside 20S-protopanaxatriol | [ginsenoside Rg1 co-treated with ginsenoside 20S-protopanaxatriol] results in increased expression of NFE2L2 protein | 22780686 |
C507965 | ginsenoside 20S-protopanaxatriol | ginsenoside 20S-protopanaxatriol results in increased expression of NFE2L2 mRNA | 22780686 |
C442759 | ginsenoside Rb1 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | 19781563 |
C442759 | ginsenoside Rb1 | fulvestrant inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | 19781563 |
C442759 | ginsenoside Rb1 | [ginsenoside Rb1 co-treated with ginsenoside 20S-protopanaxatriol] results in increased expression of NFE2L2 protein | 22780686 |
C442759 | ginsenoside Rb1 | ginsenoside Rb1 results in increased activity of and results in increased localization of NFE2L2 protein | 19781563 |
C442759 | ginsenoside Rb1 | ginsenoside Rb1 results in increased expression of NFE2L2 mRNA | 22780686 |
C442759 | ginsenoside Rb1 | Pertussis Toxin inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | 19781563 |
C442759 | ginsenoside Rb1 | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein | 25422538 |
C442759 | ginsenoside Rb1 | ginsenoside Rb1 affects the localization of NFE2L2 protein | 25422538 |
C035054 | ginsenoside Rg1 | [ginsenoside Rg1 co-treated with ginsenoside 20S-protopanaxatriol] results in increased expression of NFE2L2 protein | 22780686 |
C035054 | ginsenoside Rg1 | ginsenoside Rg1 results in increased expression of NFE2L2 mRNA | 22780686 |
C035054 | ginsenoside Rg1 | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein | 25422538 |
C035054 | ginsenoside Rg1 | ginsenoside Rg1 affects the localization of NFE2L2 protein | 25422538 |
D005907 | Gliclazide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] | 21439372 |
D005907 | Gliclazide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | 21439372 |
C119494 | glucoraphanin | glucoraphanin analog affects the localization of NFE2L2 protein | 20868228 |
D005947 | Glucose | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] | 21333731 |
D005947 | Glucose | Glucose results in decreased expression of NFE2L2 protein | 21333731 |
D005947 | Glucose | Glucose results in increased expression of NFE2L2 | 20103708 |
D005947 | Glucose | Glucose results in increased expression of NFE2L2 protein | 21333731 |
D005947 | Glucose | NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]] | 23954465 |
D005947 | Glucose | [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein] | 28400208 |
D005947 | Glucose | [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein | 28400208 |
D005947 | Glucose | Particulate Matter inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] | 28400208 |
D005947 | Glucose | rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | 21333731 |
D005947 | Glucose | Vehicle Emissions inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] | 28400208 |
D005947 | Glucose | Glucose deficiency results in increased localization of NFE2L2 protein | 17928392 |
D005947 | Glucose | NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]] | 17928392 |
D005947 | Glucose | NFE2L2 protein affects the susceptibility to Glucose | 20086057 |
D005947 | Glucose | [NFE2L2 protein binds to TXNIP promoter] inhibits the reaction [Glucose results in increased expression of TXNIP mRNA] | 22869588 |
D005947 | Glucose | [NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose | 23017736 |
D005947 | Glucose | NFE2L2 protein inhibits the reaction [Glucose results in increased expression of TXNIP mRNA] | 22869588 |
D005947 | Glucose | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of Glucose | 20086057 |
D005947 | Glucose | diallyl trisulfide promotes the reaction [Glucose results in increased expression of and affects the localization of NFE2L2 protein] | 23453443 |
D005947 | Glucose | Glucose results in decreased expression of NFE2L2 mRNA | 21818840|2377098 |
D005947 | Glucose | Glucose results in decreased expression of NFE2L2 protein | 23770986 |
D005947 | Glucose | Glucose results in increased expression of and affects the localization of NFE2L2 protein | 23453443 |
D005947 | Glucose | NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]] | 23453443 |
D005947 | Glucose | NFE2L2 protein affects the reaction [exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]] | 27939242 |
D005947 | Glucose | NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] | 20028456 |
D005947 | Glucose | NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]] | 25896937 |
D005947 | Glucose | Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA] | 23770986 |
D005947 | Glucose | Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | 23770986 |
D005947 | Glucose | Glucose results in increased expression of NFE2L2 protein | 23767859 |
D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in increased expression of NFE2L2 protein] | 23767859 |
D005961 | Glucosinolates | Glucosinolates results in increased activity of NFE2L2 protein | 15570060 |
D005978 | Glutathione | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein] | 21971136 |
D005978 | Glutathione | [3-methylquercetin affects the localization of and results in increased activity of NFE2L2 protein] which results in increased abundance of Glutathione | 24211276 |
D005978 | Glutathione | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione] | 19608619 |
D005978 | Glutathione | [Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein | 21971136 |
D005978 | Glutathione | [Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein | 21728338 |
D005978 | Glutathione | [[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 21728338 |
D005978 | Glutathione | [[[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] which results in increased abundance of Glutathione | 21728338 |
D005978 | Glutathione | Glutathione inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] | 16631525 |
D005978 | Glutathione | Glutathione inhibits the reaction [Air Pollutants results in increased expression of NFE2L2 protein] | 23649983 |
D005978 | Glutathione | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione | 19608619 |
D005978 | Glutathione | NFE2L2 gene mutant form results in decreased abundance of Glutathione | 19608619 |
D005978 | Glutathione | NFE2L2 protein affects the abundance of Glutathione | 20124447 |
D005978 | Glutathione | NFE2L2 protein affects the reaction [Silver results in increased abundance of Glutathione] | 22546375 |
D005978 | Glutathione | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] | 22491424 |
D005978 | Glutathione | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] which affects the abundance of Glutathione | 22491424 |
D005978 | Glutathione | "Glutathione inhibits the reaction [2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased expression of NFE2L2 protein]" | 20800667 |
D005978 | Glutathione | NFE2L2 affects the abundance of Glutathione | 19303893 |
D005978 | Glutathione | NFE2L2 gene mutant form promotes the reaction [Diquat results in decreased abundance of Glutathione] | 22762311 |
D005978 | Glutathione | NFE2L2 gene mutant form results in decreased abundance of Glutathione | 27633142 |
D005978 | Glutathione | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in decreased abundance of Glutathione | 23764462 |
D005978 | Glutathione | NFE2L2 protein affects the abundance of Glutathione | 11287661 |
D005978 | Glutathione | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in decreased abundance of Glutathione] | 28219650 |
D005978 | Glutathione | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in decreased abundance of Glutathione] | 28219650 |
D005978 | Glutathione | NFE2L2 protein results in increased abundance of Glutathione | 28219650 |
D005978 | Glutathione | sulforafan affects the reaction [NFE2L2 affects the abundance of Glutathione] | 19303893 |
D005978 | Glutathione | NFE2L2 protein inhibits the reaction [triptolide results in decreased abundance of Glutathione] | 22820427 |
D005978 | Glutathione | NFE2L2 protein results in increased abundance of Glutathione | 16524372 |
D005978 | Glutathione | [NFE2L2 protein results in decreased susceptibility to hydroquinone] which results in increased abundance of Glutathione | 21059386 |
D005978 | Glutathione | [NFE2L2 protein results in decreased susceptibility to quinone] which results in increased abundance of Glutathione | 21059386 |
D006003 | Glycogen | NFE2L2 protein affects the reaction [Streptozocin results in decreased abundance of Glycogen] | 20086057 |
D006034 | Glycyrrhetinic Acid | Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] | 23341968 |
D006034 | Glycyrrhetinic Acid | Glycyrrhetinic Acid results in increased expression of NFE2L2 | 23341968 |
D006034 | Glycyrrhetinic Acid | [Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride | 23341968 |
D006046 | Gold | Gold results in increased activity of NFE2L2 promoter | 21643505 |
C511402 | Grape Seed Proanthocyanidins | [arsenic trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of NFE2L2 mRNA | 25966753 |
C511402 | Grape Seed Proanthocyanidins | Grape Seed Proanthocyanidins inhibits the reaction [titanium dioxide results in decreased expression of NFE2L2 protein] | 28780322 |
C511402 | Grape Seed Proanthocyanidins | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of NFE2L2 mRNA | 25719599 |
C511402 | Grape Seed Proanthocyanidins | [Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of NFE2L2 protein | 25719599 |
C511402 | Grape Seed Proanthocyanidins | Grape Seed Proanthocyanidins inhibits the reaction [Cadmium Chloride results in decreased expression of NFE2L2 protein] | 26462792 |
C474918 | gypenoside | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one analog inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] | 24726523 |
C474918 | gypenoside | fulvestrant inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] | 24726523 |
C474918 | gypenoside | NFE2L2 mutant form inhibits the reaction [gypenoside analog results in increased expression of and results in increased activity of HMOX1 protein] | 24726523 |
C010176 | halofuginone | halofuginone results in increased expression of NFE2L2 mRNA | 17180598 |
D006418 | Heme | NFE2L2 mutant form inhibits the reaction [Heme results in increased expression of HMOX1 mRNA] | 10874044 |
D006427 | Hemin | diacetyldichlorofluorescein inhibits the reaction [Hemin affects the localization of NFE2L2 protein] | 16959797 |
D006427 | Hemin | Hemin affects the localization of NFE2L2 protein | 16959797|2152576 |
D006427 | Hemin | Hemin promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 21464371 |
D006427 | Hemin | Hemin results in increased expression of NFE2L2 protein | 27777014 |
D006427 | Hemin | NFE2L2 gene mutant form inhibits the reaction [Hemin results in increased expression of CYP2A5 mRNA] | 22859313 |
D006427 | Hemin | NFE2L2 protein affects the reaction [Hemin results in increased expression of HMOX1 mRNA] | 10473555 |
D006427 | Hemin | Hemin promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein] | 23272707 |
D006427 | Hemin | Hemin results in decreased expression of NFE2L2 protein | 25824035 |
D006427 | Hemin | Hemin results in increased expression of NFE2L2 protein | 25824035 |
D006427 | Hemin | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein | 26747958 |
D006427 | Hemin | tin protoporphyrin IX inhibits the reaction [Hemin results in decreased expression of NFE2L2 protein] | 25824035 |
D006427 | Hemin | tin protoporphyrin IX inhibits the reaction [Hemin results in increased expression of NFE2L2 protein] | 25824035 |
D006427 | Hemin | zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of NFE2L2 protein] | 25824035 |
D006493 | Heparin | Heparin analog results in increased expression of NFE2L2 mRNA | 26476401 |
C013015 | hesperetin | hesperetin inhibits the reaction [Benzo(a)pyrene results in decreased expression of NFE2L2 protein] | 26546711 |
D006569 | Hesperidin | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA] | 28935427 |
D006569 | Hesperidin | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 protein] | 28935427 |
D006581 | Hexachlorobenzene | [Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein | 28634113 |
C015924 | histidyl-proline diketopiperazine | histidyl-proline diketopiperazine affects the localization of NFE2L2 protein | 18373731|1973544 |
C015924 | histidyl-proline diketopiperazine | histidyl-proline diketopiperazine results in increased activity of NFE2L2 protein | 18373731 |
C015924 | histidyl-proline diketopiperazine | histidyl-proline diketopiperazine results in increased expression of NFE2L2 mRNA | 19735445 |
C015924 | histidyl-proline diketopiperazine | NFE2L2 mRNA affects the susceptibility to histidyl-proline diketopiperazine | 19735445 |
D017313 | Fenretinide | Fenretinide results in increased expression of NFE2L2 protein | 25246272 |
D017313 | Fenretinide | Fenretinide results in increased expression of NFE2L2 mRNA | 28973697 |
D006812 | Humic Substances | Humic Substances results in increased expression of NFE2L2 protein | 24239652 |
D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased localization of NFE2L2 protein | 18617559 |
D006854 | Hydrocortisone | [Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
D006854 | Hydrocortisone | [HSD11B1 protein affects the susceptibility to Hydrocortisone] which results in decreased activity of NFE2L2 protein | 22606287 |
D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforafan results in increased expression of NFE2L2 protein]] | 22606287 |
D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22606287 |
D006861 | Hydrogen Peroxide | butin inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein] | 22253095 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [butin affects the localization of and results in increased activity of NFE2L2 protein] | 22253095 |
D006861 | Hydrogen Peroxide | NFE2L2 protein affects the reaction [butin inhibits the reaction [Hydrogen Peroxide results in decreased expression of SOD2 protein]] | 22253095 |
D006861 | Hydrogen Peroxide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein]" | 21573189 |
D006861 | Hydrogen Peroxide | [Arsenic results in increased abundance of Hydrogen Peroxide] which results in increased expression of and results in increased localization of NFE2L2 protein | 14567983 |
D006861 | Hydrogen Peroxide | [Arsenic results in increased abundance of Hydrogen Peroxide] which results in increased expression of NFE2L2 mRNA | 14567983 |
D006861 | Hydrogen Peroxide | brusatol inhibits the reaction [Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein]] | 29274434 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of NFE2L2 mRNA | 20044591 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [MIR153 mRNA binds to NFE2L2 3' UTR] | 24866057 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA | 29274434 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of NFE2L2 protein | 21573189|2927443 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of NFE2L2 mRNA | 23410634 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased localization of NFE2L2 protein | 22021338 |
D006861 | Hydrogen Peroxide | NFE2L2 protein results in decreased susceptibility to Hydrogen Peroxide | 17360324 |
D006861 | Hydrogen Peroxide | Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA] | 29274434 |
D006861 | Hydrogen Peroxide | Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein] | 29274434 |
D006861 | Hydrogen Peroxide | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to Hydrogen Peroxide]" | 18367636 |
D006861 | Hydrogen Peroxide | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] inhibits the reaction [Hydrogen Peroxide results in increased oxidation of TXN1 protein]" | 22495766 |
D006861 | Hydrogen Peroxide | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] inhibits the reaction [Hydrogen Peroxide results in increased oxidation of TXN2 protein]" | 22495766 |
D006861 | Hydrogen Peroxide | "[1,2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Hydrogen Peroxide" | 22495766 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 25922074 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [NFE2L2 protein binds to SULT1E1 promoter] | 25922074 |
D006861 | Hydrogen Peroxide | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Hydrogen Peroxide | 19303893 |
D006861 | Hydrogen Peroxide | NFE2L2 results in decreased susceptibility to Hydrogen Peroxide | 18367636 |
D006861 | Hydrogen Peroxide | Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforafan results in increased expression of NFE2L2 protein]] | 22606287 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the localization of NFE2L2 protein | 24437944 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22606287 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of NFE2L2 protein | 22606287 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of NFE2L2 protein | 22606287 |
D006861 | Hydrogen Peroxide | NFE2L2 protein affects the reaction [exenatide inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]] | 27939242 |
D006861 | Hydrogen Peroxide | notoginsenoside R1 promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] | 24437944 |
C031927 | hydroquinone | Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of NFE2L2 promoter] | 21643505 |
C031927 | hydroquinone | ferric chloride promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein] | 28645578 |
C031927 | hydroquinone | hydroquinone affects the localization of and results in increased degradation of NFE2L2 protein | 28645578 |
C031927 | hydroquinone | hydroquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C031927 | hydroquinone | hydroquinone results in increased activity of NFE2L2 promoter | 21643505 |
C031927 | hydroquinone | hydroquinone results in increased expression of and affects the localization of NFE2L2 protein | 21059386 |
C031927 | hydroquinone | hydroquinone results in increased expression of NFE2L2 protein | 28645578 |
C031927 | hydroquinone | NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of GSS protein] | 21059386 |
C031927 | hydroquinone | NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein] | 21059386 |
C031927 | hydroquinone | NFE2L2 protein results in decreased susceptibility to hydroquinone | 21059386 |
C031927 | hydroquinone | [NFE2L2 protein results in decreased susceptibility to hydroquinone] which results in increased abundance of Glutathione | 21059386 |
D020155 | 3-Hydroxybutyric Acid | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of 3-Hydroxybutyric Acid | 20086057 |
D004441 | Ecdysterone | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]] | 26048653 |
D004441 | Ecdysterone | Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein] | 26048653 |
D004441 | Ecdysterone | NFE2L2 results in increased susceptibility to Ecdysterone | 26048653 |
D006894 | Hydroxyestrones | Hydroxyestrones results in increased expression of and results in increased localization of and results in increased activity of NFE2L2 protein | 19952498 |
D006894 | Hydroxyestrones | [Hydroxyestrones results in increased expression of and results in increased localization of and results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 19952498 |
D006894 | Hydroxyestrones | [Hydroxyestrones results in increased expression of and results in increased localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein | 19952498 |
C021304 | hyperoside | hyperoside affects the localization of NFE2L2 protein | 26772156 |
D006997 | Hypochlorous Acid | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 18156441 |
D006997 | Hypochlorous Acid | Hypochlorous Acid results in increased expression of NFE2L2 mRNA | 18156441 |
D006997 | Hypochlorous Acid | NFE2L2 protein affects the susceptibility to Hypochlorous Acid | 18156441 |
D006997 | Hypochlorous Acid | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
D006997 | Hypochlorous Acid | Buthionine Sulfoximine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
D006997 | Hypochlorous Acid | CAT protein modified form inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
D006997 | Hypochlorous Acid | Hypochlorous Acid results in increased expression of NFE2L2 protein | 17980396 |
D006997 | Hypochlorous Acid | S-ethyl glutathione inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
C082585 | iberin | iberin results in increased expression of NFE2L2 protein | 22664424 |
D007052 | Ibuprofen | Ibuprofen affects the activity of NFE2L2 protein | 25596134 |
D007052 | Ibuprofen | Ibuprofen results in increased expression of NFE2L2 mRNA | 25596134 |
C492448 | ICG 001 | ICG 001 inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | 28578904 |
C492448 | ICG 001 | ICG 001 inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | 28578904 |
D007069 | Ifosfamide | Ifosfamide affects the activity of NFE2L2 protein | 25596134 |
D007097 | Imines | Imines analog results in increased expression of NFE2L2 protein | 23298159 |
C031534 | imperatorin | NFE2L2 protein affects the susceptibility to imperatorin | 19150646 |
C027185 | indirubin | indirubin results in increased expression of NFE2L2 mRNA | 20951181 |
C016517 | indole-3-carbinol | indole-3-carbinol results in decreased activity of NFE2L2 protein | 16082211 |
C016517 | indole-3-carbinol | indole-3-carbinol affects the activity of NFE2L2 protein | 11309284 |
C016517 | indole-3-carbinol | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA] | 22129741 |
C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of NFE2L2 mRNA | 21396975 |
C016517 | indole-3-carbinol | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | 22129741 |
C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein] | 28619389 |
C016517 | indole-3-carbinol | indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] | 28619389 |
C016517 | indole-3-carbinol | Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] | 28619389 |
D007213 | Indomethacin | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] | 11909699 |
D007213 | Indomethacin | Acetylcysteine inhibits the reaction [Indomethacin results in increased localization of NFE2L2 protein] | 11909699 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein] | 11909699 |
D007213 | Indomethacin | Indomethacin results in increased localization of NFE2L2 protein | 11909699 |
D007213 | Indomethacin | Indomethacin affects the localization of NFE2L2 protein | 25110317 |
D007213 | Indomethacin | Indomethacin results in decreased expression of NFE2L2 mRNA | 28648817 |
D007213 | Indomethacin | Ranitidine inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] | 28648817 |
D007213 | Indomethacin | Silymarin inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] | 28648817 |
D007294 | Inositol | Inositol inhibits the reaction [Copper affects the localization of and results in decreased activity of NFE2L2 protein] | 25562835 |
D007460 | Iodoacetamide | Iodoacetamide results in increased expression of NFE2L2 protein | 27358234 |
D007460 | Iodoacetamide | Iodoacetamide affects the localization of and results in increased activity of NFE2L2 protein | 18785192 |
D015759 | Ionomycin | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NFE2L2 protein | 24632381 |
D015759 | Ionomycin | NFE2L2 gene mutant form results in increased susceptibility to Ionomycin | 12842875 |
D015759 | Ionomycin | NFE2L2 protein results in decreased susceptibility to Ionomycin | 12842875 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NFE2L2 mRNA | 25613284 |
D007501 | Iron | Iron results in increased activity of NFE2L2 promoter | 21643505 |
D007501 | Iron | NFE2L2 protein promotes the reaction [SLC40A1 protein results in increased export of Iron] | 21303654 |
D007501 | Iron | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA | 20302851 |
C055542 | isoimperatorin | isoimperatorin affects the localization of NFE2L2 protein | 16829687 |
C550177 | isoliquiritigenin 2'-methyl ether | isoliquiritigenin 2'-methyl ether affects the localization of NFE2L2 protein | 20040371 |
C015301 | isophorone diisocyanate | NFE2L2 affects the susceptibility to isophorone diisocyanate | 23564646 |
D007545 | Isoproterenol | Isoproterenol results in decreased expression of NFE2L2 protein | 28266775 |
C027321 | isosalipurposide | isosalipurposide affects the localization of NFE2L2 protein | 26028482 |
C027321 | isosalipurposide | MAPK1 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein] | 26028482 |
C027321 | isosalipurposide | MAPK3 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein] | 26028482 |
D017879 | Isothiocyanates | Isothiocyanates results in increased activity of NFE2L2 protein | 15570060 |
C544151 | jinfukang | jinfukang results in decreased expression of NFE2L2 mRNA | 27392435 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of NFE2L2 protein | 24733848 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of NFE2L2 mRNA | 24733848 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of NFE2L2 protein | 24733848 |
C561695 | (+)-JQ1 compound | NFE2L2 mutant form inhibits the reaction [(+)-JQ1 compound results in increased expression of HMOX1 protein] | 24733848 |
C561695 | (+)-JQ1 compound | NFE2L2 mutant form inhibits the reaction [(+)-JQ1 compound results in increased expression of NQO1 protein] | 24733848 |
C410337 | K 7174 | K 7174 results in increased expression of NFE2L2 mRNA | 24086573 |
C006552 | kaempferol | [kaempferol co-treated with Quercetin] results in increased expression of NFE2L2 mRNA | 25111660 |
C006552 | kaempferol | kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21256954 |
C006552 | kaempferol | kaempferol results in increased expression of NFE2L2 mRNA | 21256954|2511166 |
C053401 | kahweol | NFE2L2 protein affects the reaction [[cafestol co-treated with kahweol] results in decreased susceptibility to Acrolein] | 18028974 |
C053401 | kahweol | NFE2L2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA] | 18028974 |
C053401 | kahweol | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] | 17110534 |
C033997 | kahweol palmitate | [cafestol co-treated with kahweol palmitate] affects the activity of NFE2L2 protein | 11309284 |
D007608 | Kainic Acid | Kainic Acid affects the localization of NFE2L2 protein | 18619545 |
C468270 | Kangen-karyu | Kangen-karyu results in decreased expression of NFE2L2 protein | 22969821 |
D007650 | Ketanserin | Ketanserin inhibits the reaction [Tobacco Smoke Pollution affects the localization of NFE2L2 protein] | 22048642 |
D007654 | Ketoconazole | [Ketoconazole results in increased activity of AHR protein] which results in increased activity of and results in increased localization of NFE2L2 protein | 21753779 |
D007654 | Ketoconazole | Ketoconazole results in increased expression of NFE2L2 mRNA | 21753779 |
D007654 | Ketoconazole | Ketoconazole results in increased expression of NFE2L2 protein | 21753779 |
D007654 | Ketoconazole | NFE2L2 protein promotes the reaction [Ketoconazole inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]] | 21753779 |
D007654 | Ketoconazole | NFE2L2 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]] | 21753779 |
D007654 | Ketoconazole | NFE2L2 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]] | 21753779 |
C073601 | KT 5823 | KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA] | 27774770 |
C073601 | KT 5823 | KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 27774770 |
C096429 | L 709049 | L 709049 inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein] | 22964297 |
C067713 | lactacystin | lactacystin results in increased expression of NFE2L2 protein | 12446695 |
C067713 | lactacystin | lactacystin promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | 12441344 |
C067713 | lactacystin | lactacystin results in increased expression of NFE2L2 protein | 12441344|1532221 |
C067713 | lactacystin | lactacystin promotes the reaction [manganese chloride affects the localization of and results in increased activity of NFE2L2 protein] | 21384399 |
C067713 | lactacystin | lactacystin promotes the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21384399 |
C067713 | lactacystin | lactacystin results in decreased degradation of NFE2L2 protein | 26598004 |
D019344 | Lactic Acid | [NFE2L2 protein results in increased metabolism of Pyruvaldehyde] which results in increased abundance of Lactic Acid | 23954466 |
D064747 | Lansoprazole | Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA] | 28412091 |
D064747 | Lansoprazole | Lansoprazole results in increased expression of NFE2L2 mRNA | 28412091 |
D064747 | Lansoprazole | Lansoprazole results in increased phosphorylation of NFE2L2 protein | 19628634 |
D064747 | Lansoprazole | NFE2L2 mRNA affects the reaction [Lansoprazole results in increased expression of HMOX1 mRNA] | 19628634 |
D064747 | Lansoprazole | NFE2L2 mRNA affects the reaction [Lansoprazole results in increased expression of HMOX1 protein] | 19628634 |
C028521 | lanthanum chloride | lanthanum chloride results in increased expression of NFE2L2 mRNA | 24142884 |
C028521 | lanthanum chloride | lanthanum chloride results in increased expression of NFE2L2 protein | 24142884 |
C490728 | lapatinib | [CYP3A4 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 protein | 26958860 |
C490728 | lapatinib | [CYP3A5 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 protein | 26958860 |
C490728 | lapatinib | lapatinib metabolite results in increased activity of NFE2L2 protein | 26958860 |
D007854 | Lead | Lead results in increased activity of NFE2L2 promoter | 21643505 |
D007854 | Lead | Lead results in increased expression of NFE2L2 mRNA | 16243960 |
D007854 | Lead | NFE2L2 protein affects the reaction [Lead results in increased expression of GSTA1 mRNA] | 16243960 |
D007854 | Lead | NFE2L2 protein affects the reaction [Lead results in increased expression of NQO1 mRNA] | 16243960 |
C008261 | lead acetate | lead acetate results in increased activity of and affects the localization of NFE2L2 protein | 26498409 |
C008261 | lead acetate | lead acetate results in increased expression of NFE2L2 mRNA | 26498409 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased activity of and affects the localization of NFE2L2 protein] | 26498409|2649840 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLC mRNA] | 26498409 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLM mRNA] | 26498409 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GSTA1 mRNA] | 26498409 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of HMOX1 mRNA] | 26498409 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of HMOX1 protein] | 26498409 |
C008261 | lead acetate | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of NQO1 mRNA] | 26498409 |
C008261 | lead acetate | NFE2L2 protein affects the reaction [lead acetate results in increased expression of SPP1 mRNA] | 27562236 |
C008261 | lead acetate | NFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein] | 26498409 |
C008261 | lead acetate | NFE2L2 protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein] | 26498409 |
C008261 | lead acetate | NFE2L2 protein inhibits the reaction [lead acetate results in increased expression of BAX protein] | 26498409 |
C008261 | lead acetate | Genistein inhibits the reaction [lead acetate results in decreased expression of NFE2L2 protein] | 26797587 |
C008261 | lead acetate | lead acetate results in decreased expression of NFE2L2 protein | 26797587 |
C008261 | lead acetate | lead acetate results in increased expression of and affects the localization of NFE2L2 protein | 23274417 |
C008261 | lead acetate | lead acetate results in increased expression of NFE2L2 mRNA | 23274417 |
C029891 | lead chloride | lead chloride affects the localization of NFE2L2 protein | 20402460 |
C029891 | lead chloride | [lead chloride affects the localization of NFE2L2 protein] promotes the reaction [NFE2L2 protein binds to CYP2A5 promoter] | 20402460 |
C029891 | lead chloride | NFE2L2 protein affects the reaction [lead chloride results in increased expression of CYP2A5 mRNA] | 20402460 |
C045463 | leflunomide | leflunomide results in increased expression of NFE2L2 mRNA | 28988120 |
C045463 | leflunomide | leflunomide results in increased expression of NFE2L2 mRNA | 24136188 |
C067431 | letrozole | indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein] | 28619389 |
C067431 | letrozole | indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] | 28619389 |
C067431 | letrozole | letrozole results in decreased expression of NFE2L2 protein | 28619389 |
C067431 | letrozole | Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein] | 28619389 |
C067431 | letrozole | Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] | 28619389 |
D064704 | Levofloxacin | Levofloxacin results in decreased expression of NFE2L2 mRNA | 24136188 |
C027820 | ligustilide | ligustilide results in decreased methylation of NFE2L2 promoter | 23441843 |
D000069476 | Linagliptin | indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] | 28619389 |
D000069476 | Linagliptin | Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein] | 28619389 |
D000069476 | Linagliptin | Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] | 28619389 |
C018584 | linalool | linalool metabolite results in increased expression of and results in increased activity of NFE2L2 protein | 29029310 |
D001556 | Lindane | Lindane results in decreased expression of NFE2L2 mRNA | 17785943 |
C002385 | linsidomine | [linsidomine results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine | 16092930 |
C002385 | linsidomine | NFE2L2 protein results in decreased susceptibility to linsidomine | 16092930 |
C002385 | linsidomine | "1,2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to linsidomine]" | 18367636 |
C002385 | linsidomine | NFE2L2 results in decreased susceptibility to linsidomine | 18367636 |
C002385 | linsidomine | linsidomine results in increased localization of and results in increased activity of NFE2L2 protein | 12446173 |
C013091 | lipoamide | lipoamide inhibits the reaction [Acrolein results in decreased expression of NFE2L2 protein] | 18258206 |
C082161 | lipopolysaccharide A | lipopolysaccharide A promotes the reaction [nickel chloride affects the localization of NFE2L2 protein] | 16806455 |
C082161 | lipopolysaccharide A | lipopolysaccharide A results in increased expression of NFE2L2 protein | 16806455 |
C082161 | lipopolysaccharide A | nickel chloride promotes the reaction [lipopolysaccharide A results in increased expression of NFE2L2 protein] | 16806455 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "[3-(4-methylphenylsulfonyl)-2-propenenitrile co-treated with lipopolysaccharide, E. coli O26-B6] results in increased expression of NFE2L2 mRNA" | 22942241 |
C482199 | lipopolysaccharide, E coli O55-B5 | "[lipopolysaccharide, E coli O55-B5 co-treated with arsenite] results in increased expression of NFE2L2 protein" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of [IL12B protein binds to IL12A protein]]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with 2-tert-butylhydroquinone] results in increased expression of NQO1 mRNA]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with arsenite] results in increased expression of NQO1 mRNA]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NQO1 mRNA]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "beraprost inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA]" | 28887131 |
C482199 | lipopolysaccharide, E coli O55-B5 | "[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA" | 28887131 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Geraniin promotes the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of NFE2L2 protein]" | 27181634 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 affects the localization of NFE2L2 protein" | 27181634 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 promotes the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 protein]" | 23906629 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of NFE2L2 protein" | 23906629 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 gene mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12A mRNA]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 gene mutant form inhibits the reaction [arsenite inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL12B mRNA]]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "NFE2L2 gene mutant form inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with arsenite] results in increased expression of NQO1 mRNA]" | 25680285 |
C482199 | lipopolysaccharide, E coli O55-B5 | "ONO 1301 inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA]" | 28887131 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NFE2L2 protein" | 21963524 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "[manganese chloride co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NFE2L2 protein" | 21963524 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form affects the reaction [Curcumin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 protein]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form affects the reaction [phenethyl isothiocyanate promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 protein]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [Curcumin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [Curcumin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [Curcumin promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 mRNA]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 mRNA]]" | 25387343 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "NFE2L2 protein results in increased susceptibility to [lipopolysaccharide, Escherichia coli O111 B4 co-treated with phenethyl isothiocyanate]" | 25387343 |
D008070 | Lipopolysaccharides | Acetylcysteine inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 17959236 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of NFE2L2 mRNA | 26667767 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with resveratrol] results in increased expression of NFE2L2 protein | 26497626 |
D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [nickel chloride results in increased expression of NFE2L2 protein] | 18437699 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NFE2L2 protein | 26497626 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NFE2L2 protein | 17959236 |
D008070 | Lipopolysaccharides | Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 17959236 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Particulate Matter analog inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]] | 16890772 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Particulate Matter analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | 16890772 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [sulforafan inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | 16890772 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Vehicle Emissions analog inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]] | 16890772 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Vehicle Emissions analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | 16890772 |
D008070 | Lipopolysaccharides | NFE2L2 protein promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of SESN2 protein] | 25637945 |
D008070 | Lipopolysaccharides | PIK 75 inhibits the reaction [[Lipopolysaccharides co-treated with resveratrol] results in increased expression of NFE2L2 protein] | 26497626 |
D008070 | Lipopolysaccharides | sodium selenide inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 17959236 |
D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26363199 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with cobaltiprotoporphyrin] results in increased expression of NFE2L2 protein | 25171655 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NFE2L2 protein | 26363199 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NFE2L2 protein | 26505893 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of FOXO1 protein]] | 25171655 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]] | 25171655 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]] | 25171655 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] | 25171655 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [cobaltiprotoporphyrin promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]] | 25171655 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] | 21382476 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] | 21382476 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] | 24991814 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] | 24991814 |
D008070 | Lipopolysaccharides | NFE2L2 protein inhibits the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein inhibits the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein promotes the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D008070 | Lipopolysaccharides | NFE2L2 protein promotes the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] | 23942037 |
D008070 | Lipopolysaccharides | [NFE2L2 protein results in increased expression of HMOX1] affects the reaction [alpha-viniferin results in decreased susceptibility to Lipopolysaccharides] | 24859013 |
D008070 | Lipopolysaccharides | Quercetin promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 26505893 |
D008070 | Lipopolysaccharides | Saponins inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26363199 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of and affects the localization of NFE2L2 protein | 24039949 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NFE2L2 mRNA | 24039949 |
D008070 | Lipopolysaccharides | [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26497626 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of NFE2L2 protein | 26497626 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NFE2L2 protein | 22610192|2888171 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]] | 28881715 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]] | 28881715 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]] | 28881715 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] | 28881715 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]] | 28881715 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 28881715 |
D008070 | Lipopolysaccharides | NFE2L2 protein affects the reaction [Probucol promotes the reaction [Lipopolysaccharides results in increased expression of NQO1 protein]] | 28881715 |
D008070 | Lipopolysaccharides | Probucol promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 28881715 |
D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 22610192 |
C040527 | lipoxin A4 | lipoxin A4 affects the localization of NFE2L2 protein | 23826208 |
C040527 | lipoxin A4 | lipoxin A4 promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 23826208 |
D008094 | Lithium | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein | 18619545 |
D008094 | Lithium | Lithium results in increased activity of NFE2L2 protein | 18619545 |
D008095 | Lithocholic Acid | Lithocholic Acid results in decreased expression of and results in decreased activity of NFE2L2 protein | 20146260 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXN mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXNRD1 mRNA | 17724089 |
D008095 | Lithocholic Acid | Lithocholic Acid results in increased expression of and results in increased localization of and results in increased activity of NFE2L2 protein | 17724089 |
D008095 | Lithocholic Acid | NFE2L2 protein results in decreased susceptibility to Lithocholic Acid | 17724089 |
D008095 | Lithocholic Acid | S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein] | 20146260 |
D008095 | Lithocholic Acid | S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]] | 20146260 |
D008095 | Lithocholic Acid | Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein] | 20146260 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 17724089 |
D008095 | Lithocholic Acid | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXN1 mRNA | 17724089 |
D008095 | Lithocholic Acid | Lithocholic Acid results in increased localization of and results in increased activity of NFE2L2 protein | 17724089 |
D008095 | Lithocholic Acid | NFE2L2 protein inhibits the reaction [Lithocholic Acid results in increased expression of GSTA4 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCA1 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCC1 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCC2 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCC2 protein] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCC3 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCC4 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCC5 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of ABCG2 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of GCLC mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of GCLC protein] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of GSTM1 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of HMOX1 protein] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of NQO1 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of TXNRD1 mRNA] | 20977460 |
D008095 | Lithocholic Acid | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of TXNRD1 protein] | 20977460 |
C061091 | lithospermate B | lithospermate B inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in decreased localization of NFE2L2 protein] | 21295052 |
C061091 | lithospermate B | lithospermate B results in increased localization of NFE2L2 protein | 21295052 |
C059516 | loganin | loganin affects the expression of NFE2L2 protein | 21864639 |
D019808 | Losartan | Losartan inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | 28578904 |
D019808 | Losartan | Losartan inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | 28578904 |
D019808 | Losartan | Losartan results in decreased expression of NFE2L2 mRNA | 18765277 |
D008148 | Lovastatin | Doxorubicin inhibits the reaction [Lovastatin results in increased expression of NFE2L2 mRNA] | 22712078 |
D008148 | Lovastatin | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] | 28710503 |
C529637 | lucidone | lucidone affects the localization of and results in increased activity of NFE2L2 protein | 23712098 |
C529637 | lucidone | "[lucidone co-treated with 2,2'-azobis(2-amidinopropane)] affects the localization of and results in increased activity of NFE2L2 protein" | 23712098 |
C529637 | lucidone | [lucidone co-treated with Ethanol] results in increased expression of NFE2L2 mRNA | 22484158 |
C529637 | lucidone | "lucidone promotes the reaction [2,2'-azobis(2-amidinopropane) results in increased expression of NFE2L2 protein]" | 23712098 |
C529637 | lucidone | NFE2L2 protein affects the susceptibility to lucidone | 23712098 |
D014975 | Lutein | arsenic trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 mRNA] | 25815309 |
D014975 | Lutein | arsenic trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 protein] | 25815309 |
D014975 | Lutein | Lutein promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA] | 26187899 |
D014975 | Lutein | Lutein promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 26187899 |
D014975 | Lutein | Lutein results in increased expression of and affects the localization of NFE2L2 protein | 25815309 |
D014975 | Lutein | Lutein results in increased expression of NFE2L2 mRNA | 25815309|2618789 |
D014975 | Lutein | Lutein results in increased expression of NFE2L2 protein | 26187899 |
D047311 | Luteolin | Luteolin affects the localization of and results in increased activity of NFE2L2 protein | 22864849 |
D047311 | Luteolin | Luteolin results in increased activity of NFE2L2 protein | 17982879 |
D047311 | Luteolin | [Luteolin results in increased activity of NFE2L2 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium | 17982879 |
C015329 | lycopene | lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] | 27102619 |
C015329 | lycopene | lycopene results in increased expression of NFE2L2 mRNA | 27102619 |
C015329 | lycopene | lycopene results in increased expression of NFE2L2 protein | 19551842 |
C032881 | lysophosphatidic acid | LPAR1 protein affects the reaction [lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein] | 25398768 |
C032881 | lysophosphatidic acid | lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein | 25398768 |
C032881 | lysophosphatidic acid | [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid] which results in decreased expression of NFE2L2 | 25398768 |
D015636 | Magnesium Chloride | [2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA]] which results in decreased susceptibility to Magnesium Chloride | 21107535 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFE2L2 mRNA | 26378955 |
D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFE2L2 mRNA | 21641980 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NFE2L2 mRNA | 26378955 |
C030272 | maleic acid | Curcumin inhibits the reaction [maleic acid affects the expression of NFE2L2 protein] | 25119790 |
C030272 | maleic acid | maleic acid affects the expression of NFE2L2 protein | 25119790 |
D008315 | Malondialdehyde | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of Malondialdehyde] | 24633890 |
D008344 | Maneb | Maneb results in increased expression of NFE2L2 protein | 21402726 |
D008344 | Maneb | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of GCLC mRNA | 21402726 |
D008344 | Maneb | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 21402726 |
D008344 | Maneb | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of PRDX1 mRNA | 21402726 |
D008344 | Maneb | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of TXN1 mRNA | 21402726 |
D008344 | Maneb | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of TXNRD1 mRNA | 21402726 |
D008344 | Maneb | NFE2L2 gene mutant form inhibits the reaction [Maneb results in increased expression of GPX4 mRNA] | 23764462 |
D008344 | Maneb | NFE2L2 gene mutant form results in increased susceptibility to Maneb | 23764462 |
D008344 | Maneb | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in decreased abundance of Glutathione | 23764462 |
D008344 | Maneb | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in decreased expression of GSR protein | 23764462 |
D008344 | Maneb | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in decreased expression of HMOX1 protein | 23764462 |
D008344 | Maneb | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Manganese | 23764462 |
D008344 | Maneb | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Thiobarbituric Acid Reactive Substances | 23764462 |
D008345 | Manganese | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Manganese | 23764462 |
D008345 | Manganese | Manganese results in increased expression of and results in increased localization of NFE2L2 protein | 17573173 |
C025340 | manganese chloride | "[manganese chloride co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NFE2L2 protein" | 21963524 |
C025340 | manganese chloride | manganese chloride results in increased expression of NFE2L2 protein | 21963524|2528810 |
C025340 | manganese chloride | Melatonin inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein] | 25288107 |
C025340 | manganese chloride | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21384399 |
C025340 | manganese chloride | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein] | 21384399 |
C025340 | manganese chloride | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein] | 21384399 |
C025340 | manganese chloride | anacardic acid inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein] | 29054681 |
C025340 | manganese chloride | [anacardic acid results in increased susceptibility to manganese chloride] which results in increased expression of NFE2L2 mRNA | 29054681 |
C025340 | manganese chloride | lactacystin promotes the reaction [manganese chloride affects the localization of and results in increased activity of NFE2L2 protein] | 21384399 |
C025340 | manganese chloride | lactacystin promotes the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21384399 |
C025340 | manganese chloride | manganese chloride affects the expression of NFE2L2 protein | 22154916 |
C025340 | manganese chloride | manganese chloride affects the localization of and results in increased activity of NFE2L2 protein | 21384399 |
C025340 | manganese chloride | "manganese chloride inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of NFE2L2 protein]" | 22245093 |
C025340 | manganese chloride | manganese chloride promotes the reaction [anacardic acid results in increased expression of NFE2L2 mRNA] | 29054681 |
C025340 | manganese chloride | manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 21384399 |
C025340 | manganese chloride | manganese chloride promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 21107535 |
C025340 | manganese chloride | manganese chloride results in increased expression of and affects the localization of NFE2L2 protein | 22245093 |
C025340 | manganese chloride | manganese chloride results in increased expression of and results in increased activity of NFE2L2 protein | 29054681 |
C025340 | manganese chloride | manganese chloride results in increased expression of NFE2L2 protein | 21107535|2138439 |
C025340 | manganese chloride | [manganese chloride results in increased susceptibility to trichostatin A] which results in increased expression of NFE2L2 mRNA | 29054681 |
C025340 | manganese chloride | NFE2L2 protein results in decreased susceptibility to manganese chloride | 21107535 |
C025340 | manganese chloride | trichostatin A promotes the reaction [manganese chloride results in increased expression of and results in increased activity of NFE2L2 protein] | 29054681 |
C025340 | manganese chloride | [trichostatin A results in increased susceptibility to manganese chloride] which results in increased expression of NFE2L2 mRNA | 29054681 |
C013592 | mangiferin | mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein] | 22310181 |
C013592 | mangiferin | mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein] | 22310181 |
D009637 | Masoprocol | Masoprocol affects the localization of and results in increased activity of NFE2L2 protein | 18852027 |
D008466 | Mechlorethamine | NFE2L2 gene mutant form affects the susceptibility to Mechlorethamine | 26454883 |
D008466 | Mechlorethamine | NFE2L2 protein results in decreased susceptibility to Mechlorethamine | 20932822 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in increased expression of NFE2L2 mRNA | 18497975 |
D008550 | Melatonin | Melatonin results in increased expression of NFE2L2 mRNA | 20626588 |
D008550 | Melatonin | Melatonin results in increased expression of NFE2L2 protein | 20626588 |
D008550 | Melatonin | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] | 25550330 |
D008550 | Melatonin | [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein | 27871981 |
D008550 | Melatonin | Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein] | 25550330 |
D008550 | Melatonin | Melatonin inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein] | 25288107 |
D008550 | Melatonin | Melatonin results in increased expression of NFE2L2 protein | 25288107 |
D008550 | Melatonin | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] | 25550330 |
D008550 | Melatonin | Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 protein] | 20433640 |
D008550 | Melatonin | Melatonin results in increased expression of NFE2L2 protein | 20433640 |
C065757 | meloxicam | meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] | 20851755 |
C042720 | mercuric bromide | mercuric bromide results in increased expression of NFE2L2 mRNA | 26272509 |
C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
D008627 | Mercuric Chloride | Acetylcysteine inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 17959236 |
D008627 | Mercuric Chloride | Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein] | 17959236 |
D008627 | Mercuric Chloride | Mercuric Chloride affects the localization of and results in increased stability of NFE2L2 protein | 21843634 |
D008627 | Mercuric Chloride | Mercuric Chloride affects the localization of NFE2L2 protein | 24816296 |
D008627 | Mercuric Chloride | Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 17959236 |
D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of NFE2L2 protein | 17959236|2184363 |
D008627 | Mercuric Chloride | NFE2L2 mRNA affects the reaction [Mercuric Chloride results in increased activity of NQO1 protein] | 21843634 |
D008627 | Mercuric Chloride | NFE2L2 mRNA affects the reaction [Mercuric Chloride results in increased expression of NQO1 mRNA] | 21843634 |
D008627 | Mercuric Chloride | sodium selenide inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 17959236 |
D008627 | Mercuric Chloride | sodium selenide inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein] | 17959236 |
D008627 | Mercuric Chloride | Sodium Selenite affects the reaction [Mercuric Chloride affects the localization of NFE2L2 protein] | 24816296 |
D008627 | Mercuric Chloride | Mercuric Chloride results in decreased expression of NFE2L2 mRNA | 23202902 |
D008627 | Mercuric Chloride | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Mercuric Chloride | 19303893 |
D008628 | Mercury | Mercury results in increased activity of NFE2L2 promoter | 21643505 |
D008628 | Mercury | Mercury results in increased expression of NFE2L2 mRNA | 16243960 |
D008628 | Mercury | NFE2L2 protein affects the reaction [Mercury results in increased expression of GSTA1 mRNA] | 16243960 |
D008628 | Mercury | NFE2L2 protein affects the reaction [Mercury results in increased expression of NQO1 mRNA] | 16243960 |
D008687 | Metformin | Metformin inhibits the reaction [2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein] | 23707609 |
D008687 | Metformin | Metformin results in decreased expression of NFE2L2 mRNA | 23707609 |
D008687 | Metformin | Metformin results in decreased expression of NFE2L2 protein | 23707609 |
D008687 | Metformin | Metformin affects the activity of NFE2L2 protein | 25596134 |
D008687 | Metformin | Metformin results in decreased expression of NFE2L2 mRNA | 25596134 |
D008687 | Metformin | Metformin results in decreased expression of NFE2L2 protein | 22627169 |
D008694 | Methamphetamine | Methamphetamine affects the localization of NFE2L2 protein | 19564919 |
D008694 | Methamphetamine | Methamphetamine results in increased expression of NFE2L2 mRNA | 19564919 |
D008694 | Methamphetamine | SCH 23390 inhibits the reaction [Methamphetamine affects the localization of NFE2L2 protein] | 19564919 |
D008694 | Methamphetamine | SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] | 19564919 |
D008694 | Methamphetamine | Methamphetamine affects the localization of NFE2L2 protein | 23933405 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency] affects the localization of NFE2L2 protein | 20350562 |
D008715 | Methionine | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CD36 mRNA] | 20350562 |
D008715 | Methionine | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of FGF21 mRNA] | 20350562 |
D008715 | Methionine | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA] | 20350562 |
D008715 | Methionine | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of KEAP1 mRNA] | 20350562 |
D008715 | Methionine | NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of NQO1 mRNA] | 20350562 |
D008715 | Methionine | NFE2L2 affects the susceptibility to [Choline deficiency co-treated with Methionine deficiency] | 20350562 |
D008727 | Methotrexate | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] | 28414158 |
D008727 | Methotrexate | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | 28414158 |
D008727 | Methotrexate | Methotrexate results in decreased expression of NFE2L2 mRNA | 28414158 |
D008727 | Methotrexate | Methotrexate results in decreased expression of NFE2L2 protein | 28414158 |
C013598 | methoxyacetic acid | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide inhibits the reaction [methoxyacetic acid results in decreased expression of NFE2L2 protein]" | 21573189 |
C013598 | methoxyacetic acid | methoxyacetic acid results in decreased expression of NFE2L2 protein | 21573189 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of NFE2L2 protein" | 25246272|2735823 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased localization of NFE2L2 protein" | 21723306 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "NFE2L2 promotes the reaction [methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of SRXN1 protein]" | 27358234 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "NFE2L2 protein affects the reaction [methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of HMOX1 protein]" | 28790194 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein]" | 24530882 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [aristolochic acid I results in decreased expression of NFE2L2 mRNA]" | 24530882 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of NFE2L2 mRNA" | 21289052 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of NFE2L2 protein" | 21289052|2453088 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "NFE2L2 gene mutant form results in decreased susceptibility to methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate" | 27633142 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased activity of NFE2L2 protein" | 24798383 |
C080197 | methylarsine oxide | NFE2L2 mRNA affects the susceptibility to methylarsine oxide | 23000044 |
D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [AHR protein binds to NFE2L2 promoter] | 20348232 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of NFE2L2 mRNA | 20713471|2371296 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of NFE2L2 protein | 16723119 |
D008748 | Methylcholanthrene | NFE2L2 protein affects the reaction [Methylcholanthrene results in increased expression of PSMB5 mRNA] | 16723119 |
D008751 | Methylene Blue | [Methylene Blue co-treated with MAPT protein mutant form] affects the localization of NFE2L2 protein | 24556215 |
D008751 | Methylene Blue | [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of NFE2L2 mRNA | 24556215 |
D008751 | Methylene Blue | NFE2L2 gene mutant form inhibits the reaction [Methylene Blue results in increased expression of GCLC mRNA] | 24556215 |
D008751 | Methylene Blue | NFE2L2 gene mutant form inhibits the reaction [Methylene Blue results in increased expression of HMOX1 mRNA] | 24556215 |
D008751 | Methylene Blue | NFE2L2 gene mutant form inhibits the reaction [Methylene Blue results in increased expression of NQO1 mRNA] | 24556215 |
C052082 | methyl gallate | methyl gallate results in increased expression of NFE2L2 protein | 27777014 |
C004925 | methylmercuric chloride | Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein] | 27917510 |
C004925 | methylmercuric chloride | methylmercuric chloride affects the localization of NFE2L2 protein | 24816296 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NFE2L2 mRNA | 23179753|2800136 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NFE2L2 protein | 27180086|2791751 |
C004925 | methylmercuric chloride | Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein] | 24816296 |
C004925 | methylmercuric chloride | methylmercuric chloride affects the localization of NFE2L2 protein | 20402460 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of NFE2L2 mRNA | 23202902 |
C004925 | methylmercuric chloride | methylmercuric chloride affects the localization of NFE2L2 protein | 20421342|2873614 |
C004925 | methylmercuric chloride | [methylmercuric chloride affects the localization of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 20421342 |
C004925 | methylmercuric chloride | [methylmercuric chloride affects the localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 20421342 |
C004925 | methylmercuric chloride | [methylmercuric chloride affects the localization of NFE2L2 protein] which results in increased expression of SLC7A11 mRNA | 20421342 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NFE2L2 mRNA | 27298056 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of NFE2L2 protein | 20421342|2729805 |
C004925 | methylmercuric chloride | NFE2L2 protein results in decreased susceptibility to methylmercuric chloride | 20421342 |
C004925 | methylmercuric chloride | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 mRNA] | 27298056 |
C004925 | methylmercuric chloride | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein] | 27298056 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of NFE2L2 protein | 20807546 |
D008767 | Methylmercury Compounds | NFE2L2 protein results in decreased susceptibility to Methylmercury Compounds | 25271560 |
D008767 | Methylmercury Compounds | [Methylmercury Compounds co-treated with Polychlorinated Biphenyls] results in decreased expression of NFE2L2 mRNA | 20020106 |
D008767 | Methylmercury Compounds | Methylmercury Compounds inhibits the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 protein] | 26827822 |
D008767 | Methylmercury Compounds | NFE2L2 protein results in decreased susceptibility to Methylmercury Compounds | 25271560 |
D008767 | Methylmercury Compounds | NFE2L2 results in decreased susceptibility to Methylmercury Compounds | 21382770 |
D008767 | Methylmercury Compounds | Methylmercury Compounds affects the localization of and results in increased activity of NFE2L2 protein | 18815141 |
D008767 | Methylmercury Compounds | Methylmercury Compounds affects the localization of NFE2L2 protein | 21351162 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of NFE2L2 protein | 21351162 |
D008767 | Methylmercury Compounds | NFE2L2 mRNA affects the reaction [Methylmercury Compounds results in increased expression of HMOX1 mRNA] | 21351162 |
D008767 | Methylmercury Compounds | NFE2L2 mRNA affects the reaction [Methylmercury Compounds results in increased expression of NQO1 mRNA] | 21351162 |
D008767 | Methylmercury Compounds | NFE2L2 mRNA affects the reaction [Methylmercury Compounds results in increased expression of SLC7A11 mRNA] | 21351162 |
D008767 | Methylmercury Compounds | NFE2L2 protein affects the susceptibility to Methylmercury Compounds | 21351162 |
D008767 | Methylmercury Compounds | NFE2L2 protein promotes the reaction [Methylmercury Compounds results in increased expression of HMOX1 mRNA] | 18815141 |
D008767 | Methylmercury Compounds | PIK3R1 protein promotes the reaction [Methylmercury Compounds results in increased activity of NFE2L2 protein] | 18815141 |
D008741 | Methyl Methanesulfonate | NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of BTG2 mRNA] | 22003191 |
D008741 | Methyl Methanesulfonate | NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA] | 22003191 |
D008741 | Methyl Methanesulfonate | NFE2L2 protein results in decreased susceptibility to Methyl Methanesulfonate | 20932822 |
D015655 | 1-Methyl-4-phenylpyridinium | NFE2L2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenylpyridinium | 12842875 |
D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein | 26048653 |
D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased localization of NFE2L2 protein | 22019741 |
D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein | 23272707 |
D015655 | 1-Methyl-4-phenylpyridinium | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]] | 26048653 |
D015655 | 1-Methyl-4-phenylpyridinium | astaxanthine promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein] | 23272707 |
D015655 | 1-Methyl-4-phenylpyridinium | Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein] | 26048653 |
D015655 | 1-Methyl-4-phenylpyridinium | Hemin promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein] | 23272707 |
D015655 | 1-Methyl-4-phenylpyridinium | [Luteolin results in increased activity of NFE2L2 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium | 17982879 |
D015655 | 1-Methyl-4-phenylpyridinium | NFE2L2 mutant form inhibits the reaction [Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of NQO1 protein]] | 22019741 |
D015655 | 1-Methyl-4-phenylpyridinium | Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased localization of NFE2L2 protein] | 22019741 |
D015655 | 1-Methyl-4-phenylpyridinium | tin protoporphyrin IX inhibits the reaction [astaxanthine promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein]] | 23272707 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein" | 24991814 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "NFE2L2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" | 22746536 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "salvianolic acid B inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]" | 24991814 |
D008775 | Methylprednisolone | Methylprednisolone inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] | 26093215 |
C076881 | methysticin | methysticin affects the localization of NFE2L2 protein | 28448946 |
C051786 | metolachlor | metolachlor results in increased activity of NFE2L2 protein | 20143881 |
D008798 | Mevalonic Acid | Mevalonic Acid affects the reaction [Simvastatin results in increased localization of NFE2L2 protein] | 18787804 |
D015735 | Mifepristone | [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein]] | 22606287 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased activity of CAT protein] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased expression of IL10 protein] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP3 mRNA] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CYCS mRNA] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL10 mRNA] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 mRNA] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 protein] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF mRNA] | 22736252 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF protein] | 22736252 |
D015735 | Mifepristone | [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [HSD11B1 protein results in decreased activity of NFE2L2 protein] | 22606287 |
D015735 | Mifepristone | [Mifepristone co-treated with Paraquat] results in increased expression of NFE2L2 mRNA | 24812154 |
D015735 | Mifepristone | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in decreased activity of CAT protein] | 24812154 |
D015735 | Mifepristone | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL1B protein] | 24812154 |
D015735 | Mifepristone | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL6 protein] | 24812154 |
D015735 | Mifepristone | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of RELA protein] | 24812154 |
D015735 | Mifepristone | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of TNF protein] | 24812154 |
D015735 | Mifepristone | NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of HMOX1 mRNA] | 24812154 |
D015735 | Mifepristone | NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of NQO1 mRNA] | 24812154 |
C517880 | monascin | monascin affects the localization of NFE2L2 protein | 23331247 |
C517880 | monascin | monascin inhibits the reaction [S100B protein results in decreased expression of NFE2L2 protein] | 23331247 |
C517880 | monascin | monascin promotes the reaction [S100B protein affects the localization of NFE2L2 protein] | 23331247 |
C517880 | monascin | monascin results in increased expression of NFE2L2 mRNA | 23331247 |
C517880 | monascin | monascin results in increased phosphorylation of NFE2L2 protein | 23954466 |
C517880 | monascin | NFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]] | 23331247 |
C517880 | monascin | NFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in decreased expression of HMOX1 mRNA]] | 23331247 |
C517880 | monascin | NFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in increased expression of IL1B protein]] | 23331247 |
C517880 | monascin | NFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in increased expression of TNF protein]] | 23331247 |
C517880 | monascin | 2-chloro-5-nitrobenzanilide inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA] | 23954466 |
C517880 | monascin | monascin results in increased expression of NFE2L2 mRNA | 23954466 |
C517880 | monascin | PPARG mutant form inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA] | 23954466 |
C014114 | monocrotaline pyrrole | monocrotaline pyrrole affects the localization of NFE2L2 protein | 20695460 |
C020300 | monomethylarsonic acid | monomethylarsonic acid results in decreased expression of NFE2L2 mRNA | 24091636 |
C020300 | monomethylarsonic acid | monomethylarsonic acid results in increased expression of and affects the localization of NFE2L2 protein | 24161444 |
C020300 | monomethylarsonic acid | NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein] | 24161444 |
C406082 | monomethylarsonous acid | monomethylarsonous acid inhibits the reaction [KEAP1 protein mutant form results in increased ubiquitination of NFE2L2 protein] | 18417180 |
C406082 | monomethylarsonous acid | monomethylarsonous acid inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
C406082 | monomethylarsonous acid | monomethylarsonous acid promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of NFE2L2 protein | 18417180 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of NFE2L2 mRNA | 20024957 |
C008548 | morin | morin inhibits the reaction [Acetaminophen results in decreased expression of and affects the localization of NFE2L2 protein] | 26767949 |
C008548 | morin | morin inhibits the reaction [Acetaminophen results in increased ubiquitination of and results in decreased expression of NFE2L2 protein] | 26767949 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of NFE2L2 mRNA | 15674844|1895507 |
C040015 | myricetin | myricetin results in increased expression of NFE2L2 protein | 16799064 |
C587573 | myrrh resin | myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA] | 28414157 |
C587573 | myrrh resin | myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein] | 28414157 |
C554954 | N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride | N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride results in increased expression of NFE2L2 mRNA | 28174063 |
C109145 | N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal | N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] | 22964297 |
C028473 | N-acetyl-4-benzoquinoneimine | N-acetyl-4-benzoquinoneimine affects the localization of NFE2L2 protein | 18785192 |
C028473 | N-acetyl-4-benzoquinoneimine | N-acetyl-4-benzoquinoneimine results in increased activity of NFE2L2 protein | 18785192 |
C028473 | N-acetyl-4-benzoquinoneimine | NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA] | 18785192 |
C028473 | N-acetyl-4-benzoquinoneimine | NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] | 19246624 |
C064769 | N-acetylsphingosine | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of NFE2L2 protein] | 15319326 |
C064769 | N-acetylsphingosine | N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased localization of NFE2L2 protein] | 15319326 |
C064769 | N-acetylsphingosine | N-acetylsphingosine results in decreased localization of NFE2L2 protein | 15319326 |
D009285 | Naphthoquinones | Naphthoquinones affects the localization of NFE2L2 protein | 20695460 |
D015058 | 1-Naphthylisothiocyanate | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NFE2L2 mRNA | 27344345 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of HIF1A mRNA] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased abundance of Bile Acids and Salts] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC3 mRNA] | 19181614 |
D015058 | 1-Naphthylisothiocyanate | NFE2L2 promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NR0B2 mRNA] | 19181614 |
C005273 | naringenin | [naringenin co-treated with Paraquat] results in increased expression of NFE2L2 protein | 24561720 |
C005273 | naringenin | naringenin results in increased expression of and affects the localization of NFE2L2 protein | 24561720 |
C005273 | naringenin | naringenin results in increased expression of NFE2L2 mRNA | 24561720 |
C529068 | naringenin-7-O-glucoside | naringenin-7-O-glucoside results in increased expression of NFE2L2 protein | 18652870 |
C005274 | naringin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein] | 25773745 |
C005274 | naringin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein] | 25773745 |
C005274 | naringin | naringin affects the localization of NFE2L2 protein | 22871521|2577374 |
C005274 | naringin | [naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein | 22871521 |
C005274 | naringin | naringin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 27174133 |
C005274 | naringin | naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of NFE2L2 protein] | 25773745 |
C005274 | naringin | rottlerin inhibits the reaction [naringin affects the localization of NFE2L2 protein] | 25773745 |
C498045 | NCX 4040 | NCX 4040 affects the localization of NFE2L2 protein | 23035985 |
D000068577 | Nebivolol | Nebivolol results in increased expression of NFE2L2 | 23886954 |
C524653 | nectandrin-B | nectandrin-B affects the localization of NFE2L2 protein | 27511913 |
C524653 | nectandrin-B | nectandrin-B inhibits the reaction [tert-Butylhydroperoxide affects the localization of NFE2L2 protein] | 27511913 |
C051752 | nefazodone | nefazodone results in decreased expression of NFE2L2 mRNA | 24136188 |
D009532 | Nickel | Nickel results in increased expression of NFE2L2 protein | 28330870 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of APLP1 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of CAV1 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of CLSPN mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of FANCB mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of FOSL2 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of H2AFX mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of HRK mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of HSP90AB1 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of KAT2B mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of KLK3 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of MICA mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of PIM2 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of PRAME mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of RBMX mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of RUNX1 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of SLC7A6 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of TSC22D3 mRNA] | 23023193 |
C119536 | nickel acetate | NFE2L2 protein results in decreased susceptibility to nickel acetate | 23023193 |
C022838 | nickel chloride | Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of NFE2L2 protein] | 16806455 |
C022838 | nickel chloride | lipopolysaccharide A promotes the reaction [nickel chloride affects the localization of NFE2L2 protein] | 16806455 |
C022838 | nickel chloride | Lipopolysaccharides promotes the reaction [nickel chloride results in increased expression of NFE2L2 protein] | 18437699 |
C022838 | nickel chloride | nickel chloride affects the localization of NFE2L2 protein | 16806455 |
C022838 | nickel chloride | nickel chloride promotes the reaction [lipopolysaccharide A results in increased expression of NFE2L2 protein] | 16806455 |
C022838 | nickel chloride | nickel chloride results in increased expression of NFE2L2 protein | 16806455|1843769 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of NFE2L2 protein | 19033392 |
C029938 | nickel sulfate | nickel sulfate results in increased methylation of NFE2L2 promoter | 25957741 |
C029938 | nickel sulfate | Quercetin inhibits the reaction [nickel sulfate results in increased methylation of NFE2L2 promoter] | 25957741 |
D009543 | Nifedipine | Nifedipine affects the localization of NFE2L2 protein | 21525764 |
C012655 | nimesulide | nimesulide affects the localization of NFE2L2 protein | 20405857 |
C012655 | nimesulide | Sulfaphenazole affects the reaction [nimesulide affects the localization of NFE2L2 protein] | 20405857 |
C012655 | nimesulide | NFE2L2 mutant form inhibits the reaction [nimesulide results in increased expression of NQO1] | 20405857 |
C012655 | nimesulide | nimesulide affects the localization of NFE2L2 protein | 20405857 |
C012655 | nimesulide | nimesulide results in decreased expression of NFE2L2 mRNA | 24136188 |
D009569 | Nitric Oxide | NFE2L2 affects the secretion of Nitric Oxide | 24365262 |
D009573 | Nitrites | NFE2L2 protein inhibits the reaction [IFNG protein results in increased abundance of Nitrites] | 23942037 |
D009573 | Nitrites | NFE2L2 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites] | 23942037 |
D009573 | Nitrites | NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] | 23942037 |
D009573 | Nitrites | NFE2L2 protein promotes the reaction [2-tert-butylhydroquinone inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D009573 | Nitrites | NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] | 23942037 |
D009573 | Nitrites | NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D009573 | Nitrites | NFE2L2 protein promotes the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | 23942037 |
D009573 | Nitrites | [Nitrites co-treated with Oxygen deficiency] results in increased expression of NFE2L2 mRNA | 22892143 |
D009588 | Nitrogen Mustard Compounds | caffeic acid phenethyl ester promotes the reaction [Nitrogen Mustard Compounds results in increased expression of NFE2L2 protein] | 17204746 |
D009588 | Nitrogen Mustard Compounds | Nitrogen Mustard Compounds results in increased expression of NFE2L2 protein | 17204746 |
C028842 | N-methylprotoporphyrin IX | NFE2L2 gene mutant form inhibits the reaction [N-methylprotoporphyrin IX results in increased expression of CYP2A5 mRNA] | 22859313 |
C028842 | N-methylprotoporphyrin IX | NFE2L2 gene mutant form inhibits the reaction [N-methylprotoporphyrin IX results in increased expression of HMOX1 mRNA] | 22859313 |
C025256 | nonylphenol | [nonylphenol co-treated with bisphenol A] results in increased expression of NFE2L2 mRNA | 23606268 |
C025256 | nonylphenol | nonylphenol results in increased expression of NFE2L2 mRNA | 23606268 |
C072936 | notoginsenoside R1 | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein | 25422538 |
C072936 | notoginsenoside R1 | notoginsenoside R1 affects the localization of NFE2L2 protein | 25422538 |
C072936 | notoginsenoside R1 | NFE2L2 promotes the reaction [notoginsenoside R1 results in increased expression of GCLC protein] | 24437944 |
C072936 | notoginsenoside R1 | NFE2L2 promotes the reaction [notoginsenoside R1 results in increased expression of HMOX1 protein] | 24437944 |
C072936 | notoginsenoside R1 | NFE2L2 promotes the reaction [notoginsenoside R1 results in increased expression of NQO1 protein] | 24437944 |
C072936 | notoginsenoside R1 | notoginsenoside R1 affects the localization of NFE2L2 protein | 24437944|2472066 |
C072936 | notoginsenoside R1 | notoginsenoside R1 promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] | 24437944 |
C487513 | NSC 23766 | NSC 23766 inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] | 28710503 |
C464660 | obeticholic acid | obeticholic acid results in increased expression of NFE2L2 mRNA | 27939613 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in decreased expression of TGFB2 mRNA] | 28710020 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of FN1 mRNA] | 28710020 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL1B mRNA] | 28710020 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein] | 28710020 |
C025589 | ochratoxin A | NFE2L2 protein affects the susceptibility to ochratoxin A | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of GSR mRNA | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA mRNA | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of VEGFA protein | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of BBC3 protein | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of ICAM1 protein | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TGFB1 protein | 28710020 |
C025589 | ochratoxin A | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased expression of TIMP2 mRNA | 28710020 |
C025589 | ochratoxin A | ochratoxin A affects the reaction [NFE2L2 protein affects the expression of HMOX1 mRNA] | 28710020 |
C025589 | ochratoxin A | ochratoxin A promotes the reaction [NFE2L2 protein affects the expression of BBC3 mRNA] | 28710020 |
C025589 | ochratoxin A | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] | 17110534 |
C025589 | ochratoxin A | ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] | 17110534 |
C025589 | ochratoxin A | ochratoxin A results in decreased activity of NFE2L2 protein | 17110534 |
C025589 | ochratoxin A | ochratoxin A results in increased expression of NFE2L2 mRNA | 24120684 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of IL6 mRNA] | 28710020 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TGFB1 mRNA] | 28710020 |
C025589 | ochratoxin A | NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of TP53 protein] | 28710020 |
C025589 | ochratoxin A | ochratoxin A inhibits the reaction [sulforafan affects the localization of NFE2L2 protein] | 18547363 |
C025589 | ochratoxin A | ochratoxin A inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 18547363 |
C025589 | ochratoxin A | ochratoxin A inhibits the reaction [sulforafan results in increased expression of NFE2L2 mRNA] | 28710020 |
C025589 | ochratoxin A | ochratoxin A results in decreased activity of NFE2L2 protein | 18547363|1854770 |
C025589 | ochratoxin A | ochratoxin A results in decreased expression of NFE2L2 mRNA | 18547363|2871002 |
C025589 | ochratoxin A | ochratoxin A results in decreased activity of NFE2L2 protein | 19414514 |
C045354 | ochratoxin B | ochratoxin B results in decreased activity of NFE2L2 protein | 18547704 |
D019787 | Linoleic Acid | Linoleic Acid metabolite results in increased expression of NFE2L2 protein | 26879219 |
D019787 | Linoleic Acid | Linoleic Acid results in increased expression of NFE2L2 mRNA | 28555106 |
D019787 | Linoleic Acid | Linoleic Acid results in increased expression of NFE2L2 protein | 28555106 |
D019787 | Linoleic Acid | NFE2L2 mRNA promotes the reaction [Linoleic Acid metabolite results in increased expression of HMOX1 mRNA] | 26879219 |
D019787 | Linoleic Acid | NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of CYP2A6 mRNA] | 28555106 |
D019787 | Linoleic Acid | NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of CYP2A6 protein] | 28555106 |
D019787 | Linoleic Acid | NFE2L2 protein promotes the reaction [Linoleic Acid results in increased expression of GSTA1 mRNA] | 28555106 |
D019787 | Linoleic Acid | Linoleic Acid metabolite results in increased expression of NFE2L2 protein | 26879219 |
D019301 | Oleic Acid | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein]" | 26634892 |
D019301 | Oleic Acid | [gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein | 26634892 |
D019301 | Oleic Acid | Oleic Acid results in increased expression of NFE2L2 mRNA | 28555106 |
D019301 | Oleic Acid | Oleic Acid results in increased expression of NFE2L2 protein | 28555106 |
D016627 | Oxidopamine | [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine | 16092930 |
D016627 | Oxidopamine | [linsidomine results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine | 16092930 |
D016627 | Oxidopamine | NFE2L2 protein results in decreased susceptibility to Oxidopamine | 16092930 |
D016627 | Oxidopamine | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of NFE2L2 protein] | 21397656 |
D016627 | Oxidopamine | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased localization of NFE2L2 protein] | 21397656 |
D016627 | Oxidopamine | Oxidopamine affects the localization of NFE2L2 protein | 23274087 |
D016627 | Oxidopamine | Oxidopamine inhibits the reaction [NFE2L2 protein binds to MAFK protein] | 23274087 |
D016627 | Oxidopamine | Oxidopamine promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 23274087 |
D016627 | Oxidopamine | Oxidopamine results in increased activity of NFE2L2 protein | 17676812 |
D016627 | Oxidopamine | Oxidopamine results in increased expression of NFE2L2 mRNA | 21397656 |
D016627 | Oxidopamine | Oxidopamine results in increased expression of NFE2L2 protein | 21397656 |
D016627 | Oxidopamine | Oxidopamine results in increased localization of NFE2L2 protein | 21397656 |
D019319 | Okadaic Acid | Okadaic Acid results in increased expression of NFE2L2 protein | 12446695 |
C013168 | olaquindox | CDKN1A protein affects the reaction [olaquindox results in increased expression of NFE2L2 protein] | 28757460 |
C013168 | olaquindox | olaquindox results in increased expression of NFE2L2 protein | 28757460 |
D009828 | Oleanolic Acid | Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | 20100471 |
D009828 | Oleanolic Acid | Oleanolic Acid promotes the reaction [NFE2L2 protein results in increased expression of SREBF1 mRNA] | 28796629 |
D009828 | Oleanolic Acid | NFE2L2 protein affects the reaction [Oleanolic Acid results in increased activity of NQO1 protein] | 19283895 |
D009828 | Oleanolic Acid | NFE2L2 protein affects the reaction [Oleanolic Acid results in increased expression of NQO1 protein] | 19283895 |
D009828 | Oleanolic Acid | Oleanolic Acid affects the localization of NFE2L2 protein | 19283895 |
D009828 | Oleanolic Acid | Oleanolic Acid promotes the reaction [Phalloidine results in increased expression of NFE2L2 mRNA] | 25280775 |
D009828 | Oleanolic Acid | Oleanolic Acid results in increased activity of NFE2L2 protein | 19283895 |
D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of NFE2L2 mRNA | 18706400|1928389 |
D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of NFE2L2 protein | 23948738 |
D009828 | Oleanolic Acid | Phalloidine promotes the reaction [Oleanolic Acid results in increased expression of NFE2L2 mRNA] | 25280775 |
D009828 | Oleanolic Acid | Oleanolic Acid inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein] | 25111957 |
D009828 | Oleanolic Acid | Oleanolic Acid promotes the reaction [Ethanol affects the localization of NFE2L2 protein] | 25111957 |
D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of NFE2L2 mRNA | 18706400 |
C026209 | oltipraz | oltipraz results in increased activity of NFE2L2 protein | 25752797 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of ABCC3 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of ABCC4 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of ALDH1A1 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of CES1G mRNA] | 22429928 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of CES2C mRNA] | 22429928 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of CYP1A2 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTA1 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTA4 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTM1 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTM2 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTM3 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTM4 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of NQO1 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of SULT3A1 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of UGT1A6A mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of UGT2B34 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the reaction [oltipraz results in increased expression of UGT2B36 mRNA] | 22496397 |
C026209 | oltipraz | NFE2L2 protein affects the susceptibility to oltipraz | 19150646|2008605 |
C026209 | oltipraz | oltipraz affects the activity of NFE2L2 protein | 11309284 |
C026209 | oltipraz | oltipraz binds to and results in increased activity of NFE2L2 protein | 15919853 |
C026209 | oltipraz | [oltipraz co-treated with NFE2L2 protein mutant form] affects the expression of ABCG5 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz co-treated with NFE2L2 protein mutant form] results in decreased expression of UGT2B1 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz co-treated with NFE2L2 protein mutant form] results in decreased expression of UGT2B35 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA | 15833929 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC3 mRNA | 15833929|2249639 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC4 mRNA | 15833929|2249639 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC5 mRNA | 15833929 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC6 mRNA | 15833929 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ALDH1A1 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTA1 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTA4 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM1 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM2 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM3 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM4 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of MGST3 mRNA | 22496397 |
C026209 | oltipraz | [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 22496397 |
C026209 | oltipraz | oltipraz binds to and results in increased activity of NFE2L2 protein | 15833929 |
C026209 | oltipraz | oltipraz results in increased activity of NFE2L2 protein | 20086057|2242992 |
D009853 | Omeprazole | NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA] | 27725188 |
D009853 | Omeprazole | NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein] | 27725188 |
C105488 | ONO 1301 | "ONO 1301 inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFE2L2 mRNA]" | 28887131 |
C000592118 | ONO-8430506 | [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid] which results in decreased expression of NFE2L2 | 25398768 |
C030110 | oxaliplatin | NFE2L2 protein affects the susceptibility to oxaliplatin | 23933386 |
C029341 | oxophenylarsine | oxophenylarsine binds to and results in increased activity of NFE2L2 protein | 19786557 |
C029341 | oxophenylarsine | oxophenylarsine results in increased activity of NFE2L2 protein | 19808700 |
C016027 | oxyfluorofen | oxyfluorofen results in increased activity of NFE2L2 protein | 20143881 |
D010100 | Oxygen | [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein] | 28400208 |
D010100 | Oxygen | Oxygen deficiency affects the activity of NFE2L2 protein | 25596134 |
D010100 | Oxygen | [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein | 28400208 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of NFE2L2 mRNA | 25596134 |
D010100 | Oxygen | Particulate Matter inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] | 28400208 |
D010100 | Oxygen | Vehicle Emissions inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] | 28400208 |
D010100 | Oxygen | NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MYH7 mRNA] | 28373008 |
D010100 | Oxygen | NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPA mRNA] | 28373008 |
D010100 | Oxygen | NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPB mRNA] | 28373008 |
D010100 | Oxygen | NFE2L2 gene mutant form results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency] | 28373008 |
D010100 | Oxygen | NFE2L2 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of SULT1E1 mRNA] | 25922074 |
D010100 | Oxygen | NFE2L2 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of SULT1E1 protein] | 25922074 |
D010100 | Oxygen | Oxygen deficiency affects the expression of NFE2L2 mRNA | 25448280 |
D010100 | Oxygen | Oxygen deficiency affects the expression of NFE2L2 protein | 25448280 |
D010100 | Oxygen | [Oxygen deficiency co-treated with Oxygen] results in increased expression of NFE2L2 protein | 25922074 |
D010100 | Oxygen | Ethanol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein] | 26747958 |
D010100 | Oxygen | naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of NFE2L2 protein] | 25773745 |
D010100 | Oxygen | NFE2L2 mutant form inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein] | 25773745 |
D010100 | Oxygen | NFE2L2 mutant form inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein] | 25773745 |
D010100 | Oxygen | NFE2L2 mutant form promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein] | 25773745 |
D010100 | Oxygen | NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] | 20028456 |
D010100 | Oxygen | NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]] | 25896937 |
D010100 | Oxygen | NFE2L2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Oxygen] | 25773745 |
D010100 | Oxygen | [Nitrites co-treated with Oxygen deficiency] results in increased expression of NFE2L2 mRNA | 22892143 |
D010100 | Oxygen | [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein | 26747958 |
D010100 | Oxygen | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein | 26747958 |
D010100 | Oxygen | [Oxygen deficiency co-treated with Oxygen] affects the localization of NFE2L2 protein | 25773745 |
C037573 | oxymatrine | oxymatrine promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 27713174 |
D017239 | Paclitaxel | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Paclitaxel | 20530669 |
D017239 | Paclitaxel | NFE2L2 results in decreased susceptibility to Paclitaxel | 20530669 |
D017239 | Paclitaxel | Paclitaxel results in decreased expression of NFE2L2 mRNA | 15585946 |
C535072 | pallidol | pallidol results in increased activity of NFE2L2 protein | 25466015 |
C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C496932 | panobinostat | panobinostat results in increased expression of NFE2L2 mRNA | 26272509 |
D010269 | Paraquat | Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] | 20851755 |
D010269 | Paraquat | ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] | 28428137 |
D010269 | Paraquat | CAT protein inhibits the reaction [Paraquat results in decreased expression of NFE2L2 mRNA] | 24866057 |
D010269 | Paraquat | meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] | 20851755 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased activity of CAT protein] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased expression of IL10 protein] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP3 mRNA] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CYCS mRNA] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL10 mRNA] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 mRNA] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of IL6 protein] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF mRNA] | 22736252 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of TNF protein] | 22736252 |
D010269 | Paraquat | [naringenin co-treated with Paraquat] results in increased expression of NFE2L2 protein | 24561720 |
D010269 | Paraquat | NFE2L2 protein affects the reaction [ERBB2 protein results in decreased susceptibility to Paraquat] | 25467193 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of IL6 protein] | 22493042 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of TGFB1 protein] | 22493042 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [Paraquat results in increased expression of TNF protein] | 22493042 |
D010269 | Paraquat | NFE2L2 protein results in decreased susceptibility to Paraquat | 22493042 |
D010269 | Paraquat | Paraquat affects the expression of NFE2L2 protein | 28428137 |
D010269 | Paraquat | [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein | 23546295 |
D010269 | Paraquat | [Paraquat co-treated with Ellagic Acid] results in increased expression of NFE2L2 mRNA | 23546295 |
D010269 | Paraquat | [Paraquat co-treated with Quercetin] results in increased expression of NFE2L2 mRNA | 22996356 |
D010269 | Paraquat | [Paraquat co-treated with Quercetin] results in increased localization of NFE2L2 protein | 22996356 |
D010269 | Paraquat | [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein | 23649336 |
D010269 | Paraquat | Paraquat promotes the reaction [MIR153 mRNA binds to NFE2L2 3' UTR] | 24866057 |
D010269 | Paraquat | Paraquat promotes the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 24141985 |
D010269 | Paraquat | Paraquat promotes the reaction [resveratrol results in increased expression of and results in increased activity of NFE2L2 protein] | 22493042 |
D010269 | Paraquat | Paraquat promotes the reaction [Silymarin affects the localization of NFE2L2 protein] | 22709784 |
D010269 | Paraquat | Paraquat results in decreased expression of NFE2L2 mRNA | 24866057 |
D010269 | Paraquat | Paraquat results in decreased expression of NFE2L2 protein | 20851755|2486605 |
D010269 | Paraquat | Paraquat results in increased expression of and results in increased activity of NFE2L2 protein | 22493042 |
D010269 | Paraquat | Paraquat results in increased expression of NFE2L2 mRNA | 22709784|2364933 |
D010269 | Paraquat | Paraquat results in increased expression of NFE2L2 protein | 23546295|2414198 |
D010269 | Paraquat | Plant Extracts promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] | 24141985 |
D010269 | Paraquat | [resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Paraquat | 22493042 |
D010269 | Paraquat | [Silymarin co-treated with Paraquat] results in increased expression of NFE2L2 protein | 22709784 |
D010269 | Paraquat | Silymarin promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 22709784 |
D010269 | Paraquat | Thioctic Acid promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 23649336 |
D010269 | Paraquat | 2-tert-butylhydroquinone inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein] | 22983789 |
D010269 | Paraquat | AKT2 protein affects the reaction [Paraquat results in increased expression of NFE2L2 protein] | 28115273 |
D010269 | Paraquat | ARL6IP5 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] | 28428137 |
D010269 | Paraquat | NFE2L2 protein affects the reaction [Paraquat affects the expression of NFE2L2 protein] | 26935021 |
D010269 | Paraquat | Paraquat affects the expression of and results in decreased stability of NFE2L2 protein | 26935021 |
D010269 | Paraquat | Paraquat affects the expression of NFE2L2 protein | 28428137 |
D010269 | Paraquat | Paraquat results in decreased expression of NFE2L2 mRNA | 17215068 |
D010269 | Paraquat | Paraquat results in decreased expression of NFE2L2 protein | 26758514 |
D010269 | Paraquat | Paraquat results in increased expression of NFE2L2 mRNA | 25579023|2670877 |
D010269 | Paraquat | Paraquat results in increased expression of NFE2L2 protein | 22983789|2557902 |
D010269 | Paraquat | PARK7 gene mutant form affects the reaction [Paraquat affects the expression of NFE2L2 protein] | 17823202 |
D010269 | Paraquat | "plant extract, Puerariae Radix inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]" | 26758514 |
D010269 | Paraquat | SIRT1 protein inhibits the reaction [Paraquat results in decreased stability of NFE2L2 protein] | 26935021 |
D010269 | Paraquat | Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 25579023 |
D010269 | Paraquat | Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] | 25579023 |
D010269 | Paraquat | Curcumin inhibits the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 25169090 |
D010269 | Paraquat | Curcumin inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein] | 25169090 |
D010269 | Paraquat | [Mifepristone co-treated with Paraquat] results in increased expression of NFE2L2 mRNA | 24812154 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased activity of CASP3 protein] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased activity of CASP7 protein] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAK1 mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAX mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of CASP12 mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of DDIT3 mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of DDIT3 protein] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of HSPA5 mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of HSPA5 protein] | 22678742 |
D010269 | Paraquat | NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of TP53 mRNA] | 22678742 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in decreased activity of CAT protein] | 24812154 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL1B protein] | 24812154 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of IL6 protein] | 24812154 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of RELA protein] | 24812154 |
D010269 | Paraquat | NFE2L2 protein inhibits the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of TNF protein] | 24812154 |
D010269 | Paraquat | NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of HMOX1 mRNA] | 24812154 |
D010269 | Paraquat | NFE2L2 protein promotes the reaction [[Mifepristone co-treated with Paraquat] results in increased expression of NQO1 mRNA] | 24812154 |
D010269 | Paraquat | NFE2L2 protein results in increased susceptibility to Paraquat | 22678742 |
D010269 | Paraquat | Paraquat affects the localization of NFE2L2 protein | 22678742 |
D010269 | Paraquat | Paraquat results in increased expression of NFE2L2 mRNA | 20095329|2481215 |
D010269 | Paraquat | Paraquat results in increased expression of NFE2L2 protein | 25169090|2659800 |
D010269 | Paraquat | Unithiol promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 20095329 |
D052638 | Particulate Matter | EM703 inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein] | 23291319 |
D052638 | Particulate Matter | Erythromycin inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein] | 23291319 |
D052638 | Particulate Matter | NFE2L2 gene polymorphism results in increased susceptibility to Particulate Matter | 20846924 |
D052638 | Particulate Matter | NFE2L2 protein affects the reaction [Particulate Matter analog inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]] | 16890772 |
D052638 | Particulate Matter | NFE2L2 protein affects the reaction [Particulate Matter analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | 16890772 |
D052638 | Particulate Matter | Particulate Matter affects the localization of NFE2L2 protein | 12730081 |
D052638 | Particulate Matter | Particulate Matter analog affects the localization of NFE2L2 protein | 12730081 |
D052638 | Particulate Matter | Particulate Matter analog results in increased expression of NFE2L2 protein | 15322212 |
D052638 | Particulate Matter | Particulate Matter inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] | 28400208 |
D052638 | Particulate Matter | Particulate Matter results in increased activity of NFE2L2 protein | 23291319 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of NFE2L2 mRNA | 17450221 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of NFE2L2 protein | 28400208 |
D052638 | Particulate Matter | Acetylcysteine inhibits the reaction [Particulate Matter analog affects the localization of NFE2L2 protein] | 15322212 |
D052638 | Particulate Matter | [APOE protein affects the susceptibility to Dietary Fats] promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA] | 24330719 |
D052638 | Particulate Matter | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Particulate Matter analog results in increased expression of NFE2L2 protein]] | 15322212 |
D052638 | Particulate Matter | Cycloheximide inhibits the reaction [Particulate Matter analog results in increased expression of NFE2L2 protein] | 15322212 |
D052638 | Particulate Matter | NFE2L2 gene mutant form affects the susceptibility to Particulate Matter | 18614404 |
D052638 | Particulate Matter | [NFE2L2 gene mutant form affects the susceptibility to Particulate Matter] which results in increased expression of CCL17 protein | 18614404 |
D052638 | Particulate Matter | [NFE2L2 gene mutant form affects the susceptibility to Particulate Matter] which results in increased expression of IL13 protein | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter analog results in increased expression of HMOX1 mRNA] | 15322212 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of G6PDX mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GCLC mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GCLM mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GSR mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GSTA3 mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GSTM1 mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of GSTP2 mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of HMOX1 mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 gene mutant form inhibits the reaction [Particulate Matter results in increased expression of SOD2 mRNA] | 18614404 |
D052638 | Particulate Matter | NFE2L2 protein results in decreased susceptibility to Particulate Matter | 11437637 |
D052638 | Particulate Matter | Particulate Matter analog results in increased expression of and affects the localization of NFE2L2 protein | 15322212 |
D052638 | Particulate Matter | Particulate Matter analog results in increased expression of NFE2L2 protein | 15322212 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of NFE2L2 mRNA | 21873646|2433071 |
D010396 | Penicillamine | Penicillamine results in increased expression of NFE2L2 mRNA | 19575532 |
C015423 | peoniflorin | NFE2L2 protein affects the reaction [peoniflorin results in increased expression of HMOX1] | 23403272 |
C015423 | peoniflorin | peoniflorin affects the localization of NFE2L2 protein | 23403272 |
C036567 | perfluorodecanoic acid | NFE2L2 protein affects the reaction [perfluorodecanoic acid results in increased expression of ABCC3 mRNA] | 18757529 |
C036567 | perfluorodecanoic acid | NFE2L2 protein affects the reaction [perfluorodecanoic acid results in increased expression of ABCC4 mRNA] | 18757529 |
C101814 | perfluoro-n-undecanoic acid | perfluoro-n-undecanoic acid results in decreased expression of NFE2L2 mRNA | 23567314 |
C076994 | perfluorooctane sulfonic acid | NFE2L2 protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of HMOX1 mRNA] | 20200220 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of NFE2L2 mRNA | 20200220 |
C076994 | perfluorooctane sulfonic acid | sulforafan inhibits the reaction [NFE2L2 protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of HMOX1 mRNA]] | 20200220 |
C076994 | perfluorooctane sulfonic acid | sulforafan promotes the reaction [perfluorooctane sulfonic acid results in increased expression of NFE2L2 mRNA] | 20200220 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of and affects the localization of and results in decreased activity of NFE2L2 protein | 26844784 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid inhibits the reaction [NFE2L2 protein binds to NQO1 promoter] | 26548598 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased activity of NFE2L2 protein | 26548598 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of NFE2L2 mRNA | 26548598 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of and affects the localization of and results in decreased activity of NFE2L2 protein | 26844784 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of NFE2L2 mRNA | 23567314 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid affects the expression of NFE2L2 mRNA | 18281256 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of NFE2L2 mRNA | 18281256 |
C023036 | perfluorooctanoic acid | PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of NFE2L2 mRNA] | 18281256 |
C033342 | perillaldehyde | perillaldehyde promotes the reaction [NFE2L2 protein binds to TXN enhancer] | 19123792 |
D026023 | Permethrin | Permethrin results in increased expression of NFE2L2 mRNA | 23566817|2380648 |
D026023 | Permethrin | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein | 28659758 |
D010545 | Peroxides | NFE2L2 protein results in decreased susceptibility to Peroxides | 20932822 |
D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | 19781563 |
D010575 | Pesticides | Pesticides affects the localization of NFE2L2 protein | 21398409 |
D010575 | Pesticides | Pesticides results in increased expression of NFE2L2 | 21398409 |
D015232 | Dinoprostone | NFE2L2 protein inhibits the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 23942037 |
D015232 | Dinoprostone | NFE2L2 protein inhibits the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 23942037 |
D015232 | Dinoprostone | NFE2L2 protein promotes the reaction [IFNG protein results in increased abundance of Dinoprostone] | 23942037 |
D015232 | Dinoprostone | NFE2L2 protein promotes the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] | 23942037 |
D015232 | Dinoprostone | NFE2L2 affects the secretion of Dinoprostone | 24365262 |
D010590 | Phalloidine | NFE2L2 gene mutant form promotes the reaction [Phalloidine results in increased expression of CXCL1 mRNA] | 25280775 |
D010590 | Phalloidine | NFE2L2 gene mutant form promotes the reaction [Phalloidine results in increased expression of CXCL2 mRNA] | 25280775 |
D010590 | Phalloidine | NFE2L2 gene mutant form promotes the reaction [Phalloidine results in increased expression of DDIT3 mRNA] | 25280775 |
D010590 | Phalloidine | NFE2L2 gene mutant form promotes the reaction [Phalloidine results in increased expression of GADD45A mRNA] | 25280775 |
D010590 | Phalloidine | NFE2L2 gene mutant form promotes the reaction [Phalloidine results in increased expression of HMOX1 mRNA] | 25280775 |
D010590 | Phalloidine | NFE2L2 gene mutant form results in increased susceptibility to Phalloidine | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in decreased expression of MT1 mRNA | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in increased expression of CXCL1 mRNA | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in increased expression of CXCL2 mRNA | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in increased expression of DDIT3 mRNA | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in increased expression of GADD45A mRNA | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in increased expression of HMOX1 mRNA | 25280775 |
D010590 | Phalloidine | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in increased expression of SLCO1B2 mRNA | 25280775 |
D010590 | Phalloidine | Oleanolic Acid promotes the reaction [Phalloidine results in increased expression of NFE2L2 mRNA] | 25280775 |
D010590 | Phalloidine | Phalloidine promotes the reaction [KEAP1 gene mutant form results in increased expression of NFE2L2 mRNA] | 25280775 |
D010590 | Phalloidine | Phalloidine promotes the reaction [Oleanolic Acid results in increased expression of NFE2L2 mRNA] | 25280775 |
D010590 | Phalloidine | Phalloidine results in increased expression of NFE2L2 mRNA | 25280775 |
C058305 | phenethyl isothiocyanate | Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein] | 26945724 |
C058305 | phenethyl isothiocyanate | diphenyleneiodonium inhibits the reaction [phenethyl isothiocyanate affects the localization of NFE2L2 protein] | 26945724 |
C058305 | phenethyl isothiocyanate | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein]] | 26945724 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein | 26945724 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of NFE2L2 protein | 25246272 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form affects the reaction [phenethyl isothiocyanate promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 protein]]" | 25387343 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]]" | 25387343 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]" | 25387343 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]]" | 25387343 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]]" | 25387343 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]]" | 25387343 |
C058305 | phenethyl isothiocyanate | "NFE2L2 gene mutant form inhibits the reaction [phenethyl isothiocyanate promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HMOX1 mRNA]]" | 25387343 |
C058305 | phenethyl isothiocyanate | NFE2L2 protein affects the reaction [phenethyl isothiocyanate results in increased expression of CYP2A5 mRNA] | 20402460 |
C058305 | phenethyl isothiocyanate | "NFE2L2 protein results in increased susceptibility to [lipopolysaccharide, Escherichia coli O111 B4 co-treated with phenethyl isothiocyanate]" | 25387343 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate affects the localization of NFE2L2 protein | 20402460 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased expression of NFE2L2 protein | 22664424 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate promotes the reaction [[[NFE2L2 protein binds to MAF protein] which binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 15832810 |
D010634 | Phenobarbital | NFE2L2 gene mutant form affects the reaction [Phenobarbital results in increased expression of CYP2A5 mRNA] | 22859313 |
D010634 | Phenobarbital | NFE2L2 gene mutant form inhibits the reaction [Phenobarbital results in increased expression of CYP2A5 mRNA] | 24494203 |
D010634 | Phenobarbital | NFE2L2 gene mutant form inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] | 24494203 |
D010634 | Phenobarbital | NFE2L2 gene mutant form inhibits the reaction [Phenobarbital results in increased expression of NQO1 mRNA] | 24494203 |
D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NFE2L2 mRNA] | 19482888 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of NFE2L2 mRNA | 19482888|2716021 |
D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA | 28414157 |
D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein | 28414157 |
D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NFE2L2 protein | 20935162 |
D010634 | Phenobarbital | myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA] | 28414157 |
D010634 | Phenobarbital | myrrh resin analog inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein] | 28414157 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of NFE2L2 mRNA | 19162173 |
D010634 | Phenobarbital | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA] | 28414157 |
D010634 | Phenobarbital | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein] | 28414157 |
C497968 | phenylglycidol | NFE2L2 protein results in decreased susceptibility to phenylglycidol | 20932822 |
C016050 | phenylglycidyl ether | phenylglycidyl ether analog promotes the reaction [NFE2L2 protein results in increased expression of AKR1C2 mRNA] | 21751775 |
C016050 | phenylglycidyl ether | phenylglycidyl ether analog results in increased activity of NFE2L2 protein | 21751775 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of NFE2L2 mRNA | 26272509 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone affects the localization of NFE2L2 protein | 25422538 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 protein] | 25348283 |
D010695 | Phlorhizin | Phlorhizin results in decreased expression of NFE2L2 mRNA | 22538082 |
C018637 | phorone | NFE2L2 gene mutant form inhibits the reaction [phorone results in increased expression of CYP2A5 mRNA] | 24494203 |
C018637 | phorone | NFE2L2 gene mutant form inhibits the reaction [phorone results in increased expression of CYP2B10 mRNA] | 24494203 |
D010798 | Phycocyanin | Phycocyanin inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein] | 26079211 |
D064209 | Phytochemicals | Phytochemicals inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] | 26093215 |
D048789 | Phytoestrogens | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] | 24726523 |
D048789 | Phytoestrogens | fulvestrant inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] | 24726523 |
D048789 | Phytoestrogens | NFE2L2 mutant form inhibits the reaction [Phytoestrogens results in increased expression of and results in increased activity of HMOX1 protein] | 24726523 |
C030614 | picolinic acid | picolinic acid inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 22790776 |
C549211 | PIK 75 | PIK 75 inhibits the reaction [[Lipopolysaccharides co-treated with resveratrol] results in increased expression of NFE2L2 protein] | 26497626 |
D010882 | Piperonyl Butoxide | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | 19690152 |
D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of NFE2L2 mRNA | 19690152 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of NFE2L2 mRNA | 18445702|2093613 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of NFE2L2 mRNA | 16985257 |
C442842 | plant extract, Puerariae Radix | "plant extract, Puerariae Radix inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein]" | 26758514 |
D010936 | Plant Extracts | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 21840424 |
D010936 | Plant Extracts | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Plant Extracts results in increased activity of NFE2L2 protein]" | 24646717 |
D010936 | Plant Extracts | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [[Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA]" | 24646717 |
D010936 | Plant Extracts | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 21840424 |
D010936 | Plant Extracts | AKT1 mRNA inhibits the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 21840424 |
D010936 | Plant Extracts | MAPK3 mRNA inhibits the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 21840424 |
D010936 | Plant Extracts | NFE2L2 mRNA affects the reaction [Plant Extracts results in increased expression of HMOX1 protein] | 21840424 |
D010936 | Plant Extracts | Paraquat promotes the reaction [Plant Extracts affects the localization of NFE2L2 protein] | 24141985 |
D010936 | Plant Extracts | Plant Extracts affects the localization of NFE2L2 protein | 18304597|2348561 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | 27050144 |
D010936 | Plant Extracts | Plant Extracts promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] | 24141985 |
D010936 | Plant Extracts | Plant Extracts results in increased activity of NFE2L2 protein | 21972102|2464671 |
D010936 | Plant Extracts | [Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 24646717 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of and affects the localization of NFE2L2 protein | 21840424|2414198 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of NFE2L2 mRNA | 24141985 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of NFE2L2 protein | 24141985 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of NFE2L2 protein modified form | 21972102 |
D010936 | Plant Extracts | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
D010936 | Plant Extracts | U 0126 inhibits the reaction [Plant Extracts results in increased activity of NFE2L2 protein] | 24646717 |
D010936 | Plant Extracts | U 0126 inhibits the reaction [[Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA] | 24646717 |
D010936 | Plant Extracts | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
D010936 | Plant Extracts | Plant Extracts affects the localization of NFE2L2 protein | 24213006 |
D010936 | Plant Extracts | [Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein | 25449124 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of NFE2L2 mRNA] | 19182440 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 27723467 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA] | 27723467 |
D010936 | Plant Extracts | Plant Extracts results in increased activity of NFE2L2 protein | 15570060|2403614 |
D010936 | Plant Extracts | [Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 24646717 |
D010936 | Plant Extracts | [Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 24646717 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of and affects the localization of NFE2L2 protein | 25449124 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of NFE2L2 protein | 23352929 |
D010936 | Plant Extracts | pyrazolanthrone inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
D010936 | Plant Extracts | SB 203580 promotes the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
D010936 | Plant Extracts | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 20399244 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA] | 28414157 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 protein] | 28414157 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Streptozocin affects the localization of NFE2L2 protein] | 21799698 |
D010936 | Plant Extracts | Plant Extracts promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 20399244 |
D010936 | Plant Extracts | Plant Extracts promotes the reaction [Potassium Dichromate results in increased expression of NFE2L2 protein] | 18548744 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of and results in increased activity of NFE2L2 protein | 27166148 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of NFE2L2 mRNA | 20399244 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of NFE2L2 protein | 22008531 |
D010936 | Plant Extracts | Plant Extracts results in increased localization of NFE2L2 protein | 20399244 |
D010936 | Plant Extracts | [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
D010936 | Plant Extracts | U 0126 inhibits the reaction [Plant Extracts promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 20399244 |
D028321 | Plant Preparations | Plant Preparations results in increased expression of NFE2L2 mRNA | 26597533 |
D028321 | Plant Preparations | Plant Preparations results in increased expression of NFE2L2 protein | 26597533 |
D028321 | Plant Preparations | Plant Preparations affects the localization of NFE2L2 protein | 24675710 |
D028321 | Plant Preparations | Plant Preparations inhibits the reaction [Fructose results in increased expression of NFE2L2 protein] | 27531227 |
D028321 | Plant Preparations | [Cadmium co-treated with Plant Preparations] results in increased expression of NFE2L2 mRNA | 22995158 |
D028321 | Plant Preparations | Plant Preparations results in increased expression of NFE2L2 mRNA | 24973489 |
C014758 | plumbagin | NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide] | 20028456 |
C014758 | plumbagin | NFE2L2 mRNA affects the reaction [plumbagin results in increased expression of HMOX1 mRNA] | 20028456 |
C014758 | plumbagin | NFE2L2 mRNA affects the susceptibility to plumbagin | 20028456 |
C014758 | plumbagin | plumbagin affects the localization of NFE2L2 protein | 20028456 |
C014758 | plumbagin | NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] | 20028456 |
D011078 | Polychlorinated Biphenyls | Acetylcysteine inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein] | 24361488 |
D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in increased expression of and affects the localization of NFE2L2 protein | 24361488 |
D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in increased expression of NFE2L2 mRNA | 24361488 |
D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein | 24361488 |
D011078 | Polychlorinated Biphenyls | Thioctic Acid inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein] | 24361488 |
D011078 | Polychlorinated Biphenyls | Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein] | 24361488 |
D011078 | Polychlorinated Biphenyls | [Methylmercury Compounds co-treated with Polychlorinated Biphenyls] results in decreased expression of NFE2L2 mRNA | 20020106 |
D059808 | Polyphenols | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
D011192 | Potassium Dichromate | Potassium Dichromate inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 16775837 |
D011192 | Potassium Dichromate | Potassium Dichromate inhibits the reaction [sodium arsenite results in increased localization of NFE2L2 protein] | 16775837 |
D011192 | Potassium Dichromate | NFE2L2 protein results in decreased susceptibility to Potassium Dichromate | 17420218 |
D011192 | Potassium Dichromate | Potassium Dichromate affects the localization of and results in decreased ubiquitination of NFE2L2 protein | 17420218 |
D011192 | Potassium Dichromate | [Potassium Dichromate affects the localization of and results in decreased ubiquitination of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 17420218 |
D011192 | Potassium Dichromate | [Potassium Dichromate affects the localization of and results in decreased ubiquitination of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 17420218 |
D011192 | Potassium Dichromate | Potassium Dichromate inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 17420218 |
D011192 | Potassium Dichromate | Potassium Dichromate promotes the reaction [NFE2L2 protein affects the abundance of Reactive Oxygen Species] | 17420218 |
D011192 | Potassium Dichromate | Potassium Dichromate promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 17420218 |
D011192 | Potassium Dichromate | Potassium Dichromate promotes the reaction [NFE2L2 protein binds to NQO1 enhancer] | 17420218 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased activity of NFE2L2 protein | 17420218 |
D011192 | Potassium Dichromate | Plant Extracts promotes the reaction [Potassium Dichromate results in increased expression of NFE2L2 protein] | 18548744 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of NFE2L2 protein | 18548744 |
D011192 | Potassium Dichromate | S-allylcysteine promotes the reaction [Potassium Dichromate results in increased expression of NFE2L2 protein] | 18548744 |
C023617 | pregna-4,17-diene-3,16-dione | "NFE2L2 protein affects the susceptibility to pregna-4,17-diene-3,16-dione" | 22851183 |
D011341 | Probucol | NFE2L2 protein inhibits the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | 23942037 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]] | 28881715 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]] | 28881715 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]] | 28881715 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] | 28881715 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]] | 28881715 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 28881715 |
D011341 | Probucol | NFE2L2 protein affects the reaction [Probucol promotes the reaction [Lipopolysaccharides results in increased expression of NQO1 protein]] | 28881715 |
D011341 | Probucol | Probucol promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 28881715 |
C479580 | procyanidin B2 | procyanidin B2 inhibits the reaction [Carrageenan affects the localization of NFE2L2 protein] | 28844677 |
D011374 | Progesterone | Progesterone affects the expression of NFE2L2 mRNA | 24777823 |
D011420 | Propiolactone | NFE2L2 protein results in decreased susceptibility to Propiolactone | 20932822 |
C531013 | protocatechuic acid methyl ester | protocatechuic acid methyl ester inhibits the reaction [Sodium Fluoride results in increased expression of NFE2L2 mRNA] | 28012895 |
C107773 | pterostilbene | 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
C107773 | pterostilbene | Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
C107773 | pterostilbene | Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
C107773 | pterostilbene | CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] | 25341683 |
C107773 | pterostilbene | pterostilbene results in increased phosphorylation of NFE2L2 protein | 25341683 |
C107773 | pterostilbene | NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]] | 21355597 |
C107773 | pterostilbene | NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]] | 21355597 |
C107773 | pterostilbene | pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 26700463 |
C107773 | pterostilbene | pterostilbene inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 26700463 |
C107773 | pterostilbene | pterostilbene inhibits the reaction [Streptozocin results in decreased phosphorylation of and affects the localization of NFE2L2 protein] | 26700463 |
C107773 | pterostilbene | pterostilbene results in increased expression of and results in increased localization of NFE2L2 protein | 21355597 |
C107773 | pterostilbene | pterostilbene results in increased expression of NFE2L2 protein | 26700463 |
C107773 | pterostilbene | pterostilbene results in increased phosphorylation of and affects the localization of NFE2L2 protein | 26700463 |
C034912 | puag-haad | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [puag-haad results in increased phosphorylation of NFE2L2 protein] | 26102008 |
C034912 | puag-haad | puag-haad affects the localization of and results in increased phosphorylation of and results in increased activity of NFE2L2 protein | 26102008 |
C034912 | puag-haad | puag-haad analog results in increased expression of NFE2L2 protein | 23298159 |
C033607 | puerarin | puerarin affects the localization of NFE2L2 protein | 24975872 |
C033607 | puerarin | puerarin inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] | 24975872 |
D011710 | Pyocyanine | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein]" | 24015256 |
D011710 | Pyocyanine | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with tyrphostin AG 1478] inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
D011710 | Pyocyanine | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
D011710 | Pyocyanine | Pyocyanine results in increased expression of and affects the localization of NFE2L2 protein | 24015256 |
D011710 | Pyocyanine | [Pyocyanine results in increased localization of NFE2L2 protein] which results in increased expression of GCLC mRNA | 24015256 |
D011710 | Pyocyanine | [Pyocyanine results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 24015256 |
D011710 | Pyocyanine | trigonelline inhibits the reaction [Pyocyanine results in increased expression of and affects the localization of NFE2L2 protein] | 24015256 |
D011710 | Pyocyanine | tyrphostin AG 1478 inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
D011710 | Pyocyanine | Pyocyanine results in increased expression of and affects the localization of NFE2L2 protein | 24015256 |
D011710 | Pyocyanine | Pyocyanine results in increased activity of NFE2L2 protein | 27613716 |
C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of NFE2L2 mRNA | 27029645 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] | 23535287 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [[3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 23535287 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] | 16631525 |
C432165 | pyrazolanthrone | pyrazolanthrone results in decreased expression of NFE2L2 protein | 25649257 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] | 17640564 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | 28087833 |
C031280 | pyrazole | pyrazole affects the localization of NFE2L2 protein | 25478736 |
D011729 | Pyridostigmine Bromide | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein | 28659758 |
C020972 | pyrrolidine dithiocarbamic acid | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of NFE2L2 mRNA | 15477007 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid results in increased expression of NFE2L2 mRNA | 15477007 |
D011765 | Pyruvaldehyde | NFE2L2 protein affects the reaction [resveratrol affects the reaction [Pyruvaldehyde affects the expression of GLO1 protein]] | 22917016 |
D011765 | Pyruvaldehyde | NFE2L2 protein affects the reaction [resveratrol affects the reaction [Pyruvaldehyde affects the expression of HMOX1 protein]] | 22917016 |
D011765 | Pyruvaldehyde | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde affects the localization of SLC2A2 protein]] | 22917016 |
D011765 | Pyruvaldehyde | "NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]" | 22917016 |
D011765 | Pyruvaldehyde | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein]] | 22917016 |
D011765 | Pyruvaldehyde | NFE2L2 protein affects the susceptibility to Pyruvaldehyde | 28263721 |
D011765 | Pyruvaldehyde | Pyruvaldehyde affects the localization of NFE2L2 protein | 25451587 |
D011765 | Pyruvaldehyde | Pyruvaldehyde results in decreased phosphorylation of NFE2L2 protein | 22917016 |
D011765 | Pyruvaldehyde | resveratrol inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of NFE2L2 protein] | 22917016 |
D011765 | Pyruvaldehyde | [resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Pyruvaldehyde | 23954466 |
D011765 | Pyruvaldehyde | Pyruvaldehyde affects the localization of NFE2L2 protein | 23331247 |
D011765 | Pyruvaldehyde | NFE2L2 protein results in decreased susceptibility to Pyruvaldehyde | 23954466 |
D011765 | Pyruvaldehyde | NFE2L2 protein results in increased metabolism of Pyruvaldehyde | 23954466 |
D011765 | Pyruvaldehyde | [NFE2L2 protein results in increased metabolism of Pyruvaldehyde] which results in increased abundance of Lactic Acid | 23954466 |
D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] | 17433488 |
D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [SB 203580 inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] | 17433488 |
D011794 | Quercetin | Cycloheximide inhibits the reaction [Quercetin results in increased expression of NFE2L2 protein] | 25896339 |
D011794 | Quercetin | Cycloheximide inhibits the reaction [SB 203580 affects the reaction [Quercetin affects the localization of NFE2L2 protein]] | 22197970 |
D011794 | Quercetin | Cycloheximide inhibits the reaction [[SB 203580 co-treated with Quercetin] results in increased expression of NFE2L2 protein] | 22197970 |
D011794 | Quercetin | [kaempferol co-treated with Quercetin] results in increased expression of NFE2L2 mRNA | 25111660 |
D011794 | Quercetin | NFE2L2 protein affects the susceptibility to Quercetin | 19576171 |
D011794 | Quercetin | NFE2L2 protein inhibits the reaction [Quercetin results in decreased expression of BCL2 protein] | 25896339 |
D011794 | Quercetin | NFE2L2 protein inhibits the reaction [Quercetin results in increased cleavage of CASP3 protein] | 25896339 |
D011794 | Quercetin | NFE2L2 protein inhibits the reaction [Quercetin results in increased cleavage of PARP1 protein] | 25896339 |
D011794 | Quercetin | NFE2L2 protein inhibits the reaction [Quercetin results in increased expression of BAX protein] | 25896339 |
D011794 | Quercetin | NFE2L2 protein results in decreased susceptibility to Quercetin | 25896339 |
D011794 | Quercetin | [Paraquat co-treated with Quercetin] results in increased expression of NFE2L2 mRNA | 22996356 |
D011794 | Quercetin | [Paraquat co-treated with Quercetin] results in increased localization of NFE2L2 protein | 22996356 |
D011794 | Quercetin | Quercetin affects the localization of and results in increased activity of NFE2L2 protein | 27454768 |
D011794 | Quercetin | Quercetin affects the localization of NFE2L2 protein | 17433488|2152576 |
D011794 | Quercetin | Quercetin analog results in increased expression of NFE2L2 protein | 27777014 |
D011794 | Quercetin | Quercetin inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | 21256954 |
D011794 | Quercetin | Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | 27050144 |
D011794 | Quercetin | Quercetin results in decreased activity of NFE2L2 protein | 22197970 |
D011794 | Quercetin | Quercetin results in decreased expression of NFE2L2 mRNA | 21632981 |
D011794 | Quercetin | Quercetin results in decreased expression of NFE2L2 protein | 22197970 |
D011794 | Quercetin | Quercetin results in decreased ubiquitination of and results in decreased degradation of and results in increased stability of and results in increased expression of NFE2L2 protein | 17462537 |
D011794 | Quercetin | Quercetin results in increased activity of NFE2L2 protein | 17462537|2219797 |
D011794 | Quercetin | Quercetin results in increased expression of NFE2L2 mRNA | 17462537|2125695 |
D011794 | Quercetin | Quercetin results in increased expression of NFE2L2 protein | 16799064|1957617 |
D011794 | Quercetin | Quercetin results in increased localization of NFE2L2 protein | 20933534|2299635 |
D011794 | Quercetin | SB 203580 affects the reaction [Quercetin affects the localization of NFE2L2 protein] | 22197970 |
D011794 | Quercetin | [SB 203580 co-treated with Cycloheximide] inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] | 22197970 |
D011794 | Quercetin | [SB 203580 co-treated with Quercetin] results in increased expression of NFE2L2 protein | 22197970 |
D011794 | Quercetin | SB 203580 inhibits the reaction [Quercetin affects the localization of and results in increased activity of NFE2L2 protein] | 27454768 |
D011794 | Quercetin | SB 203580 inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] | 17433488 |
D011794 | Quercetin | SB 203580 inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] | 22197970 |
D011794 | Quercetin | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] | 17433488 |
D011794 | Quercetin | NFE2L2 results in increased susceptibility to Quercetin | 26445592 |
D011794 | Quercetin | Quercetin affects the localization of NFE2L2 protein | 22138401 |
D011794 | Quercetin | Quercetin inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA] | 25471833 |
D011794 | Quercetin | Quercetin inhibits the reaction [Dietary Fats results in increased expression of NFE2L2 mRNA] | 27260466 |
D011794 | Quercetin | Quercetin inhibits the reaction [nickel sulfate results in increased methylation of NFE2L2 promoter] | 25957741 |
D011794 | Quercetin | Quercetin inhibits the reaction [TLR7 protein affects the localization of NFE2L2 protein] | 26329008 |
D011794 | Quercetin | Quercetin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] | 22902988 |
D011794 | Quercetin | Quercetin promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 26505893 |
D011794 | Quercetin | Quercetin results in increased activity of NFE2L2 protein | 20579867 |
D011794 | Quercetin | Quercetin results in increased expression of and affects the localization of NFE2L2 protein | 21216973 |
D011794 | Quercetin | Quercetin results in increased expression of NFE2L2 mRNA | 23295412|2758344 |
D011794 | Quercetin | Quercetin results in increased expression of NFE2L2 protein | 26505893|2777701 |
D011794 | Quercetin | U 0126 inhibits the reaction [Quercetin results in increased expression of NFE2L2 protein] | 26505893 |
D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] | 22056766|2433169 |
D011794 | Quercetin | Quercetin affects the localization of NFE2L2 protein | 20554019|2205676 |
D011794 | Quercetin | Quercetin inhibits the reaction [[Dietary Carbohydrates co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | 22535755 |
D011794 | Quercetin | Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 mRNA] | 23770986 |
D011794 | Quercetin | Quercetin inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | 23770986 |
D011794 | Quercetin | Quercetin results in decreased expression of NFE2L2 protein | 25339115 |
D011794 | Quercetin | Quercetin results in increased expression of and results in increased activity of NFE2L2 protein | 27166148 |
D011794 | Quercetin | Quercetin results in increased expression of NFE2L2 protein | 16303981 |
D011794 | Quercetin | Quercetin results in increased activity of NFE2L2 protein | 18094037 |
C428865 | quercetin 3-arabinopyranoside | [quercetin 3-arabinopyranoside results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 16574296 |
C428865 | quercetin 3-arabinopyranoside | quercetin 3-arabinopyranoside results in increased localization of NFE2L2 protein | 16574296 |
C502851 | quinocetone | Curcumin promotes the reaction [quinocetone results in increased expression of NFE2L2 mRNA] | 27375190 |
C502851 | quinocetone | quinocetone results in increased expression of NFE2L2 mRNA | 27375190 |
C502851 | quinocetone | quinocetone results in increased expression of NFE2L2 protein | 27046791 |
C004532 | quinone | NFE2L2 mRNA affects the reaction [quinone results in increased expression of GSS protein] | 21059386 |
C004532 | quinone | NFE2L2 mRNA affects the reaction [quinone results in increased expression of HMOX1 protein] | 21059386 |
C004532 | quinone | quinone affects the localization of and results in increased degradation of NFE2L2 protein | 28645578 |
C004532 | quinone | quinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] | 28645578 |
C004532 | quinone | quinone results in increased expression of and affects the localization of NFE2L2 protein | 21059386 |
C004532 | quinone | quinone results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | 25437431 |
C004532 | quinone | NFE2L2 protein results in decreased susceptibility to quinone | 21059386 |
C004532 | quinone | [NFE2L2 protein results in decreased susceptibility to quinone] which results in increased abundance of Glutathione | 21059386 |
D011899 | Ranitidine | Ranitidine inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] | 28648817 |
D017382 | Reactive Oxygen Species | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]] | 22546375 |
D017382 | Reactive Oxygen Species | Acetylcysteine inhibits the reaction [[Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein] | 19234301 |
D017382 | Reactive Oxygen Species | [Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein | 21728338 |
D017382 | Reactive Oxygen Species | [[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | 21728338 |
D017382 | Reactive Oxygen Species | [[[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] which results in increased abundance of Glutathione | 21728338 |
D017382 | Reactive Oxygen Species | NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]] | 23954465 |
D017382 | Reactive Oxygen Species | NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species] | 22546375 |
D017382 | Reactive Oxygen Species | NFE2L2 protein inhibits the reaction [arsenic trioxide results in increased abundance of Reactive Oxygen Species] | 21327864 |
D017382 | Reactive Oxygen Species | NFE2L2 protein inhibits the reaction [BRCA1 inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]] | 22192953 |
D017382 | Reactive Oxygen Species | NFE2L2 protein inhibits the reaction [Ethanol results in increased abundance of Reactive Oxygen Species] | 23994065 |
D017382 | Reactive Oxygen Species | NFE2L2 protein promotes the reaction [Ketoconazole inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]] | 21753779 |
D017382 | Reactive Oxygen Species | NFE2L2 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]] | 21753779 |
D017382 | Reactive Oxygen Species | NFE2L2 protein results in decreased abundance of Reactive Oxygen Species | 28330870 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [sulforafan promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein]] | 22019695 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of NFE2L2 mRNA | 25800948 |
D017382 | Reactive Oxygen Species | [Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein | 19234301 |
D017382 | Reactive Oxygen Species | [MAP3K7 protein results in increased expression of NFE2L2 protein] which results in decreased abundance of Reactive Oxygen Species | 20855879 |
D017382 | Reactive Oxygen Species | NFE2L2 protein affects the abundance of Reactive Oxygen Species | 17420218 |
D017382 | Reactive Oxygen Species | NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] | 19647727 |
D017382 | Reactive Oxygen Species | NFE2L2 protein inhibits the reaction [cinnamic aldehyde results in increased abundance of Reactive Oxygen Species] | 28219650 |
D017382 | Reactive Oxygen Species | NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased abundance of Reactive Oxygen Species] | 28219650 |
D017382 | Reactive Oxygen Species | Potassium Dichromate promotes the reaction [NFE2L2 protein affects the abundance of Reactive Oxygen Species] | 17420218 |
D017382 | Reactive Oxygen Species | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 21384399 |
D017382 | Reactive Oxygen Species | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased activity of NFE2L2 protein] | 21384399 |
D017382 | Reactive Oxygen Species | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride results in increased expression of NFE2L2 protein] | 21384399 |
D017382 | Reactive Oxygen Species | NFE2L2 protein inhibits the reaction [triptolide results in increased abundance of Reactive Oxygen Species] | 22820427 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in decreased expression of NFE2L2 mRNA | 29085557 |
D017382 | Reactive Oxygen Species | NFE2L2 protein affects the susceptibility to Reactive Oxygen Species | 22245129 |
C059514 | resveratrol | resveratrol results in decreased expression of NFE2L2 protein | 21244525 |
C059514 | resveratrol | arsenic trioxide promotes the reaction [resveratrol results in increased expression of NFE2L2 protein] | 26772155 |
C059514 | resveratrol | Ascorbic Acid inhibits the reaction [resveratrol results in increased activity of NFE2L2 promoter] | 21199573 |
C059514 | resveratrol | [Doxorubicin co-treated with resveratrol] results in decreased expression of NFE2L2 protein | 26969377 |
C059514 | resveratrol | [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with resveratrol] results in increased activity of NFE2L2 protein | 27818126 |
C059514 | resveratrol | [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of NFE2L2 mRNA | 26667767 |
C059514 | resveratrol | [Lipopolysaccharides co-treated with resveratrol] results in increased expression of NFE2L2 protein | 26497626 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol affects the reaction [Pyruvaldehyde affects the expression of GLO1 protein]] | 22917016 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol affects the reaction [Pyruvaldehyde affects the expression of HMOX1 protein]] | 22917016 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde affects the localization of SLC2A2 protein]] | 22917016 |
C059514 | resveratrol | "NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]" | 22917016 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein]] | 22917016 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol results in increased expression of GCLC mRNA] | 20418481 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol results in increased expression of HMOX1 mRNA] | 20418481 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol results in increased expression of NQO1 mRNA] | 20418481 |
C059514 | resveratrol | NFE2L2 protein affects the susceptibility to resveratrol | 20418481 |
C059514 | resveratrol | Paraquat promotes the reaction [resveratrol results in increased expression of and results in increased activity of NFE2L2 protein] | 22493042 |
C059514 | resveratrol | PIK 75 inhibits the reaction [[Lipopolysaccharides co-treated with resveratrol] results in increased expression of NFE2L2 protein] | 26497626 |
C059514 | resveratrol | resveratrol affects the localization of NFE2L2 protein | 22917016|2382953 |
C059514 | resveratrol | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
C059514 | resveratrol | [resveratrol co-treated with Polyphenols] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in decreased activity of NFE2L2 protein] | 21289251 |
C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 25130429 |
C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 25130429 |
C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in increased methylation of NFE2L2 promoter] | 24894866 |
C059514 | resveratrol | resveratrol inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | 16948474 |
C059514 | resveratrol | resveratrol inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of NFE2L2 protein] | 22917016 |
C059514 | resveratrol | resveratrol promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 26772155 |
C059514 | resveratrol | resveratrol promotes the reaction [NFE2L2 protein binds to FTH1 enhancer] | 23829535 |
C059514 | resveratrol | resveratrol results in decreased expression of NFE2L2 mRNA | 25667456 |
C059514 | resveratrol | resveratrol results in decreased methylation of NFE2L2 promoter | 24894866 |
C059514 | resveratrol | resveratrol results in increased activity of NFE2L2 promoter | 21199573 |
C059514 | resveratrol | resveratrol results in increased activity of NFE2L2 protein | 20418481|2395446 |
C059514 | resveratrol | [resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Paraquat | 22493042 |
C059514 | resveratrol | [resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Pyruvaldehyde | 23954466 |
C059514 | resveratrol | [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | 20418481 |
C059514 | resveratrol | [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA | 20418481 |
C059514 | resveratrol | [resveratrol results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 20418481 |
C059514 | resveratrol | resveratrol results in increased expression of and results in increased activity of NFE2L2 protein | 22192953|2249304 |
C059514 | resveratrol | [resveratrol results in increased expression of and results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Benzo(a)pyrene | 22192953 |
C059514 | resveratrol | resveratrol results in increased expression of NFE2L2 mRNA | 20060927|2896078 |
C059514 | resveratrol | resveratrol results in increased expression of NFE2L2 protein | 26497626|2677215 |
C059514 | resveratrol | resveratrol results in increased phosphorylation of and affects the localization of NFE2L2 protein | 16948474 |
C059514 | resveratrol | resveratrol inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NFE2L2 mRNA] | 27070252 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Dietary Fats results in increased activity of CASP3 protein]] | 20418481 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of CDH5 protein]] | 25979658 |
C059514 | resveratrol | NFE2L2 protein affects the susceptibility to resveratrol | 20418481 |
C059514 | resveratrol | NFE2L2 protein promotes the reaction [resveratrol promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]] | 21355597 |
C059514 | resveratrol | NFE2L2 protein promotes the reaction [resveratrol promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]] | 21355597 |
C059514 | resveratrol | NFE2L2 protein promotes the reaction [resveratrol results in increased expression of HMOX1 protein] | 25954969 |
C059514 | resveratrol | "[resveratrol co-treated with 3,4,3',4'-tetrachlorobiphenyl] results in increased expression of NFE2L2 mRNA" | 24231106 |
C059514 | resveratrol | [resveratrol co-treated with HMGB1 protein] affects the localization of NFE2L2 protein | 25979658 |
C059514 | resveratrol | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein] | 16322078 |
C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] | 24812660 |
C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of NFE2L2 mRNA] | 27260466 |
C059514 | resveratrol | resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of NFE2L2 mRNA] | 25979658 |
C059514 | resveratrol | resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of NFE2L2 protein] | 25979658 |
C059514 | resveratrol | resveratrol promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 25954969 |
C059514 | resveratrol | resveratrol results in decreased expression of NFE2L2 mRNA | 22610192 |
C059514 | resveratrol | resveratrol results in decreased expression of NFE2L2 protein | 22610192 |
C059514 | resveratrol | resveratrol results in increased activity of NFE2L2 protein | 16322078|2048621 |
C059514 | resveratrol | resveratrol results in increased expression of and results in increased localization of NFE2L2 protein | 21355597 |
C059514 | resveratrol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol affects the localization of NFE2L2 protein] | 20486211 |
C059514 | resveratrol | [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26497626 |
C059514 | resveratrol | resveratrol affects the localization of and results in increased activity of NFE2L2 protein | 15882976 |
C059514 | resveratrol | resveratrol affects the localization of NFE2L2 protein | 20486211|2262716 |
C059514 | resveratrol | resveratrol inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 mRNA] | 24327821 |
C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 23551926 |
C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] | 24894866 |
C059514 | resveratrol | resveratrol inhibits the reaction [Estradiol results in decreased expression of NFE2L2 protein] | 24894866 |
C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein] | 22610192 |
C059514 | resveratrol | resveratrol inhibits the reaction [Rotenone results in increased activity of NFE2L2 protein] | 27016191 |
C059514 | resveratrol | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] | 21439372 |
C059514 | resveratrol | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | 21439372 |
C059514 | resveratrol | resveratrol inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] | 24740756 |
C059514 | resveratrol | resveratrol promotes the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA] | 26361869 |
C059514 | resveratrol | resveratrol promotes the reaction [Streptozocin affects the localization of NFE2L2 protein] | 24740756 |
C059514 | resveratrol | resveratrol results in decreased expression of NFE2L2 protein | 22610192 |
C059514 | resveratrol | resveratrol results in increased expression of and results in increased localization of NFE2L2 protein | 18616940 |
C059514 | resveratrol | resveratrol results in increased expression of NFE2L2 mRNA | 18616940|2050186 |
C059514 | resveratrol | resveratrol results in increased expression of NFE2L2 protein | 20501860|2185048 |
C059514 | resveratrol | sirtinol inhibits the reaction [resveratrol results in increased expression of NFE2L2 protein] | 24395567 |
C059514 | resveratrol | [KEAP1 protein results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to resveratrol | 20418481 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol results in decreased activity of TNF protein] | 20418481 |
C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in increased expression of NFE2L2 protein] | 23767859 |
D012172 | Retinaldehyde | Retinaldehyde results in increased expression of NFE2L2 mRNA | 25331497|2775175 |
C064755 | Ro 31-7549 | Ro 31-7549 inhibits the reaction [Cadmium Chloride affects the localization of NFE2L2 protein] | 21787730 |
C085989 | Ro 32-0432 | Ro 32-0432 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] | 21333731 |
C089730 | rosiglitazone | NFE2L2 protein promotes the reaction [rosiglitazone results in increased expression of PPARG protein] | 22684020 |
C089730 | rosiglitazone | NFE2L2 protein promotes the reaction [rosiglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
C089730 | rosiglitazone | rosiglitazone affects the activity of NFE2L2 protein | 25596134 |
C089730 | rosiglitazone | [rosiglitazone co-treated with Rotenone] results in increased expression of NFE2L2 protein | 24374061 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | 21333731 |
C089730 | rosiglitazone | rosiglitazone results in increased expression of NFE2L2 protein | 24374061 |
C089730 | rosiglitazone | rosiglitazone results in decreased expression of NFE2L2 mRNA | 25596134 |
D012402 | Rotenone | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one affects the reaction [Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein]]" | 28245986 |
D012402 | Rotenone | Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein] | 28245986 |
D012402 | Rotenone | NFE2L2 protein results in decreased susceptibility to Rotenone | 17360324 |
D012402 | Rotenone | PARK7 protein affects the reaction [Bibenzyls promotes the reaction [Rotenone affects the localization of NFE2L2 protein]] | 28245986 |
D012402 | Rotenone | [rosiglitazone co-treated with Rotenone] results in increased expression of NFE2L2 protein | 24374061 |
D012402 | Rotenone | Rotenone affects the localization of NFE2L2 protein | 28245986 |
D012402 | Rotenone | [Rotenone co-treated with Bibenzyls] results in increased expression of NFE2L2 protein | 28245986 |
D012402 | Rotenone | NFE2L2 gene mutant form results in increased susceptibility to Rotenone | 12842875 |
D012402 | Rotenone | NFE2L2 protein results in decreased susceptibility to Rotenone | 12842875 |
D012402 | Rotenone | Rotenone promotes the reaction [NFE2L2 protein binds to FTH1 enhancer] | 18325346 |
D012402 | Rotenone | Rotenone results in increased expression of NFE2L2 mRNA | 23186747 |
D012402 | Rotenone | "1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one affects the reaction [[Rotenone co-treated with Bibenzyls] affects the localization of NFE2L2 protein]" | 28245986 |
D012402 | Rotenone | [Bibenzyls co-treated with Rotenone] affects the localization of NFE2L2 protein | 27180985 |
D012402 | Rotenone | PARK7 protein affects the reaction [[Rotenone co-treated with Bibenzyls] affects the localization of NFE2L2 protein] | 28245986 |
D012402 | Rotenone | resveratrol inhibits the reaction [Rotenone results in increased activity of NFE2L2 protein] | 27016191 |
D012402 | Rotenone | [Rotenone co-treated with Bibenzyls] affects the localization of and results in increased expression of NFE2L2 protein | 28245986 |
D012402 | Rotenone | Rotenone results in increased activity of NFE2L2 protein | 27016191 |
D012402 | Rotenone | Rotenone results in increased expression of NFE2L2 protein | 25446674 |
D012402 | Rotenone | saxagliptin inhibits the reaction [Rotenone results in increased expression of NFE2L2 protein] | 25446674 |
D012402 | Rotenone | [safranal co-treated with Rotenone] affects the localization of NFE2L2 protein | 28145852 |
C085746 | rottlerin | rottlerin inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] | 24211276 |
C085746 | rottlerin | rottlerin inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein] | 24211276 |
C085746 | rottlerin | rottlerin inhibits the reaction [Acrolein affects the localization of NFE2L2 protein] | 18048804 |
C085746 | rottlerin | rottlerin inhibits the reaction [Cadmium Chloride affects the localization of NFE2L2 protein] | 21787730 |
C085746 | rottlerin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]] | 25895139 |
C085746 | rottlerin | rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein] | 25895139 |
C085746 | rottlerin | rottlerin inhibits the reaction [naringin affects the localization of NFE2L2 protein] | 25773745 |
C560377 | rutacarpine | NFE2L2 protein affects the reaction [rutacarpine results in increased expression of HMOX1 protein] | 28025122 |
C560377 | rutacarpine | rutacarpine affects the localization of NFE2L2 protein | 28025122 |
C560377 | rutacarpine | rutacarpine promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 28025122 |
D012431 | Rutin | Rutin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] | 22902988 |
C087963 | safranal | [safranal co-treated with Rotenone] affects the localization of NFE2L2 protein | 28145852 |
C065299 | S-allylcysteine | S-allylcysteine promotes the reaction [Potassium Dichromate results in increased expression of NFE2L2 protein] | 18548744 |
C076944 | salvianolic acid B | NFE2L2 protein affects the reaction [salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] | 24991814 |
C076944 | salvianolic acid B | NFE2L2 protein affects the reaction [salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] | 24991814 |
C076944 | salvianolic acid B | NFE2L2 protein affects the reaction [salvianolic acid B results in increased expression of GDNF mRNA] | 24991814 |
C076944 | salvianolic acid B | NFE2L2 protein affects the reaction [salvianolic acid B results in increased secretion of GDNF protein] | 24991814 |
C076944 | salvianolic acid B | "salvianolic acid B inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]" | 24991814 |
C076944 | salvianolic acid B | salvianolic acid B results in increased expression of NFE2L2 protein | 24991814 |
C076944 | salvianolic acid B | salvianolic acid B results in increased secretion of and affects the localization of NFE2L2 protein | 24991814 |
C018381 | salvin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased activity of NFE2L2 protein] | 26577515|2668657 |
C018381 | salvin | NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of GCLC protein] | 26577515 |
C018381 | salvin | NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of GCLM protein] | 26577515 |
C018381 | salvin | NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of GSR protein] | 26577515 |
C018381 | salvin | NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of GSTP1 protein] | 26577515 |
C018381 | salvin | NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of SOD2 protein] | 26577515 |
C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of GCLC protein] | 26686574 |
C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of GCLM protein] | 26686574 |
C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of GSR protein] | 26686574 |
C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of HMOX1 protein] | 26686574 |
C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of NQO1 protein] | 26686574 |
C018381 | salvin | NFE2L2 protein promotes the reaction [salvin results in increased expression of SOD2 protein] | 26686574 |
C018381 | salvin | salvin affects the localization of and results in increased activity of NFE2L2 protein | 26686574 |
C018381 | salvin | salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 mRNA] | 28159594 |
C018381 | salvin | salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein] | 28159594 |
C018381 | salvin | salvin results in increased activity of NFE2L2 protein | 26577515 |
D012503 | Saponins | brusatol inhibits the reaction [Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein]] | 29274434 |
D012503 | Saponins | Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA] | 29274434 |
D012503 | Saponins | Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein] | 29274434 |
D012503 | Saponins | Saponins inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | 26363199 |
D012503 | Saponins | Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] | 25892055 |
C502994 | saxagliptin | saxagliptin inhibits the reaction [Rotenone results in increased expression of NFE2L2 protein] | 25446674 |
C502994 | saxagliptin | saxagliptin results in increased expression of NFE2L2 protein | 25446674 |
C093642 | SB 203580 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [SB 203580 inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] | 17433488 |
C093642 | SB 203580 | Cycloheximide inhibits the reaction [SB 203580 affects the reaction [Quercetin affects the localization of NFE2L2 protein]] | 22197970 |
C093642 | SB 203580 | Cycloheximide inhibits the reaction [[SB 203580 co-treated with Quercetin] results in increased expression of NFE2L2 protein] | 22197970 |
C093642 | SB 203580 | SB 203580 affects the reaction [Quercetin affects the localization of NFE2L2 protein] | 22197970 |
C093642 | SB 203580 | [SB 203580 co-treated with Cycloheximide] inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] | 22197970 |
C093642 | SB 203580 | [SB 203580 co-treated with Quercetin] results in increased expression of NFE2L2 protein | 22197970 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [gallium nitrate results in increased activity of NFE2L2 protein] | 18586083 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Quercetin affects the localization of and results in increased activity of NFE2L2 protein] | 27454768 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] | 17433488 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] | 22197970 |
C093642 | SB 203580 | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] | 17433488 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA] | 22488045 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [farrerol affects the localization of NFE2L2 protein] | 26111761 |
C093642 | SB 203580 | SB 203580 promotes the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] | 25449124 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] | 17640564 |
C534628 | SCH 23390 | SCH 23390 inhibits the reaction [Methamphetamine affects the localization of NFE2L2 protein] | 19564919 |
C534628 | SCH 23390 | SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] | 19564919 |
C587178 | SCH772984 | SCH772984 inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | 28087833 |
C015499 | schizandrin B | [Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NFE2L2 mRNA | 25946486 |
C015499 | schizandrin B | [Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NFE2L2 protein | 25946486 |
C015499 | schizandrin B | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of HMOX1 mRNA] | 25946486 |
C015499 | schizandrin B | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of HMOX1 protein] | 25946486 |
C015499 | schizandrin B | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NQO1 mRNA] | 25946486 |
C015499 | schizandrin B | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NQO1 protein] | 25946486 |
C015499 | schizandrin B | NFE2L2 mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of SOD1 mRNA] | 25946486 |
C015499 | schizandrin B | schizandrin B affects the localization of NFE2L2 protein | 21250784 |
D012642 | Selegiline | Selegiline inhibits the reaction [Smoke analog affects the localization of NFE2L2 protein] | 28108387 |
D012642 | Selegiline | NFE2L2 mutant form inhibits the reaction [Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of NQO1 protein]] | 22019741 |
D012642 | Selegiline | NFE2L2 mutant form inhibits the reaction [Selegiline results in increased activity of NQO1 protein] | 22019741 |
D012642 | Selegiline | Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased localization of NFE2L2 protein] | 22019741 |
D012642 | Selegiline | Selegiline results in increased localization of NFE2L2 protein | 22019741 |
D012643 | Selenium | [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA | 19244175 |
D012643 | Selenium | Selenium results in decreased expression of NFE2L2 mRNA | 19244175 |
D012643 | Selenium | NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] | 18279678 |
D012643 | Selenium | Selenium affects the activity of NFE2L2 protein | 18279678 |
C009226 | selenocystine | NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of GCLC mRNA] | 22807314 |
C009226 | selenocystine | NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of NQO1 mRNA] | 22807314 |
C009226 | selenocystine | NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of TXNRD1 mRNA] | 22807314 |
C009226 | selenocystine | selenocystine affects the localization of NFE2L2 protein | 22807314 |
C078903 | seocalcitol | seocalcitol results in increased expression of NFE2L2 mRNA | 12040012 |
D020280 | Sertraline | Sertraline results in increased expression of NFE2L2 mRNA | 24865413 |
C042431 | S-ethyl glutathione | S-ethyl glutathione inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | 17980396 |
C040115 | shogaol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 25148906 |
C040115 | shogaol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein] | 25148906 |
C040115 | shogaol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form] | 25148906 |
C040115 | shogaol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 25148906 |
C040115 | shogaol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein] | 25148906 |
C040115 | shogaol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form] | 25148906 |
C040115 | shogaol | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] | 25148906 |
C040115 | shogaol | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein] | 25148906 |
C040115 | shogaol | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form] | 25148906 |
C040115 | shogaol | shogaol affects the localization of NFE2L2 protein | 25148906 |
C040115 | shogaol | shogaol analog results in increased expression of NFE2L2 protein | 23899529 |
C040115 | shogaol | shogaol metabolite affects the localization of NFE2L2 protein | 25148906 |
C040115 | shogaol | shogaol metabolite affects the localization of NFE2L2 protein modified form | 25148906 |
C040115 | shogaol | shogaol metabolite results in increased expression of and results in increased phosphorylation of NFE2L2 protein | 25148906 |
C040115 | shogaol | shogaol results in increased expression of and results in increased phosphorylation of NFE2L2 protein | 25148906 |
C040115 | shogaol | KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein] | 23899529 |
C040115 | shogaol | NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of GCLC mRNA] | 25148906 |
C040115 | shogaol | NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of HMOX1 protein] | 25148906 |
C040115 | shogaol | NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 mRNA] | 25148906 |
C040115 | shogaol | NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 protein] | 25148906 |
C040115 | shogaol | shogaol affects the localization of NFE2L2 protein | 25148906 |
C040115 | shogaol | shogaol analog results in increased expression of NFE2L2 protein | 23899529 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of and affects the localization of NFE2L2 protein | 19602432 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of NFE2L2 protein | 22985735 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased activity of NFE2L2 protein | 23973437 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of NFE2L2 mRNA | 21602193 |
D012834 | Silver | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]] | 22546375 |
D012834 | Silver | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the susceptibility to Silver] | 22546375 |
D012834 | Silver | Acetylcysteine inhibits the reaction [Silver analog results in increased expression of NFE2L2 mRNA] | 24126012 |
D012834 | Silver | NFE2L2 mutant form inhibits the reaction [Silver analog results in increased expression of HMOX1 mRNA] | 24126012 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased abundance of Glutathione] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of CDKN1A protein] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLC mRNA] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLM mRNA] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of GPX2 mRNA] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of HMOX1 mRNA] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of NQO1 mRNA] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of SOD1 mRNA] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased expression of TP53 protein] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased phosphorylation of CDC25C protein] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the reaction [Silver results in increased phosphorylation of CDK1 protein] | 22546375 |
D012834 | Silver | NFE2L2 protein affects the susceptibility to Silver | 22546375 |
D012834 | Silver | NFE2L2 protein promotes the reaction [Silver results in increased expression of AKR1C1 mRNA] | 22036727 |
D012834 | Silver | NFE2L2 protein promotes the reaction [Silver results in increased expression of EPHX1 mRNA] | 22036727 |
D012834 | Silver | NFE2L2 protein promotes the reaction [Silver results in increased expression of HMOX1 mRNA] | 22036727 |
D012834 | Silver | NFE2L2 protein promotes the reaction [Silver results in increased expression of HMOX1 protein] | 22036727 |
D012834 | Silver | NFE2L2 protein promotes the reaction [Silver results in increased expression of TXNRD1 mRNA] | 22036727 |
D012834 | Silver | Silver analog results in increased expression of and affects the localization of NFE2L2 protein | 24126012 |
D012834 | Silver | Silver analog results in increased expression of NFE2L2 mRNA | 24126012 |
D012834 | Silver | Silver results in increased activity of NFE2L2 promoter | 21643505 |
D012834 | Silver | Silver results in increased activity of NFE2L2 protein | 23872425 |
D012834 | Silver | Silver results in increased expression of NFE2L2 mRNA | 22036727 |
D012834 | Silver | Silver results in increased expression of NFE2L2 protein | 22036727|2810974 |
D018030 | Silver Compounds | Silver Compounds affects the localization of and results in decreased activity of NFE2L2 protein | 21925250 |
D012835 | Silver Nitrate | Silver Nitrate results in decreased expression of NFE2L2 mRNA | 19733233 |
D012835 | Silver Nitrate | Silver Nitrate results in increased activity of NFE2L2 protein | 23872425 |
C440975 | silybin | silybin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2] | 24062023 |
D012838 | Silymarin | NFE2L2 mutant form inhibits the reaction [Silymarin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]] | 23331247 |
D012838 | Silymarin | NFE2L2 mutant form inhibits the reaction [Silymarin inhibits the reaction [S100B protein results in decreased expression of HMOX1 mRNA]] | 23331247 |
D012838 | Silymarin | Paraquat promotes the reaction [Silymarin affects the localization of NFE2L2 protein] | 22709784 |
D012838 | Silymarin | Silymarin affects the localization of NFE2L2 protein | 22709784 |
D012838 | Silymarin | [Silymarin co-treated with Paraquat] results in increased expression of NFE2L2 protein | 22709784 |
D012838 | Silymarin | Silymarin inhibits the reaction [S100B protein results in decreased expression of NFE2L2 protein] | 23331247 |
D012838 | Silymarin | Silymarin promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 22709784 |
D012838 | Silymarin | Silymarin promotes the reaction [S100B protein affects the localization of NFE2L2 protein] | 23331247 |
D012838 | Silymarin | Silymarin results in increased expression of NFE2L2 mRNA | 22709784 |
D012838 | Silymarin | Silymarin inhibits the reaction [Cisplatin results in increased expression of NFE2L2 protein] | 27616468 |
D012838 | Silymarin | Silymarin inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] | 28648817 |
D012838 | Silymarin | Silymarin results in increased expression of and affects the localization of NFE2L2 protein | 28137608 |
D012838 | Silymarin | Silymarin results in increased expression of NFE2L2 mRNA | 28137608 |
D019821 | Simvastatin | NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]] | 17928392 |
D019821 | Simvastatin | Simvastatin results in increased localization of NFE2L2 protein | 17928392 |
D019821 | Simvastatin | Mevalonic Acid affects the reaction [Simvastatin results in increased localization of NFE2L2 protein] | 18787804 |
D019821 | Simvastatin | Simvastatin results in increased localization of NFE2L2 protein | 18787804 |
C024711 | siomycin A | siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of NFE2L2 protein] | 27517622 |
C439060 | sirtinol | sirtinol inhibits the reaction [resveratrol results in increased expression of NFE2L2 protein] | 24395567 |
C403258 | si-wu-tang | si-wu-tang results in increased activity of NFE2L2 protein | 21464939 |
C424127 | SL 327 | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] | 25550330 |
D012906 | Smoke | Selegiline inhibits the reaction [Smoke analog affects the localization of NFE2L2 protein] | 28108387 |
D012906 | Smoke | Smoke analog affects the localization of NFE2L2 protein | 28108387 |
D012906 | Smoke | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Smoke results in increased expression of NFE2L2 mRNA] | 23069111 |
D012906 | Smoke | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Smoke results in increased expression of NFE2L2 protein] | 23069111 |
D012906 | Smoke | NFE2L2 results in decreased susceptibility to Smoke analog | 23056183 |
D012906 | Smoke | Smoke results in increased expression of NFE2L2 mRNA | 23069111 |
D012906 | Smoke | Smoke results in increased expression of NFE2L2 protein | 23069111 |
C009277 | sodium arsenate | sodium arsenate results in increased expression of NFE2L2 protein | 12745069 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of NFE2L2 protein | 21602192 |
C017947 | sodium arsenite | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 25201354 |
C017947 | sodium arsenite | Acetylcysteine inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 16959797|2629127 |
C017947 | sodium arsenite | Acetylcysteine inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer]] | 26291278 |
C017947 | sodium arsenite | Brefeldin A inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | 20805060 |
C017947 | sodium arsenite | diacetyldichlorofluorescein inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 16959797 |
C017947 | sodium arsenite | HMOX1 protein promotes the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 20519851 |
C017947 | sodium arsenite | KEAP1 protein promotes the reaction [sodium arsenite results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
C017947 | sodium arsenite | KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA] | 27774770 |
C017947 | sodium arsenite | KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 27774770 |
C017947 | sodium arsenite | NFE2L2 gene mutant form inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 26291278|2629127 |
C017947 | sodium arsenite | NFE2L2 gene SNP affects the susceptibility to sodium arsenite | 26039680 |
C017947 | sodium arsenite | NFE2L2 mutant form inhibits the reaction [sodium arsenite results in increased expression of FTH1 mRNA] | 23699174 |
C017947 | sodium arsenite | NFE2L2 mutant form inhibits the reaction [sodium arsenite results in increased expression of FTL mRNA] | 23699174 |
C017947 | sodium arsenite | NFE2L2 mutant form inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA] | 10874044 |
C017947 | sodium arsenite | NFE2L2 mutant form inhibits the reaction [sodium arsenite results in increased expression of NQO1 protein] | 24161444 |
C017947 | sodium arsenite | "NFE2L2 promotes the reaction [sodium arsenite promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1A1 mRNA]]" | 26535918 |
C017947 | sodium arsenite | NFE2L2 promotes the reaction [sodium arsenite results in increased expression of CYP1A1 mRNA] | 26535918 |
C017947 | sodium arsenite | NFE2L2 promotes the reaction [sodium arsenite results in increased expression of HMOX1 mRNA] | 26535918 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of GCLC mRNA] | 28125038 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of HMOX1 mRNA] | 28125038 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of KRT16 mRNA] | 18629308 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of NQO1 mRNA] | 28125038 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of SQSTM1 mRNA] | 28125038 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of SQSTM1 protein] | 28125038 |
C017947 | sodium arsenite | NFE2L2 protein results in decreased susceptibility to sodium arsenite | 17765279 |
C017947 | sodium arsenite | Potassium Dichromate inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 16775837 |
C017947 | sodium arsenite | Potassium Dichromate inhibits the reaction [sodium arsenite results in increased localization of NFE2L2 protein] | 16775837 |
C017947 | sodium arsenite | sodium arsenite affects the localization of and results in increased activity of NFE2L2 protein | 20100676 |
C017947 | sodium arsenite | sodium arsenite affects the localization of NFE2L2 protein | 16959797|2629127 |
C017947 | sodium arsenite | sodium arsenite inhibits the reaction [KEAP1 protein mutant form results in increased ubiquitination of NFE2L2 protein] | 18417180 |
C017947 | sodium arsenite | sodium arsenite inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
C017947 | sodium arsenite | sodium arsenite promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
C017947 | sodium arsenite | sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | 20083128|2629127 |
C017947 | sodium arsenite | sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 16775837 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFE2L2 protein | 27459794 |
C017947 | sodium arsenite | sodium arsenite results in decreased ubiquitination of and results in decreased degradation of NFE2L2 protein | 18417180 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of NFE2L2 promoter | 21643505 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of NFE2L2 protein | 12220541|2080506 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of and affects the localization of NFE2L2 protein | 23738048|2520135 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of and results in decreased degradation of and results in increased localization of NFE2L2 protein | 18629308 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of and results in increased activity of NFE2L2 protein | 23589329 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of NFE2L2 mRNA | 23165982|2373804 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of NFE2L2 protein | 18417180|2051985 |
C017947 | sodium arsenite | sodium arsenite results in increased localization of NFE2L2 protein | 16775837 |
C017947 | sodium arsenite | SQSTM1 protein promotes the reaction [sodium arsenite results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
C017947 | sodium arsenite | tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 26404762 |
C017947 | sodium arsenite | Thapsigargin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | 20805060 |
C017947 | sodium arsenite | tubastatin A inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 22367689 |
C017947 | sodium arsenite | Tunicamycin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | 20805060 |
C017947 | sodium arsenite | NFE2L1 protein alternative form inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA] | 28549828 |
C017947 | sodium arsenite | NFE2L1 protein alternative form inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 28549828 |
C017947 | sodium arsenite | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to sodium arsenite | 19303893 |
C017947 | sodium arsenite | NFE2L2 gene mutant form inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA] | 29108910 |
C017947 | sodium arsenite | NFE2L2 gene mutant form inhibits the reaction [sodium arsenite results in increased expression of HMOX1 protein] | 26291278 |
C017947 | sodium arsenite | NFE2L2 gene mutant form results in increased susceptibility to sodium arsenite | 29108910 |
C017947 | sodium arsenite | NFE2L2 protein affects the reaction [sodium arsenite results in increased expression of BTG2 mRNA] | 22003191 |
C017947 | sodium arsenite | NFE2L2 protein affects the reaction [sodium arsenite results in increased expression of HMOX1 protein] | 21266531 |
C017947 | sodium arsenite | NFE2L2 protein affects the reaction [sodium arsenite results in increased expression of SRXN1 mRNA] | 22003191 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of HMOX1 mRNA] | 18404528 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sodium arsenite results in increased expression of HMOX1 protein] | 18404528 |
C017947 | sodium arsenite | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to sodium arsenite] | 20932822 |
C017947 | sodium arsenite | NFE2L2 protein results in decreased susceptibility to sodium arsenite | 20932822 |
C017947 | sodium arsenite | Plant Extracts inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] | 27723467 |
C017947 | sodium arsenite | Plant Extracts inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA] | 27723467 |
C017947 | sodium arsenite | sodium arsenite affects the localization of NFE2L2 protein | 27723467 |
C017947 | sodium arsenite | sodium arsenite inhibits the reaction [[CUL3 protein binds to KEAP1 protein] which binds to and results in increased ubiquitination of NFE2L2 protein] | 16785233 |
C017947 | sodium arsenite | sodium arsenite promotes the reaction [[NFE2L2 protein binds to MAFG protein] which binds to NQO1 promoter] | 16785233 |
C017947 | sodium arsenite | sodium arsenite promotes the reaction [[NFE2L2 protein binds to MAFK protein] which binds to NQO1 promoter] | 16785233 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFE2L2 mRNA | 19822182 |
C017947 | sodium arsenite | sodium arsenite results in decreased ubiquitination of and results in decreased degradation of and results in increased stability of and results in increased expression of NFE2L2 protein | 16785233 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of NFE2L2 mRNA | 21396911|2647389 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of NFE2L2 protein | 12745069|1700347 |
C017947 | sodium arsenite | coenzyme Q10 inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 27174133 |
C017947 | sodium arsenite | Curcumin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 protein] | 24952339 |
C017947 | sodium arsenite | naringin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 27174133 |
C017947 | sodium arsenite | Plant Extracts inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
C017947 | sodium arsenite | silybin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2] | 24062023 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFE2L2 | 24062023 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFE2L2 mRNA | 20699118|2608505 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFE2L2 protein | 24952339|2676736 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of NFE2L2 mRNA | 19933942|2069911 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of NFE2L2 protein | 21465251 |
C017947 | sodium arsenite | [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
C017947 | sodium arsenite | Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
C016104 | sodium bichromate | sodium bichromate results in decreased expression of NFE2L2 mRNA | 22155349 |
C016104 | sodium bichromate | sodium bichromate results in increased expression of NFE2L2 mRNA | 22155349 |
C016104 | sodium bichromate | sodium bichromate results in increased expression of NFE2L2 mRNA | 22561333 |
C025451 | sodium bisulfide | sodium bisulfide inhibits the reaction [uranyl acetate affects the localization of NFE2L2 protein] | 26523793 |
D017673 | Sodium Chloride, Dietary | "2-tert-butylhydroquinone inhibits the reaction [Sodium Chloride, Dietary results in decreased expression of NFE2L2 protein]" | 28844481 |
D017673 | Sodium Chloride, Dietary | "Sodium Chloride, Dietary results in decreased expression of NFE2L2 protein" | 28844481 |
D020358 | Sodium Cholate | "[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein" | 27394961 |
D020358 | Sodium Cholate | "MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein]" | 27394961 |
D012969 | Sodium Fluoride | protocatechuic acid methyl ester inhibits the reaction [Sodium Fluoride results in increased expression of NFE2L2 mRNA] | 28012895 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of NFE2L2 mRNA | 28012895 |
D012969 | Sodium Fluoride | Sodium Fluoride affects the expression of NFE2L2 mRNA | 25132241 |
C037341 | sodium selenide | sodium selenide inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] | 17959236 |
C037341 | sodium selenide | sodium selenide inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein] | 17959236 |
D018038 | Sodium Selenite | Sodium Selenite affects the reaction [Mercuric Chloride affects the localization of NFE2L2 protein] | 24816296 |
D018038 | Sodium Selenite | Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein] | 24816296 |
D018038 | Sodium Selenite | Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein] | 19429247 |
D018038 | Sodium Selenite | Sodium Selenite promotes the reaction [arsenite affects the localization of NFE2L2 protein] | 19429247 |
D018038 | Sodium Selenite | [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | 26085057 |
C017719 | solanesol | solanesol affects the localization of and results in increased activity of NFE2L2 protein | 25645596 |
C017719 | solanesol | solanesol inhibits the reaction [KEAP1 protein binds to NFE2L2 protein] | 25645596 |
C017719 | solanesol | solanesol results in decreased ubiquitination of and results in decreased degradation of NFE2L2 protein | 25645596 |
D012999 | Soman | Soman results in increased expression of NFE2L2 mRNA | 19281266 |
D013095 | Spermidine | Spermidine affects the localization of NFE2L2 protein | 12763045 |
D013096 | Spermine | Spermine affects the localization of NFE2L2 protein | 12763045 |
D013148 | Spironolactone | Spironolactone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 25204689 |
D019311 | Staurosporine | Staurosporine inhibits the reaction [Ethanol affects the localization of NFE2L2 protein] | 22530035 |
D019311 | Staurosporine | Staurosporine affects the localization of NFE2L2 protein | 22530035 |
C031183 | stearic acid | stearic acid results in increased expression of NFE2L2 mRNA | 28555106 |
C031183 | stearic acid | stearic acid results in increased expression of NFE2L2 protein | 28555106 |
D013311 | Streptozocin | NFE2L2 protein affects the reaction [Streptozocin results in decreased abundance of Glycogen] | 20086057 |
D013311 | Streptozocin | NFE2L2 protein affects the susceptibility to Streptozocin | 20086057 |
D013311 | Streptozocin | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of 3-Hydroxybutyric Acid | 20086057 |
D013311 | Streptozocin | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of Glucose | 20086057 |
D013311 | Streptozocin | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of Triglycerides | 20086057 |
D013311 | Streptozocin | pterostilbene inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 26700463 |
D013311 | Streptozocin | pterostilbene inhibits the reaction [Streptozocin results in decreased phosphorylation of and affects the localization of NFE2L2 protein] | 26700463 |
D013311 | Streptozocin | [Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA | 24707343 |
D013311 | Streptozocin | [Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein | 24707343 |
D013311 | Streptozocin | [Streptozocin co-treated with sulforafan] results in increased expression of NFE2L2 | 22023613 |
D013311 | Streptozocin | Streptozocin results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein | 24967692 |
D013311 | Streptozocin | Streptozocin results in decreased expression of NFE2L2 mRNA | 24967692 |
D013311 | Streptozocin | Streptozocin results in decreased expression of NFE2L2 protein | 26700463 |
D013311 | Streptozocin | Streptozocin results in decreased phosphorylation of and affects the localization of NFE2L2 protein | 26700463 |
D013311 | Streptozocin | Streptozocin results in increased expression of NFE2L2 mRNA | 23319174 |
D013311 | Streptozocin | sulforafan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA] | 24707343 |
D013311 | Streptozocin | sulforafan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | 24707343 |
D013311 | Streptozocin | sulforafan inhibits the reaction [Streptozocin results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein] | 24967692 |
D013311 | Streptozocin | sulforafan inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] | 24967692 |
D013311 | Streptozocin | 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] | 20399799 |
D013311 | Streptozocin | 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 protein] | 20399799 |
D013311 | Streptozocin | chromium histidinate inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 22790776 |
D013311 | Streptozocin | Curcumin inhibits the reaction [Streptozocin affects the localization of NFE2L2 protein] | 25541178 |
D013311 | Streptozocin | diallyl trisulfide inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 23453443 |
D013311 | Streptozocin | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] | 21439372 |
D013311 | Streptozocin | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | 21439372 |
D013311 | Streptozocin | picolinic acid inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | 22790776 |
D013311 | Streptozocin | Plant Extracts inhibits the reaction [Streptozocin affects the localization of NFE2L2 protein] | 21799698 |
D013311 | Streptozocin | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] | 21439372 |
D013311 | Streptozocin | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | 21439372 |
D013311 | Streptozocin | resveratrol inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] | 24740756 |
D013311 | Streptozocin | resveratrol promotes the reaction [Streptozocin affects the localization of NFE2L2 protein] | 24740756 |
D013311 | Streptozocin | Streptozocin affects the localization of NFE2L2 protein | 21799698|2474075 |
D013311 | Streptozocin | [Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA | 21439372 |
D013311 | Streptozocin | [Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein | 21439372 |
D013311 | Streptozocin | Streptozocin results in decreased expression of NFE2L2 mRNA | 24740756 |
D013311 | Streptozocin | Streptozocin results in decreased expression of NFE2L2 protein | 22790776|2345344 |
D013311 | Streptozocin | Streptozocin results in increased expression of NFE2L2 mRNA | 20399799 |
D013311 | Streptozocin | Streptozocin results in increased expression of NFE2L2 protein | 20399799 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFE2L2 mRNA | 26378955 |
D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFE2L2 mRNA | 21641980 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NFE2L2 mRNA | 26378955 |
C020804 | succinylacetone | NFE2L2 gene mutant form affects the reaction [succinylacetone results in increased expression of CYP2A5 mRNA] | 22859313 |
C020804 | succinylacetone | NFE2L2 gene mutant form inhibits the reaction [succinylacetone results in increased expression of ALAS1 mRNA] | 22859313 |
D013426 | Sulfaphenazole | Sulfaphenazole affects the reaction [nimesulide affects the localization of NFE2L2 protein] | 20405857 |
D012460 | Sulfasalazine | Acetylcysteine inhibits the reaction [[Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein] | 19234301 |
D012460 | Sulfasalazine | [Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein | 19234301 |
D012460 | Sulfasalazine | NFE2L2 protein promotes the reaction [Sulfasalazine results in increased expression of HMOX1 mRNA] | 19234301 |
D012460 | Sulfasalazine | NFE2L2 protein promotes the reaction [Sulfasalazine results in increased expression of HMOX1 protein] | 19234301 |
D012460 | Sulfasalazine | Sulfasalazine promotes the reaction [NFE2L2 protein binds to HMOX1 promoter] | 19234301 |
D013448 | Sulfobromophthalein | NFE2L2 protein affects the abundance of Sulfobromophthalein | 19246623 |
D013448 | Sulfobromophthalein | NFE2L2 protein results in increased glutathionylation of Sulfobromophthalein | 19246623 |
D013448 | Sulfobromophthalein | NFE2L2 protein results in increased transport of Sulfobromophthalein | 19246623 |
C016766 | sulforafan | sulforafan inhibits the reaction [NFE2L2 protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of HMOX1 mRNA]] | 20200220 |
C016766 | sulforafan | sulforafan promotes the reaction [perfluorooctane sulfonic acid results in increased expression of NFE2L2 mRNA] | 20200220 |
C016766 | sulforafan | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C016766 | sulforafan | Acetylcysteine inhibits the reaction [sulforafan affects the localization of NFE2L2 protein] | 22019695 |
C016766 | sulforafan | Acetylcysteine inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C016766 | sulforafan | ammonium metavanadate affects the reaction [sulforafan affects the localization of NFE2L2 mRNA] | 20599494 |
C016766 | sulforafan | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C016766 | sulforafan | cyanoginosin LR promotes the reaction [sulforafan affects the localization of NFE2L2 protein] | 20600217 |
C016766 | sulforafan | Cycloheximide inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C016766 | sulforafan | Dactinomycin inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22019695 |
C016766 | sulforafan | [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | [Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | KEAP1 protein mutant form inhibits the reaction [sulforafan results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
C016766 | sulforafan | KEAP1 protein promotes the reaction [sulforafan results in increased expression of and results in increased activity of NFE2L2 protein] | 23589329 |
C016766 | sulforafan | [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein]] | 22606287 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of GCLC mRNA] | 22807314 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of HMOX1 protein] | 20600217 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of NQO1 mRNA] | 22807314 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of NQO1 protein] | 20600217|2280731 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA] | 22807314 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of TXNRD1 protein] | 22807314 |
C016766 | sulforafan | NFE2L2 protein affects the reaction [sulforafan inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | 16890772 |
C016766 | sulforafan | NFE2L2 protein affects the reaction [sulforafan results in increased expression of CES1 mRNA alternative form] | 19715681 |
C016766 | sulforafan | NFE2L2 protein affects the reaction [sulforafan results in increased expression of HMOX1] | 22019695 |
C016766 | sulforafan | NFE2L2 protein affects the reaction [sulforafan results in increased expression of HMOX1 protein] | 28790194 |
C016766 | sulforafan | NFE2L2 protein mutant form results in increased susceptibility to sulforafan | 23589329 |
C016766 | sulforafan | NFE2L2 protein results in increased susceptibility to sulforafan | 20600217 |
C016766 | sulforafan | Reactive Oxygen Species affects the reaction [sulforafan promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein]] | 22019695 |
C016766 | sulforafan | sulforafan affects the localization of and results in increased activity of NFE2L2 protein | 28733231 |
C016766 | sulforafan | sulforafan affects the localization of and results in increased expression of NFE2L2 protein | 22807314 |
C016766 | sulforafan | sulforafan affects the localization of NFE2L2 mRNA | 20599494 |
C016766 | sulforafan | sulforafan affects the localization of NFE2L2 protein | 20600217|2086822 |
C016766 | sulforafan | sulforafan binds to and results in increased activity of NFE2L2 protein | 20806931 |
C016766 | sulforafan | "sulforafan promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA]" | 23583297 |
C016766 | sulforafan | "sulforafan promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 protein]" | 23583297 |
C016766 | sulforafan | sulforafan promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | 18417180 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to CES1 promoter] | 19715681 |
C016766 | sulforafan | sulforafan promotes the reaction [[NFE2L2 protein binds to CES1 promoter] which results in increased expression of CES1 mRNA alternative form] | 19715681 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to EPHX1 enhancer] | 24704207 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 22558124 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein] | 22019695 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein results in increased expression of SREBF1 mRNA] | 28796629 |
C016766 | sulforafan | sulforafan promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein] | 18385089 |
C016766 | sulforafan | sulforafan results in increased activity of NFE2L2 protein | 19715681|2260628 |
C016766 | sulforafan | [sulforafan results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Cisplatin | 25159039 |
C016766 | sulforafan | [sulforafan results in increased activity of NFE2L2 protein] which results in increased expression of CYP2A6 mRNA | 20887713 |
C016766 | sulforafan | sulforafan results in increased expression of and affects the localization of NFE2L2 protein | 24161444|2915535 |
C016766 | sulforafan | sulforafan results in increased expression of and results in decreased degradation of NFE2L2 protein | 22558124 |
C016766 | sulforafan | sulforafan results in increased expression of and results in increased activity of NFE2L2 protein | 22192953|2358932 |
C016766 | sulforafan | [sulforafan results in increased expression of and results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Benzo(a)pyrene | 22192953 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 mRNA | 19558496|2511166 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 protein | 22019695|2358329 |
C016766 | sulforafan | sulforafan results in increased localization of NFE2L2 protein | 21723306 |
C016766 | sulforafan | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Acrolein] | 19303893 |
C016766 | sulforafan | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Chlorambucil] | 19303893 |
C016766 | sulforafan | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Acrolein]] | 20932822 |
C016766 | sulforafan | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Chlorambucil]] | 20932822 |
C016766 | sulforafan | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to cumene hydroperoxide]] | 20932822 |
C016766 | sulforafan | NFE2L2 affects the susceptibility to sulforafan | 19303893 |
C016766 | sulforafan | "[NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to 1,2-naphthoquinone" | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Acrolein | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to benzyl isothiocyanate | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Cadmium Chloride | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Carmustine | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Chlorambucil | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Cisplatin | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to cumene hydroperoxide | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Diamide | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Dinitrochlorobenzene | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Doxorubicin | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Ethacrynic Acid | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Hydrogen Peroxide | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Mercuric Chloride | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to sodium arsenite | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Vitamin K 3 | 19303893 |
C016766 | sulforafan | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to zinc chloride | 19303893 |
C016766 | sulforafan | NFE2L2 gene mutant form inhibits the reaction [sulforafan results in increased expression of ABCC1 mRNA] | 26454883 |
C016766 | sulforafan | NFE2L2 gene mutant form inhibits the reaction [sulforafan results in increased expression of and results in increased activity of ABCC1 protein] | 26454883 |
C016766 | sulforafan | NFE2L2 gene mutant form results in decreased susceptibility to sulforafan | 26454883 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of HMOX1 protein] | 20600217 |
C016766 | sulforafan | NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of NQO1 protein] | 20600217 |
C016766 | sulforafan | "NFE2L2 protein affects the reaction [sulforafan affects the reaction [1,2-Dimethylhydrazine affects the expression of HDAC3 protein]]" | 26388957 |
C016766 | sulforafan | "[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which affects the susceptibility to sulforafan" | 26388957 |
C016766 | sulforafan | "NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to 1,2-naphthoquinone]" | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to 4-nitrobenzaldehyde] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Acrolein] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to allyl isothiocyanate] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to benzyl isothiocyanate] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Cadmium Chloride] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Chlorambucil] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to chromous chloride] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to cumene hydroperoxide] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Ethacrynic Acid] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to sodium arsenite] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Vitamin K 3] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GCLC mRNA] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GCLM mRNA] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GSTA1 mRNA] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GSTM1 mRNA] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GSTP1 mRNA] | 20932822 |
C016766 | sulforafan | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of NQO1 mRNA] | 20932822 |
C016766 | sulforafan | NFE2L2 protein results in decreased susceptibility to sulforafan | 20932822 |
C016766 | sulforafan | NFE2L2 protein results in increased susceptibility to sulforafan | 20600217 |
C016766 | sulforafan | NFE2L2 results in increased susceptibility to sulforafan | 21382770 |
C016766 | sulforafan | [Streptozocin co-treated with sulforafan] results in increased expression of NFE2L2 | 22023613 |
C016766 | sulforafan | sulforafan affects the activity of NFE2L2 protein | 11309284 |
C016766 | sulforafan | sulforafan affects the localization of NFE2L2 protein | 20600217 |
C016766 | sulforafan | sulforafan affects the reaction [NFE2L2 affects the abundance of Glutathione] | 19303893 |
C016766 | sulforafan | [sulforafan co-treated with Dibutyl Phthalate] results in increased expression of NFE2L2 protein | 28295950 |
C016766 | sulforafan | "sulforafan inhibits the reaction [[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of CDKN2A mRNA]" | 26388957 |
C016766 | sulforafan | sulforafan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA] | 24707343 |
C016766 | sulforafan | sulforafan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | 24707343 |
C016766 | sulforafan | sulforafan inhibits the reaction [Streptozocin results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein] | 24967692 |
C016766 | sulforafan | sulforafan inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] | 24967692 |
C016766 | sulforafan | sulforafan results in increased activity of NFE2L2 protein | 26454883 |
C016766 | sulforafan | sulforafan results in increased expression of and results in increased phosphorylation of NFE2L2 protein | 24967692 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 | 22023613 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 mRNA | 21177068|2168430 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 protein | 22558124|2389952 |
C016766 | sulforafan | sulforafan results in increased localization of NFE2L2 protein | 21684301 |
C016766 | sulforafan | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforafan results in increased expression of NFE2L2 protein]] | 22606287 |
C016766 | sulforafan | Hydrocortisone inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | Hydrocortisone inhibits the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | Hydrogen Peroxide promotes the reaction [sulforafan results in increased activity of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | Hydrogen Peroxide promotes the reaction [sulforafan results in increased expression of NFE2L2 protein] | 22606287 |
C016766 | sulforafan | sulforafan affects the localization of NFE2L2 protein | 19071154|2060021 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer] | 20237067 |
C016766 | sulforafan | [sulforafan promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA | 20237067 |
C016766 | sulforafan | sulforafan promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | 22558124 |
C016766 | sulforafan | sulforafan results in decreased phosphorylation of NFE2L2 protein | 22558124 |
C016766 | sulforafan | sulforafan results in increased activity of NFE2L2 protein | 20237067|2260628 |
C016766 | sulforafan | sulforafan results in increased expression of and results in decreased degradation of NFE2L2 protein | 22558124 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 protein | 20237067|2260628 |
C016766 | sulforafan | NFE2L2 protein affects the reaction [sulforafan results in increased expression of HMOX1 protein] | 28710020 |
C016766 | sulforafan | NFE2L2 protein affects the reaction [sulforafan results in increased expression of NQO1 protein] | 28710020 |
C016766 | sulforafan | ochratoxin A inhibits the reaction [sulforafan affects the localization of NFE2L2 protein] | 18547363 |
C016766 | sulforafan | ochratoxin A inhibits the reaction [sulforafan results in increased activity of NFE2L2 protein] | 18547363 |
C016766 | sulforafan | ochratoxin A inhibits the reaction [sulforafan results in increased expression of NFE2L2 mRNA] | 28710020 |
C016766 | sulforafan | sulforafan affects the localization of NFE2L2 protein | 18547363|1991360 |
C016766 | sulforafan | sulforafan results in increased activity of NFE2L2 protein | 18547363 |
C016766 | sulforafan | sulforafan results in increased expression of and results in increased activity of NFE2L2 protein | 21130106 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 mRNA | 28710020 |
C016766 | sulforafan | sulforafan inhibits the reaction [KEAP1 protein results in increased ubiquitination of NFE2L2 protein] | 18417180 |
C016766 | sulforafan | sulforafan promotes the reaction [[[NFE2L2 protein binds to MAF protein] which binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA] | 15832810 |
C016766 | sulforafan | sulforafan results in increased activity of and results in decreased ubiquitination of NFE2L2 protein | 22558124 |
C016766 | sulforafan | sulforafan results in increased activity of NFE2L2 protein | 20887713 |
C016766 | sulforafan | sulforafan results in increased expression of NFE2L2 mRNA | 25818464 |
C473643 | sulphoraphene | sulphoraphene affects the localization of NFE2L2 protein | 29247643 |
C009365 | surfactin peptide | NFE2L2 protein affects the susceptibility to [surfactin peptide results in increased expression of HMOX1 protein] | 20833156 |
C009365 | surfactin peptide | surfactin peptide affects the localization of and results in increased expression of NFE2L2 protein | 20833156 |
D013605 | T-2 Toxin | T-2 Toxin results in decreased expression of NFE2L2 mRNA | 20854872 |
D016559 | Tacrolimus | Tacrolimus results in increased expression of NFE2L2 protein | 23958496 |
C061133 | tamibarotene | tamibarotene results in decreased expression of NFE2L2 mRNA | 15498508 |
C059006 | tangeretin | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA]" | 24995432 |
C059006 | tangeretin | "tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]" | 24995432 |
C059006 | tangeretin | tangeretin inhibits the reaction [Cisplatin results in increased expression of NFE2L2 protein] | 27616468 |
C030141 | taurine-ursodeoxycholate conjugate | taurine-ursodeoxycholate conjugate results in increased activity of and results in increased localization of NFE2L2 protein | 18687751 |
D013656 | Taurocholic Acid | Taurocholic Acid results in increased expression of NFE2L2 mRNA | 27160211 |
C003377 | taxifolin | taxifolin results in increased expression of NFE2L2 protein | 16799064 |
D013662 | Tea | Tea results in increased activity of NFE2L2 protein | 24815822 |
C001803 | tempol | tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 25204689 |
C001803 | tempol | tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
C041359 | terbinafine | NFE2L2 protein affects the susceptibility to terbinafine | 21540358 |
C000591600 | tetrachlorobenzoquinone | NFE2L2 protein promotes the reaction [tetrachlorobenzoquinone results in increased expression of SQSTM1 protein] | 27393035 |
C000591600 | tetrachlorobenzoquinone | SQSTM1 protein promotes the reaction [tetrachlorobenzoquinone results in increased expression of NFE2L2 protein] | 27393035 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in decreased ubiquitination of and results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | 27393035 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in decreased ubiquitination of NFE2L2 protein | 25742418 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | 25742418 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in increased expression of NFE2L2 mRNA | 25742418 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | 16443690 |
D013749 | Tetrachlorodibenzodioxin | ammonium metavanadate affects the reaction [Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA] | 20599494 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 mRNA affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | 21843634 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | 24161444 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA | 20599494 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | 20106945|2290382 |
D013749 | Tetrachlorodibenzodioxin | AHR affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] | 21995607 |
D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] | 16214954 |
D013749 | Tetrachlorodibenzodioxin | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] | 19474220|1975909 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MYC mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PPARGC1A mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SCD1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SREBF1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP8B1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CASP3 protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CASP8 protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1A mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of COL1A1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of H2AFX protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of HMOX1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ICAM1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TNF mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ABCG8 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CAT mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CFD mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CYP27A1 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPARG mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACTA2 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CEBPB mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FAN1 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GADD45B mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ODC1 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PRDX1 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PTGS2 mRNA | 21846477 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTA1 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM2 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM6 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTP2 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTT2 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of MGST1 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 protein] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGDH mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A5 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A6 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A9 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT2B34 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT2B35 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT2B36 mRNA] | 19474220 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA | 24058054|2637764 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the localization of and results in increased activity of NFE2L2 protein | 19474220 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of NFE2L2 mRNA | 25975270 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form affects the localization of RELA protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased activity of XDH protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of DGAT2 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of EPHX1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of GCLC mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of JUN mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of NQO1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of TXNRD1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of UGT2B35 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in increased activity of CAT protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in increased expression of ACLY mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in increased expression of PPARGC1A mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NFE2L2 promoter] | 21889950 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in decreased expression of ABCG5 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in decreased expression of APOB mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in decreased expression of CYP7B1 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of FGF21 mRNA] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of H2AFX protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of MKI67 protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of TOP2A protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 exon mutant form | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | 15034205|1566782 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | 16267337 |
D013749 | Tetrachlorodibenzodioxin | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] | 23196670 |
D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] | 19497421 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | 16054898|1846511 |
D013755 | Tetradecanoylphorbol Acetate | Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate promotes the reaction [NFE2L2 protein binds to EP300 protein]] | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | Arsenicals promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of and affects the localization of NFE2L2 protein] | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA] | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NFE2L2 protein | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [NFE2L2 protein binds to EP300 protein] | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of NFE2L2 protein | 20438634 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of and affects the localization of NFE2L2 protein | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA | 24632381 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NFE2L2 mRNA | 25613284 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of ACTA2 mRNA] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of ACTA2 protein] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of COL1A1 mRNA] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of COL1A1 protein] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of CTNNB1 mRNA] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of CTNNB1 protein] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of FN1 mRNA] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of FN1 protein] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein results in increased susceptibility to tetramethylpyrazine | 27477297 |
C017953 | tetramethylpyrazine | tetramethylpyrazine analog results in increased expression of NFE2L2 protein | 25056784 |
C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 26404762 |
C017953 | tetramethylpyrazine | tetramethylpyrazine results in increased expression of NFE2L2 mRNA | 27477297 |
C017953 | tetramethylpyrazine | tetramethylpyrazine results in increased expression of NFE2L2 protein | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in decreased expression of PPARA protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of ACTA2 protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of COL1A1 protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of FN1 protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of HIF1A mRNA]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of HIF1A protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of RELA protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of SREBF1 protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in increased expression of TNF protein]] | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 affects the susceptibility to tetramethylpyrazine | 27837167 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFKBIA protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL3A1 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of EGFR mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of EGFR protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of FN1 mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of FN1 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of IFNG protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of NLRP3 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFBR1 mRNA]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFBR1 protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]] | 27477297 |
C017953 | tetramethylpyrazine | NFE2L2 protein results in increased susceptibility to tetramethylpyrazine | 27477297 |
C020809 | tetrathiomolybdate | tetrathiomolybdate analog affects the localization of and results in increased activity of NFE2L2 protein | 19323979 |
D013792 | Thalidomide | Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 25579023 |
D013792 | Thalidomide | Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] | 25579023 |
D019284 | Thapsigargin | Thapsigargin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | 20805060 |
D013853 | Thioacetamide | Thioacetamide inhibits the reaction [SOD1 gene mutant form results in decreased expression of NFE2L2 protein] | 27349771 |
D013853 | Thioacetamide | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NFE2L2 mRNA | 23830814 |
D013853 | Thioacetamide | Thioacetamide results in increased expression of NFE2L2 mRNA | 23411599 |
D017392 | Thiobarbituric Acid Reactive Substances | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Thiobarbituric Acid Reactive Substances | 23764462 |
D008063 | Thioctic Acid | [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein | 23649336 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Acrolein results in decreased expression of NFE2L2 protein] | 17197552|1825820 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein] | 24361488 |
D008063 | Thioctic Acid | Thioctic Acid promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 23649336 |
D008063 | Thioctic Acid | Thioctic Acid results in increased expression of and affects the localization of NFE2L2 protein | 23649336 |
D008063 | Thioctic Acid | Thioctic Acid results in increased expression of NFE2L2 mRNA | 23649336 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 mRNA] | 22488045 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | 22488045 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Dietary Fats results in increased expression of NFE2L2 mRNA] | 27260466 |
D008063 | Thioctic Acid | Thioctic Acid results in decreased expression of NFE2L2 mRNA | 22488045 |
D008063 | Thioctic Acid | Thioctic Acid results in decreased expression of NFE2L2 protein | 22488045 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 mRNA] | 27298056 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein] | 27298056 |
D008063 | Thioctic Acid | Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer] | 20237067 |
D008063 | Thioctic Acid | [Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA | 20237067 |
D008063 | Thioctic Acid | Thioctic Acid results in increased activity of NFE2L2 protein | 20237067 |
D008063 | Thioctic Acid | Thioctic Acid results in increased expression of NFE2L2 protein | 20237067 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
C003466 | thymoquinone | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] | 24355171 |
C003466 | thymoquinone | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein]" | 24355171 |
C003466 | thymoquinone | Acetylcysteine inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] | 24355171 |
C003466 | thymoquinone | thymoquinone affects the localization of and results in increased activity of NFE2L2 protein | 24355171 |
C003466 | thymoquinone | [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 protein | 24355171 |
C003466 | thymoquinone | thymoquinone inhibits the reaction [Doxorubicin results in decreased activity of NFE2L2 protein] | 25268985 |
C003466 | thymoquinone | thymoquinone inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA] | 25268985 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX results in decreased expression of NFE2L2 protein | 20807546 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [astaxanthine promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein]] | 23272707 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [Hemin results in decreased expression of NFE2L2 protein] | 25824035 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [Hemin results in increased expression of NFE2L2 protein] | 25824035 |
C009495 | titanium dioxide | Grape Seed Proanthocyanidins inhibits the reaction [titanium dioxide results in decreased expression of NFE2L2 protein] | 28780322 |
C009495 | titanium dioxide | titanium dioxide results in decreased expression of NFE2L2 protein | 28780322 |
D014028 | Tobacco Smoke Pollution | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NFE2L2 protein] | 25568320 |
D014028 | Tobacco Smoke Pollution | DDIT3 mutant form inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of NFE2L2 protein] | 25568320 |
D014028 | Tobacco Smoke Pollution | Ketanserin inhibits the reaction [Tobacco Smoke Pollution affects the localization of NFE2L2 protein] | 22048642 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution results in increased secretion of CXCL8 protein] | 22048642 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution analog results in increased cleavage of CASP3 protein] | 25568320 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of DDIT3 protein] | 25568320 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein results in decreased susceptibility to Tobacco Smoke Pollution analog | 25568320 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the localization of NFE2L2 protein | 22048642 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution analog results in increased expression of NFE2L2 protein | 24733848|2556832 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of NFE2L2 mRNA | 27404394 |
D014028 | Tobacco Smoke Pollution | Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of NFE2L2 protein] | 26139382 |
D014028 | Tobacco Smoke Pollution | Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of NFE2L2 mRNA] | 26139382 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of ACP5 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of ADAM8 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of AGR2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of ALDH3A1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of ARNTL mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of AURKA mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CCL2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CCL3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CCL5 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CCL6 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CCNB2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CD68 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CD86 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CTSK mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CTSS mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CXCL10 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CXCL1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CXCL5 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CXCL9 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CYP1A1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of ELF3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of GPX2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of GSR mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of IL4RA mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of LAMA1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of MMP12 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of MMP8 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of NUSAP1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of SCGB3A1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of SLPI mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of SOCS3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of TIMP1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of TPX2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of AHRR mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of AQP4 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of ATP11A mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of CD177 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of CDKN1A mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of CLCA2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of CYP1B1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of DMBT1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of HIPK3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of IL1R2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of MT1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of MT2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of PGF mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of RAB27A mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of RAMP3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of SERPINA3M mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of SIRPB1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of SLC13A2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of STK25 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of TSPAN11 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution affects the expression of UTS2R mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal] | 24633890 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of Malondialdehyde] | 24633890 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of ADCYAP1R1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of ADH7 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of AKR1B8 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of AKR1C19 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of ASF1B mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of AURKB mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of BIRC5 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CCL20 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CCNA2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CDCA3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CDCA5 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CDCA8 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CEP55 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CES1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of CTSE mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of GCLM mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of GSTA2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of HIST1H2AO mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of IGK mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of IKBKG mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of JCHAIN mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of KIF2C mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of KRT85 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of LILRB4 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of MCOLN3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of MKI67 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of MS4A6D mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of MSR1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of MYO5A mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of NCAPG2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of NQO1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of ORM2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of RACGAP1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of SAA3 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of SLC7A11 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of SRXN1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of TXNRD1 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein results in decreased susceptibility to Tobacco Smoke Pollution | 20133372 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of NFE2L2 mRNA | 20133372 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of and results in increased activity of NFE2L2 protein | 26139382 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of NFE2L2 mRNA | 15289447|1613772 |
C066340 | tolcapone | tolcapone results in decreased expression of NFE2L2 mRNA | 28526448 |
C483909 | torcetrapib | torcetrapib results in increased expression of NFE2L2 mRNA | 23228038 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | NFE2L2 protein affects the susceptibility to Tosylphenylalanyl Chloromethyl Ketone | 22851183 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [arsenic trioxide affects the localization of NFE2L2 protein] | 25003661 |
D014212 | Tretinoin | Tretinoin results in decreased expression of NFE2L2 mRNA | 15498508 |
D014212 | Tretinoin | Tretinoin results in increased expression of NFE2L2 mRNA | 23724009 |
D014212 | Tretinoin | Tretinoin results in increased expression of NFE2L2 mRNA | 20488242 |
C011559 | tributyltin | PRKCD gene mutant form promotes the reaction [tributyltin affects the localization of and results in increased activity of NFE2L2 protein] | 25895139 |
C011559 | tributyltin | Acetylcysteine inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein] | 26079211 |
C011559 | tributyltin | Phycocyanin inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein] | 26079211 |
C011559 | tributyltin | tributyltin results in increased expression of NFE2L2 protein | 24055800|2607921 |
C476530 | tricarbonylchloro(glycinato)ruthenium(II) | NFE2L2 mutant form inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of COX4I1 protein] | 24041027 |
C476530 | tricarbonylchloro(glycinato)ruthenium(II) | NFE2L2 mutant form inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of NDUFB8 protein] | 24041027 |
C476530 | tricarbonylchloro(glycinato)ruthenium(II) | NFE2L2 mutant form inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of NRF1 mRNA] | 24041027 |
C476530 | tricarbonylchloro(glycinato)ruthenium(II) | NFE2L2 mutant form inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of PPARGC1A mRNA] | 24041027 |
C476530 | tricarbonylchloro(glycinato)ruthenium(II) | NFE2L2 mutant form inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of UQCRC1 protein] | 24041027 |
C476530 | tricarbonylchloro(glycinato)ruthenium(II) | tricarbonylchloro(glycinato)ruthenium(II) affects the localization of NFE2L2 protein | 24041027 |
C447082 | tricarbonyldichlororuthenium (II) dimer | tricarbonyldichlororuthenium (II) dimer results in increased expression of NFE2L2 protein | 20807546 |
D014236 | Trichlorfon | Trichlorfon results in increased activity of NFE2L2 protein | 20143881 |
C012589 | trichostatin A | trichostatin A results in increased expression of NFE2L2 mRNA | 15901671 |
C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA" | 27188386 |
C012589 | trichostatin A | trichostatin A affects the expression of NFE2L2 mRNA | 28542535 |
C012589 | trichostatin A | trichostatin A results in increased expression of NFE2L2 mRNA | 24935251|2627250 |
C012589 | trichostatin A | [decitabine co-treated with trichostatin A] results in decreased methylation of NFE2L2 promoter | 26991801 |
C012589 | trichostatin A | [manganese chloride results in increased susceptibility to trichostatin A] which results in increased expression of NFE2L2 mRNA | 29054681 |
C012589 | trichostatin A | trichostatin A promotes the reaction [manganese chloride results in increased expression of and results in increased activity of NFE2L2 protein] | 29054681 |
C012589 | trichostatin A | [trichostatin A results in increased susceptibility to manganese chloride] which results in increased expression of NFE2L2 mRNA | 29054681 |
D014280 | Triglycerides | NFE2L2 protein affects the reaction [Ethanol results in increased abundance of Triglycerides] | 22627062 |
D014280 | Triglycerides | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of Triglycerides | 20086057 |
C009560 | trigonelline | trigonelline inhibits the reaction [Pyocyanine results in increased expression of and affects the localization of NFE2L2 protein] | 24015256 |
C015559 | trimellitic anhydride | NFE2L2 affects the susceptibility to trimellitic anhydride | 23564646 |
C052920 | trimethylarsine oxide | NFE2L2 mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of NQO1 protein] | 24161444 |
C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of and affects the localization of NFE2L2 protein | 24161444 |
C046488 | trimethyltin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]] | 25895139 |
C046488 | trimethyltin | rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein] | 25895139 |
C046488 | trimethyltin | trimethyltin affects the localization of and results in increased activity of NFE2L2 protein | 25895139 |
C050414 | tripterine | tripterine inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | 26768587 |
C050414 | tripterine | tripterine results in increased expression of NFE2L2 protein | 26768587 |
C001899 | triptolide | triptolide results in decreased expression of NFE2L2 protein | 25169008 |
C001899 | triptolide | Acetylcysteine inhibits the reaction [triptolide affects the expression of NFE2L2 protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in decreased abundance of Glutathione] | 22820427 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in decreased expression of BCL2 protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in decreased expression of GCLC protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in decreased expression of HMOX1 protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in decreased expression of NQO1 protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in increased abundance of Reactive Oxygen Species] | 22820427 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in increased cleavage of CASP3 protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in increased expression of APAF1 protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein inhibits the reaction [triptolide results in increased expression of BAX protein] | 25169008 |
C001899 | triptolide | NFE2L2 protein results in decreased susceptibility to triptolide | 22820427 |
C001899 | triptolide | triptolide affects the expression of NFE2L2 mRNA | 25169008 |
C001899 | triptolide | triptolide affects the expression of NFE2L2 protein | 25169008 |
C001899 | triptolide | triptolide affects the localization of NFE2L2 protein | 22820427 |
D014315 | Triterpenes | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triterpenes analog affects the localization of NFE2L2 protein] | 25239868 |
D014315 | Triterpenes | NFE2L2 mutant form inhibits the reaction [Triterpenes analog results in increased expression of HMOX1 protein] | 25239868 |
D014315 | Triterpenes | Triterpenes analog affects the localization of NFE2L2 protein | 25239868 |
C057693 | troglitazone | NFE2L2 protein affects the susceptibility to troglitazone | 21540358 |
C057693 | troglitazone | NFE2L2 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide] | 22684020 |
C057693 | troglitazone | troglitazone results in decreased expression of NFE2L2 mRNA | 25596134 |
C553587 | tubastatin A | tubastatin A inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | 22367689 |
C002802 | tungsten carbide | CAT protein inhibits the reaction [[[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA] | 20528745 |
C002802 | tungsten carbide | [tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein | 20528745 |
C002802 | tungsten carbide | [[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA | 20528745 |
D014415 | Tunicamycin | Tunicamycin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | 20805060 |
D014415 | Tunicamycin | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA] | 22959925 |
D014415 | Tunicamycin | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GSR mRNA] | 22959925 |
D014415 | Tunicamycin | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of NQO1 mRNA] | 22959925 |
D014415 | Tunicamycin | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB5 mRNA] | 22959925 |
D014415 | Tunicamycin | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB6 mRNA] | 22959925 |
D014415 | Tunicamycin | NFE2L2 mRNA affects the susceptibility to Tunicamycin | 22959925 |
D014415 | Tunicamycin | Tunicamycin results in increased expression of NFE2L2 mRNA | 22959925 |
C101044 | tyrphostin AG 1478 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with tyrphostin AG 1478] inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | 24015256 |
C113580 | U 0126 | U 0126 affects the localization of NFE2L2 protein | 23994249 |
C113580 | U 0126 | U 0126 inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] | 29136249 |
C113580 | U 0126 | "U 0126 inhibits the reaction [Drugs, Chinese Herbal results in increased expression of and affects the localization of NFE2L2 protein]" | 28733231 |
C113580 | U 0126 | U 0126 inhibits the reaction [Ethanol affects the localization of NFE2L2 protein] | 22530035 |
C113580 | U 0126 | U 0126 inhibits the reaction [Plant Extracts results in increased activity of NFE2L2 protein] | 24646717 |
C113580 | U 0126 | U 0126 inhibits the reaction [[Plant Extracts results in increased activity of NFE2L2 protein] which results in increased expression of NQO1 mRNA] | 24646717 |
C113580 | U 0126 | U 0126 results in decreased expression of NFE2L2 protein | 12446695|2399424 |
C113580 | U 0126 | U 0126 inhibits the reaction [Bleomycin affects the localization of NFE2L2 protein] | 23570914 |
C113580 | U 0126 | U 0126 inhibits the reaction [Bleomycin results in increased phosphorylation of NFE2L2 protein] | 23570914 |
C113580 | U 0126 | U 0126 inhibits the reaction [farrerol affects the localization of NFE2L2 protein] | 26111761 |
C113580 | U 0126 | U 0126 inhibits the reaction [Quercetin results in increased expression of NFE2L2 protein] | 26505893 |
C113580 | U 0126 | U 0126 inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | 28087833 |
C113580 | U 0126 | U 0126 inhibits the reaction [Plant Extracts promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | 20399244 |
C113580 | U 0126 | U 0126 results in decreased expression of NFE2L2 protein | 28087833 |
D014494 | Unithiol | Unithiol promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] | 20095329 |
C005460 | uranyl acetate | sodium bisulfide inhibits the reaction [uranyl acetate affects the localization of NFE2L2 protein] | 26523793 |
C005460 | uranyl acetate | uranyl acetate affects the localization of NFE2L2 protein | 26523793 |
D014502 | Uranyl Nitrate | Uranyl Nitrate affects the expression of NFE2L2 mRNA | 26362510 |
D014580 | Ursodeoxycholic Acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased localization of NFE2L2 protein] | 19073151 |
D014580 | Ursodeoxycholic Acid | S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]] | 20146260 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein] | 20146260 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased localization of NFE2L2 protein | 19073151 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC2 mRNA] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC2 protein] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC3 mRNA] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC3 protein] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC4 mRNA] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC4 protein] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of GCLC mRNA] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of NR1I2 mRNA] | 18687751 |
D014580 | Ursodeoxycholic Acid | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of NR5A2 mRNA] | 18687751 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased expression of NFE2L2 mRNA | 25582706 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased localization of NFE2L2 protein | 18687751|1907315 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid promotes the reaction [NFE2L2 protein binds to ABCC3 promoter] | 18687751 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid promotes the reaction [NFE2L2 protein binds to ABCC4 promoter] | 18687751 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid promotes the reaction [NFE2L2 protein binds to NQO1 promoter] | 18687751 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased activity of and results in increased localization of NFE2L2 protein | 18687751 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased localization of NFE2L2 protein | 19073151 |
C073339 | usnic acid | NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AFX protein modified form] | 27369375 |
C073339 | usnic acid | NFE2L2 protein promotes the reaction [usnic acid results in increased expression of GCLC protein] | 27369375 |
C073339 | usnic acid | usnic acid results in increased expression of and affects the localization of NFE2L2 protein | 27369375 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of NFE2L2 mRNA | 15901671 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of NFE2L2 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of NFE2L2 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of NFE2L2 mRNA | 24935251|2627250 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of NFE2L2 mRNA | 24935251|2800136 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of NFE2L2 gene | 29154799 |
D014635 | Valproic Acid | NFE2L2 protein affects the susceptibility to Valproic Acid | 25454122 |
D001335 | Vehicle Emissions | EM703 inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein] | 23291319 |
D001335 | Vehicle Emissions | Erythromycin inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein] | 23291319 |
D001335 | Vehicle Emissions | NFE2L2 protein affects the reaction [Vehicle Emissions analog inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]] | 16890772 |
D001335 | Vehicle Emissions | NFE2L2 protein affects the reaction [Vehicle Emissions analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | 16890772 |
D001335 | Vehicle Emissions | Vehicle Emissions affects the localization of NFE2L2 protein | 12730081|2250788 |
D001335 | Vehicle Emissions | Vehicle Emissions analog affects the localization of NFE2L2 protein | 12730081 |
D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of NFE2L2 protein | 15322212 |
D001335 | Vehicle Emissions | Vehicle Emissions inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] | 28400208 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased activity of NFE2L2 protein | 23291319 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of NFE2L2 protein | 28400208 |
D001335 | Vehicle Emissions | Acetylcysteine inhibits the reaction [Vehicle Emissions analog affects the localization of NFE2L2 protein] | 15322212 |
D001335 | Vehicle Emissions | [APOE protein affects the susceptibility to Dietary Fats] promotes the reaction [Vehicle Emissions results in increased expression of NFE2L2 mRNA] | 24330719 |
D001335 | Vehicle Emissions | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cycloheximide inhibits the reaction [Vehicle Emissions analog results in increased expression of NFE2L2 protein]] | 15322212 |
D001335 | Vehicle Emissions | Cycloheximide inhibits the reaction [Vehicle Emissions analog results in increased expression of NFE2L2 protein] | 15322212 |
D001335 | Vehicle Emissions | NFE2L2 affects the susceptibility to Vehicle Emissions | 20404090 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form affects the susceptibility to Vehicle Emissions | 18614404 |
D001335 | Vehicle Emissions | [NFE2L2 gene mutant form affects the susceptibility to Vehicle Emissions] which results in increased expression of CCL17 protein | 18614404 |
D001335 | Vehicle Emissions | [NFE2L2 gene mutant form affects the susceptibility to Vehicle Emissions] which results in increased expression of IL13 protein | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions analog results in increased expression of HMOX1 mRNA] | 15322212 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of G6PDX mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GCLC mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GCLM mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GSR mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GSTA3 mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GSTM1 mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of GSTP2 mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of HMOX1 mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 gene mutant form inhibits the reaction [Vehicle Emissions results in increased expression of SOD2 mRNA] | 18614404 |
D001335 | Vehicle Emissions | NFE2L2 protein results in decreased susceptibility to Vehicle Emissions | 11437637 |
D001335 | Vehicle Emissions | Vehicle Emissions affects the expression of NFE2L2 mRNA | 22906174 |
D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of and affects the localization of NFE2L2 protein | 15322212 |
D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of NFE2L2 protein | 15322212 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of NFE2L2 mRNA | 24330719 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of NFE2L2 gene | 25560391 |
D014700 | Verapamil | Verapamil affects the localization of NFE2L2 protein | 21525764 |
C025643 | vinclozolin | vinclozolin affects the expression of NFE2L2 mRNA | 19015723 |
D009536 | Niacinamide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] | 21439372 |
D009536 | Niacinamide | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | 21439372 |
D009536 | Niacinamide | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] | 21439372 |
D009536 | Niacinamide | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | 21439372 |
D009536 | Niacinamide | [Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA | 21439372 |
D009536 | Niacinamide | [Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein | 21439372 |
D014810 | Vitamin E | [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA | 19244175 |
D014810 | Vitamin E | Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein] | 24361488 |
D014810 | Vitamin E | Vitamin E results in decreased expression of NFE2L2 mRNA | 19244175 |
D024483 | Vitamin K 3 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 | 19608619 |
D024483 | Vitamin K 3 | Vitamin K 3 affects the expression of NFE2L2 mRNA | 20044591 |
D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of NFE2L2 mRNA | 23410634 |
D024483 | Vitamin K 3 | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to Vitamin K 3 | 19303893 |
D024483 | Vitamin K 3 | NFE2L2 protein promotes the reaction [sulforafan results in decreased susceptibility to Vitamin K 3] | 20932822 |
C017967 | W 7 | W 7 inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | 24512358 |
D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in decreased expression of NFE2L2 mRNA" | 25475078 |
C009684 | withaferin A | withaferin A binds to NFE2L2 protein | 22973447 |
C104536 | xanthohumol | xanthohumol affects the localization of NFE2L2 protein | 23085367 |
C104536 | xanthohumol | xanthohumol results in increased activity of NFE2L2 protein | 23085367 |
C104536 | xanthohumol | xanthohumol results in increased expression of NFE2L2 mRNA | 23085367 |
C104536 | xanthohumol | xanthohumol results in increased expression of NFE2L2 protein | 23085367 |
D015032 | Zinc | Zinc deficiency affects the localization of NFE2L2 protein | 23377617 |
D015032 | Zinc | Zinc results in increased activity of NFE2L2 promoter | 21643505 |
D015032 | Zinc | NFE2L2 protein affects the reaction [Zinc results in increased expression of HMOX1 mRNA] | 10473555 |
D015032 | Zinc | Zinc deficiency promotes the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] | 27370414 |
D015032 | Zinc | Zinc deficiency results in decreased expression of NFE2L2 protein | 21078376 |
D015032 | Zinc | Zinc inhibits the reaction [Dietary Fats results in decreased expression of and affects the localization of NFE2L2 protein] | 27370414 |
D015032 | Zinc | Zinc deficiency affects the localization of NFE2L2 protein | 23377617 |
C016837 | zinc chloride | zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein] | 18385089 |
C016837 | zinc chloride | [NFE2L2 affects the susceptibility to sulforafan] which affects the susceptibility to zinc chloride | 19303893 |
D015034 | Zinc Oxide | Zinc Oxide analog results in decreased expression of NFE2L2 protein | 24614525 |
C017803 | zinc protoporphyrin | Acetylcysteine inhibits the reaction [zinc protoporphyrin results in increased expression of NFE2L2 protein] | 19735445 |
C017803 | zinc protoporphyrin | zinc protoporphyrin affects the expression of NFE2L2 mRNA | 23704825 |
C017803 | zinc protoporphyrin | zinc protoporphyrin affects the expression of NFE2L2 protein | 23704825 |
C017803 | zinc protoporphyrin | zinc protoporphyrin affects the localization of and results in increased expression of NFE2L2 protein | 19735445 |
C017803 | zinc protoporphyrin | zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of NFE2L2 protein] | 25824035 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of NFE2L2 mRNA | 20977926 |